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ABSTRACT
Metabolic engineering and synthetic biology enable controlled manipulation of whole-cell
biocatalysts to produce valuable chemicals from renewable feedstocks in a rapid and efficient
manner, helping reduce our reliance on the conventional petroleum-based chemical synthesis.
However, strain engineering process is costly and time-consuming that developing economically
competitive bioprocess at industrial scale is still challenging. To accelerate the strain engineering
process, modular cell engineering has been proposed as an innovative approach that harnesses
modularity of metabolism for designing microbial cell factories. It is important to understand
biological modularity and to develop design principles for effective implementation of modular
cell engineering. In this dissertation, the modularity of ester biosynthesis was engineered from the
molecular to the microbial community levels. Specifically, three important features of modularity
(i.e., robustness, efficiency, and compatibility) were engineered and quantitatively analyzed across
different scales. At the molecular (enzymatic) level, thermostability and promiscuity of alcohol
acyltransferases were engineered to develop a robust designer ester biosynthesis. At the metabolic
network (cellular) level, metabolism of Escherichia coli was rewired to overproduce isoamyl
acetate through metabolic engineering and synthetic biology strategies. Also, by harnessing the
engineered robust alcohol acyltransferase, a non-model thermophilic bacterium Clostridium
thermocellum was engineered to produce medium chain esters directly from recalcitrant
lignocellulosic biomass at elevated temperatures. Finally, at the microbial community level, a
syntrophic E. coli co-culture was engineered for isobutyl butyrate production from a mixture of
glucose and xylose. The successful engineering of the modularity of ester biosynthesis not only
sheds light into the modular design principles of biological systems, but also seeks to develop
industrially relevant ester production platforms.
v
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1. Chapter 1. Introduction
Biotechnology has led to breakthroughs in many areas including pharmaceutical, agricultural,
chemical, material, and environmental industries. Understanding living organisms is increasingly
important to tackle many contemporary problems but living organisms are highly complex and
diverse. How can we understand and effectively engineer biological systems for multiple purposes?
This chapter is a review of current biotechnology for commodity chemical production, providing
background information relevant to the work presented throughout in this dissertation.

1-1 Biotechnology for value-added chemical production
Human societies are facing unprecedent challenges such as pandemic1, climate change and global
warming2, and environmental pollution3. Many of the contemporary problems have attributed to
our reliance on petroleum4, 5. Therefore, it is one of the most urgent tasks to develop sustainable
biochemical manufacturing for reducing our reliance on fossil derived energy and materials. White
biotechnology, a branch of biotechnology, uses living cells such as yeasts, bacteria, and plants to
synthesize products that are easily degradable, require less energy, and create less waste during
their production6. White biotechnology has suggested an alternative way of synthesizing valuable
chemicals from renewable resources that can potentially replace the current petroleum-dependent
carbon emitting chemical manufacturing with carbon neutral or negative bioprocessing.
While current biotechnology enables engineering various living organisms from a simple
single-cell microbe to multicellular organisms such as plants and animals. Microbes have been
commonly deployed as hosts for biochemical production because of their relatively simple
metabolisms and fast growth (e.g., minutes to hours for doubling) that makes them tractable in the

1

laboratory. Also, many microbes are generally recognized as safe, hence engineering them does
not provoke ethical problems. Microbes live in almost everywhere: air, water, soil, food, animal
intestines, plant roots, rocks, glaciers, hot springs, and even in deep-sea hydrothermal vents7. The
wide variety of habitats reflects biochemical and metabolic diversity of microbes suggesting
unlimited potential of microbial biotechnology.
Traditional microbial biotechnology for value-added chemical production largely focused
on natural producers through classical bioprocess engineering. One of the most popular examples
is penicillin production by Penicillium notatum. After Alexander Fleming’s discovery of penicillin
in 1928, bioprocess engineering improved production yield and recovery rate and successfully
industrialized in the 1940s8. The commercialized penicillin has saved millions of human lives since
World War II, and many penicillin-derived antibiotic drugs have been clinically used until now.
The following decades increasingly utilized microorganisms to synthesize natural products of
pharmaceutical interests such as antibiotics and anti-cancer drugs9. In this period, strain
engineering was limited to mutagenesis and screening due to the lack of techniques for quantitative
analysis of cellular metabolism.
In early 1990s, bioinformatics and mathematical modeling methods allowing quantitative
analysis brought new insights into cellular metabolism, leading to the beginning of metabolic
engineering and synthetic biology that enable specific genetic manipulations altering metabolic
flux towards the product of interest10. The advent of metabolic engineering and synthetic biology
could develop novel bioprocesses by rationally engineering cellular metabolism. Particularly,
heterologous pathway engineering could expand bioproducts beyond the traditional natural
products. Currently, not only natural products, but also a large space of valuable chemicals
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including fuels, polymers, and building block molecules that have been manufactured from fossil
feedstock can be synthesized by engineered microbes using renewable resources11, 12.

1-2 Challenges of engineering biological systems
State-of-the-art systems metabolic engineering tools have improved overall bioprocess from strain
engineering to fermentation and product recovery13. However, developing a cost competitive
bioprocess to the established petroleum-based chemical processes is still challenging. A major
barrier is the costly strain development process which typically requires more than a decade and
over $50 million to meet the economic requirements for industrial scale production14. The primary
reason of the costly process is rooted from the nature of living organisms comprising of complex
regulation and interactions in metabolic networks. Cellular regulation machinery is a result of
long-time evolution ensuring metabolic homeostasis under environmental fluctuations. Therefore,
rewiring the metabolism for the overproduction of desired products requires extensive
manipulation of regulation machinery and/or insertion of heterologous pathways.
Compatibility of heterologous pathways to a host cell is critical to achieve optimal
phenotypes (e.g., efficient production of desired chemicals with stable cell viability). Engineering
heterologous pathways often witnesses undesirable metabolic imbalance such as inefficient protein
expression, metabolic burden, redox imbalances that reduce production efficiency with low titers,
yields, and productivities. The problems are unsatisfactorily predictable that iterative trial-anderror optimization so called design-build-test-learn (DBTL) cycle is required to achieve desirable
phenotypes. To accelerate the DBTL cycle, many multiplex engineering tools, high-throughput
screening techniques, and bioinformatic methodologies have been developed. Examples of the
multiplex engineering tools include multiplex automated genome engineering (MAGE)15,
3

trackable multiplex recombineering (TRMR)16, tracking combinatorial engineered libraries
(TRACE)17. Recently, clustered regularly interspaced short palindromic repeats (CRISPR)
genome editing technologies has been integrated to the multiplex genome engineering techniques,
further accelerating the strain development process18. The techniques particularly contribute to
rapid design and build of a large space of genotypes.
Testing a library of genotypic variants is the most time-consuming and laborious task that
often requires high-throughput screening methods. When the desirable phenotypes are related to
observable characteristics such as color, fluorescence, and size, the desired mutant cells can be
easily acquired using colorimetric assays, fluorescence-activated cell sorting (FACS),
spectrophotometer, and microfluidic sorting devices. However, in strain engineering, the desirable
phenotypes are not easily observable. Therefore, lack of proper high-throughput methods becomes
a critical bottleneck to acquiring the top performing mutants from a population with a large library
of genotypes. Synthetic biology strategies can address the issues by coupling the desirable
phenotype with expression of observable biological parts (e.g., reporter genes)19. Examples include
transcription regulators20,

21

, or riboswitch mediated biosensors22,

23

, expressing fluorescence

proteins in response to target molecules.
Another strategy of heterologous pathway engineering is metabolic coupling driven
selection. A core principle of the strategy is to couple cell growth with synthesis of desired
chemicals so that the phenotype can be funneled to maximize the chemical production by
employing growth as a simple selection criterion24, 25. The RNA mediated biosensors can also
couple the cell growth to a metabolite through the genetic circuits regulating expression of
antibiotics resistance genes. However, the RNA mediated growth coupling has principal barriers,
the possibility of “evolutionary escape” caused by mutations in the biosensor components (e.g.,
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transcription factor, reporter gene, promoters), such that the biosensor output does not correspond
to concentration of the target metabolites26. Cell growth coupling at metabolic pathway level
without the specialized biological parts can avoid the unfavorable mutations. Modular cell
(MODCELL) engineering is a representative selection-based strain engineering framework which
aims to design an auxotrophic chassis cell containing core metabolic pathways that are necessary
yet insufficient to support healthy cell growth without the production module27. The modular
chassis cells can be designed for growth coupling to various biochemical production pathways
through computational metabolic pathway modeling and simulations28,

29

. Theoretically, the

approach can bypass the iterative DBTL cycle because the best production module can be isolated
through simple transfers of cell cultures under a controlled condition. The modular chassis cell can
then select the most compatible heterologous pathway achieving the maximum production from
the library of production modules29. For example, the modular cell engineering could select the
best ethanol pathway enzymes by strong coupling between the production module and cell growth
under anaerobic conditions30. However, it is critical to ensure that there is a significantly efficient
and compatible module to be selected among the library pool to avoid undesirable adaptive
evolution of the chassis cell over generations. Without appropriate constraint of a production
module library, the cell could adapt to restore the cell growth without metabolic coupling to a
production module30.
Therefore, it is important to establish the design principles for engineering the modules not
only for efficient DBTL cycle, but also for practical implementation of the modular cell
engineering.
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1-3 Biological modularity and modular design in biotechnology
Modular design is a proven engineering principle which has been applied to various manufactures.
Many complex systems such as architectures, vehicles, factories, and computers are assembly of
separable and exchangeable modules. The module is defined as a separable component, frequently
one that is interchangeable with others, for assembly into units of differing size, complexity, or
function. Flexible combinations of modules enable rapid construction of a system with improved
robustness and efficiency, reducing manufacturing costs31. From the definition, modularity is a
degree of flexibility determining how much the interfaces can be separated or combined to create
a system. Therefore, the idea of modularity refers to a connected pattern where elements are
grouped into physically or dynamically connected subsets32. Modular design is an engineering
principle to subdivide a system into the modules, allowing redesign of the system by combining
the modules in various ways.
Biology has been shaped in myriad phenotypes to survive better under diverse
environments over millions of years. Although a natural organism is not designed, it comprises
separable independent components that allow for the separate evolution of each component33, 34.
In developmental biology, the modularity has become a central concept describing evolution35, 36.
The biological module may evolve with limited perturbation to each other, enabling more effective
and thorough search for fitness maxima over the evolution2. Biological modularity is observed
across all scales of biology from DNA and RNA to ecosystem37. At molecular level, interactions
between intracellular molecules (e.g., proteins, DNA, RNA) formulate a network contributing
robust cellular metabolism against environmental perturbations. The most simplified example of
the biological modularity at molecular level is an enzyme reaction, physical and chemical
interactions between a ligand and a protein. The catalytic mechanism is often shared among the
6

proteins in a protein family, reflected by their related functions and similarities in structure. The
shared features often result in substrate promiscuity of enzymes. At cellular level, many interaction
between biomolecules such as DNA38, RNA39, 40, proteins32, and metabolites41 display modularity
that is highly associated with cellular functions and pathways. Therefore, cellular metabolism is
operated by the metabolic networks highly connected between the biomolecules and their
interactions with one another. Metabolic pathways are sometimes highly conserved in many
classes of living organisms. Modularity also exists at microbial community level represented by a
network of individual organism interacting each other through consumption, symbiosis, or
competition42.
The modularity of biology brings a lot of insights to biotechnology. In biotechnology,
modular design principle can be implemented to reconstruct biological systems rapidly and
effectively by engineering and harnessing the modularity27. Many metabolic engineering and
synthetic biology strategies have utilized the modularity in strain development process. Since
metabolic pathways are linked together, deletion/down-regulation or overexpression of a single
gene can disrupt or activate a whole pathway module without exhaustive genetic engineering43, 44.
Engineering a global regulatory protein linked to multiple gene regulation allows multiplex
phenotype engineering45. A synthetic oscillator can be generated by genetic circuits linked together
by biomolecules46. A wide range of products can be synthesized by engineering modular
polyketide synthase47-49. Many more biotechnology studies have implemented the modular design
principle to understand and engineer biological systems although the principle might not be stated
in the contexts. Because a large space of commodity chemicals can be derived from modular
metabolic networks11, modular design principle is particularly helpful to search for an optimal
design of cellular metabolism for chemical production.

7

1-4 Modularity of ester biosynthesis
Natural formulation of ester is an excellent example representing the modularity across multiple
scales (Figure 1-1). At the molecular level, chemistry of ester biosynthesis consists of three key
modules: two chemical moieties, an alcohol and an acyl-CoA, that are condensed to esters by an
alcohol acetyltransferase (AAT, EC 2.3.1.84). At the cellular level, metabolic pathways form
exchangeable production modules providing alcohols and acyl-CoAs from reducing carbon
sources, and intracellularly expressed AATs are combined with these modules to produce various
esters. Finally, the ester production module is combined with other volatile metabolites to
determine floral scents, and also interacts with other environmental modules such as pollinators
and pathogens at a community level. The flexible and broad interaction creates a driving force for
molecular evolution of the AATs.
In addition to their important roles in nature, esters are an important class of industrially
important chemicals that can be used as flavors, fragrances, solvents, and drop-in fuels. Since
esters are mainly manufactured from petroleum feedstocks through chemical processes, microbial
ester biosynthesis using renewable and sustainable feedstocks (e.g., cellulosic biomass) is a
promising alternative approach. Especially, the AAT-dependent pathway is thermodynamically
favorable as compared to other chemical and biological pathways such as esterase/lipase pathway,
and therefore microbial catalysts that harbor the AAT-dependent pathway can be best used for
conversion of fermentable sugars to esters under mild aqueous conditions. For example, an
engineered Escherichia coli overexpressing ATF1 from Saccharomyces cerevisiae produced
isobutyl acetate up to 17.5 g/L from glucose50, suggesting a feasible microbial catalyst for ester
production. Also, engineered E. coli biocatalysts expressing the AATs originating from plants
could upgrade waste organic acids to esters51.
8

Figure 1-1: Ester formulation in nature and its modularity across different scales.

9

For efficient microbial ester biosynthesis, cellular metabolism should be rewired to
overproduce a precursor alcohol and acyl-CoA. Alcohols longer than ethanol can be synthesized
through the two recursive elongation pathways52-54 (Figure 1-2A). In nature, the +1 recursive
elongation pathway synthesizes 2-ketoisocaproate, the precursor of leucine, from 2ketoisovalerate by LeuABCD operon. The elongation begins with the condensation of acetyl-CoA
to 2-ketoisovalerate catalyzed by 2-isopropylmalate synthase (IPMS, LeuA). Although the wild
type IPMS in E. coli is not capable of synthesizing long chain ketoacids, engineering the IPMS
can improved substrate specificity towards ketoacids longer than 2-ketoisovalerate, activating the
+1 recursive elongation pathway54, 55. The activated elongation module can be employed for
longer chain alcohol synthesis upon decarboxylation and reduction by ketoacid decarboxylase and
alcohol dehydrogenase55. The synthetic elongation pathway can produce ketoacids up to 2ketooctanoate (C8) that can be converted into heptanol, a C7 chain length alcohol (Figure 1-2A).
Another alcohol production module is reverse -oxidation cycle which is reversal of fatty
acid oxidation metabolism. Since -oxidation cycle is governed by fad and ato regulons activated
by the presence of fatty acids56, constitutive expression of the pathway is necessary to exploit the
pathway for long-chain alcohol synthesis52. Here, specificity of alcohol dehydrogenase is critical
for a controllable alcohol production through the reverse -oxidation cycle because the cycle
iteration is not regulated for a specific carbon length52. The alcohol production pathway modules
can be exploited for ester biosynthesis upon enzymatic esterification by a compatible AAT. The
reverse -oxidation cycle necessitates synthesis of various length of acyl-CoAs, another key
precursor for ester biosynthesis (Figure 1-2B). A well-studied bioprocess employing the acyl-CoA
synthesis module is production of polyhydroxyalkanoate (PHA), which can serve as biodegradable
plastic57. In the PHA production pathway, a partial reverse -oxidation cycle synthesizes
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acetoacetyl-CoA, enoyl-CoA, and 3-hydroxyacyl-CoA those can be subsequently polymerized
into various PHAs having different physical properties of the bioplastic57. Because the +2 recursive
elongation module can produce both alcohol and acyl-CoA, a programmable ester biosynthesis
module will be critical to achieve a desirable metabolic balance. The modular alcohol and acylCoA pathways suggest that a wide variety of esters can be synthesized by harnessing the alcohol
and acyl-CoA pathway modules and a compatible ester biosynthesis module.
The current ester biosynthesis system, however, encounters several engineering challenges
such as limited application to various bacterial hosts and ester products. Particularly, most of the
eukaryotic AATs characterized to date for ester biosynthesis exhibit low modularity due to limited
host and product compatibility, and poor thermostability. For instance, a well characterized ATF1
from S. cerevisiae exhibits no activity against longer acyl-CoAs and therefore, products are
confined to acetate esters. The limited range of ester biosynthesis necessitates laborious
bioprospecting of the AATs for individual target ester production. Also, the eukaryotic AATs
exhibit low thermostability, confining the ester production in temperatures lower than 42℃,
although ester production at elevated temperatures can benefit downstream product separation and
lower the overall production costs. Thus, engineering modularity of ester biosynthesis will enable
rapid development of novel cell factories for scalable designer ester production.
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Figure 1-2: Representative alcohol and acyl-CoA biosynthesis pathways. The pathways can be
subsidized as modules due to the modularity.
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1-5 Outline of dissertation
This dissertation is my efforts to understand biological systems by engineering its modularity
across scales. The focus of this dissertation is to demonstrate rapid development of designer ester
production platforms by engineering modularity of biological systems at different scales (Figure
1-3).
There are six chapters in this dissertation. The Introduction chapter discusses engineering
modularity in biotechnology for commodity chemical production. To demonstrate the concept,
ester biosynthesis modules are created with high modularity exhibiting high compatibility,
efficiency, and robustness at different scales throughout the following chapters. Chapter 2 is
focused on engineering molecular level modularity of ester biosynthesis, and chapter 3
demonstrates engineering metabolic network level modularity for a model organism, a mesophilic
gram-negative bacterium Escherichia coli. Chapter 4 expands the concept to a non-model
organism, a thermophilic and cellulolytic gram-positive bacterium Clostridium thermocellum.
Chapter 5 demonstrates engineering of modularity at a community level by designing E. coli-E.
coli syntrophic co-culture systems. Finally, Chapter 6 discusses the significance of this dissertation.
Most of the contents are slightly modified versions of published or submitted works in
collaboration with Jong-Won Lee, Sergio Garcia, Preston Nicely, Noah Dunlap, Gillian Castro,
Heidi Schindel, Richard Giannone, Adam Guss, Priyanka Singh, and others. They have been
reproduced here with appropriate citation and/or the permission of the copyright holder.
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Figure 1-3: Engineering modularity of ester biosynthesis across the three biological scales.
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2. Chapter 2. Engineering molecular level modularity of ester
biosynthesis
This chapter focuses on engineering a robust and efficient AAT through bioprospecting and
rational design of a promiscuous and thermostable chloramphenicol O-acetyltransferase (CAT, EC
2.3.1.28). Some of the results and discussion were slightly modified from published papers58, 59.
At the molecular level, combinatorial interaction between alcohols and acyl-CoAs
facilitated by an AAT can synthesize large space of various esters. The scientific question is: what
is an “ideal” AAT to engineer modularity of ester biosynthesis across biological scales? I
hypothesized that an ideal AAT having high compatibility, robustness, and efficiency can be
generated by engineering promiscuity of the CAT.

2.1 Motivation
Enzymes are essential modules that facilitate interchangeable design of metabolic pathways to
perform desirable functions across microbial hosts. Critical to the optimal design of heterologous
pathways is the availability of robust and efficient enzymes that are compatible with various
endogenous pathways and microbial hosts to enable combinatorial biosynthesis of desirable
molecules. Engineering microbial systems to produce a diverse class of esters requires the broad
enzymatic robustness, efficiency, and compatibility.
Industrially, short to medium chain (C4-C14) volatile esters have versatile applications as
flavors60, fragrances50, solvents61, and fuels62, 63. In nature, esters are formulated by an AAT that
condenses an alcohol and an acyl-CoA in a thermodynamically favorable reaction, providing
flavors and fragrances in ripening fruits and fermenting yeasts and having an ecological role in
15

pollination64. Inspired by nature, most of the metabolic engineering and synthetic biology
strategies have deployed eukaryotic AATs originating from plants or yeasts for microbial
biosynthesis of target esters50, 61, 65. However, these eukaryotic AATs lack sufficient robustness,
efficiency, and compatibility for an interchangeable catalytic module as they commonly exhibit
poor enzyme expression66, solubility67, and thermostability68 in microbes, thus limiting optimal
microbial production of esters. Although some AATs have been modified69 or codon-optimized50
to improve the host compatibility, efficient expression of these AATs has remained problematic
in the heterologous hosts such as Escherichia coli likely due to different protein expression
machineries and cellular environments67. In addition, limited knowledge on substrate profiles and
specificities of AATs often requires laborious bioprospecting of AATs for individual target
esters50, 61, 63, 65, 66. Therefore, developing robust and efficient AATs compatible with multiple
pathways and microbial hosts is critical to expand biological routes for designer ester biosynthesis.
Chloramphenicol O-acetyltransferase (CAT, EC 2.3.1.28) is an antibiotic resistant enzyme
that acetylates and detoxifies chloramphenicol, a potent drug that inhibits protein elongation70.
Organisms become resistant to this drug by expressing CATs that recruit acetyl-CoA(s) as an
acetyl donor to inactivate chloramphenicol. In nature, the cat gene is one of the most widespread
genetic elements71, expressing a functional enzyme in many organisms including plants72,
animals73, and bacteria74. Interestingly, when being used as antibiotic selection in a recombinant
E. coli, some CATs exhibited substrate promiscuity resulting in unexpected production of some
esters including perillyl acetate75 and isobutyl isobutyrate50. However, utility of CATs as an
enzyme module in developing whole-cell biocatalysts for biosynthesis of designer esters was
marginally studied due to low product yield and titer. It has been suggested that high enzyme
stability and promiscuous activities help drive enzyme evolvability76-78 to uncover novel functions
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for de novo pathway engineering79. Thus, stability and promiscuity of CATs can be potentially
exploited for an efficient ester biosynthesis platform. In this study, we identified and engineered
promiscuity of CATs to function as robust and efficient AATs via screening of enzyme diversity
and model-guided protein engineering to develop novel biomanufacturing microbial platforms for
designer ester biosynthesis.

2.2 Materials and methods
2.2.1 Bacterial strains and plasmids
E. coli BL21(DE3) was used for protein expression and purification. Plasmids used in this study
were listed in Table 2-1.

2.2.2 Chemicals and reagents
All chemicals were purchased from Sigma-Aldrich (MO, USA) and/or Thermo Fisher Scientific
(MA, USA), unless specified elsewhere. For molecular cloning, restriction enzymes and T4 ligase
were obtained from New England Biolabs (MA, USA). Phusion Hot Start II DNA polymerase was
used for polymerase chain reaction (PCR).

2.2.3 Media and cultivation
For molecular cloning and protein expression, E. coli strains were grown in lysogeny broth (LB)
containing appropriate antibiotics unless noted otherwise. For in vivo characterization of CATsa
in E. coli, M9 hybrid medium80 with 20 g/L glucose was used. Optical density (OD) was measured
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Table 2-1: A list of plasmids and E. coli strains used in this study.
Name
Plasmids

Descriptions

Source

pETDuet-1

pBR322 ori, AmpR, lacI, T7lac promoter

Novagen

pET29a

pBR322 ori, KanR, lacI, T7lac promoter

Novagen

pET_CATsa

CATsa wild type encoding gene between BamHI, SacI site,
This study
pETDuet-1 backbone, 6X His-tag at N-terminus

E. coli
BL21(DE3)
Top10

F– ompT gal dcm lon hsdSB(rB–mB–) λ(DE3 [lacI Novagen
lacUV5-T7p07 ind1 sam7 nin5]) [malB+]K-12(λS)
Host for molecular cloning, mcrA, ∆(mrr-hsdRMS- Invitrogen
mcrBC), Phi80lacZ(del)M15, ∆lacX74, deoR, recA1,
araD139, ∆(ara-leu)7697, galU, galK, rpsL(SmR), endA1,
nupG
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by a spectrophotometer at 600 nm wavelength (Spectronic 200+, Thermo Fisher Scientific, MA,
USA).

2.2.4 Multiple sequence alignment analysis
Multiple sequence alignment (MSA) analysis was performed using MEGA781. Protein sequences
were aligned by ClustalW82 and visualized by ESPript 3.0 (http://espript.ibcp.fr)83. The key
features in protein structures of 3U9F84, 4CLA85, and 2XAT86 were extracted from
CAT1_ECOLIX, CAT3_ECOLIX, and CAT4_PSEAE, respectively.

2.2.5 Molecular modeling and docking simulations
Swiss-Model87 and the ‘Builder’ tools of the commercial software MOE (Molecular Operating
Environment software, version 2019.01) were used to generate the three-dimensional (3D)
structures of CATs, alcohols, acyl-CoAs, and their complexes, as described in Seo et al.58. To
perform docking simulations in MOE, potential binding pocket was searched using the ‘Site
Finder’ tool and selecting the best-scored site that is consistent with the reported catalytic sites 88.
Next, docking simulations were performed for acyl-CoA and alcohol with CATs using the induced
fit protocol with the Triangle Matcher placement method and the London G scoring function.
The best-scored binding pose exhibiting the interaction between the residue and the substrate at
root-mean-square-deviation (RMSD) < 2.3 Å was selected. To identify the potential residue
candidates for mutagenesis of the acyl-CoA-alcohol-CAT complex, ‘alanine scan’ and ‘residue
scan’ tools of MOE were used based on the Stability and/or Affinity values calculated. Mutant
candidates with small values of the Stability and/or Affinity were chosen for experimental
testing. To perform the protein contact analysis, ‘Protein Contacts’ tool of MOE was used.
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2.2.6. Molecular cloning
Plasmids were constructed by the standard molecular cloning technique of ligase dependent
method and/or Gibson assembly89 using the primers listed in Table 2-2. The constructed plasmids
were introduced into E. coli TOP10 by heat shock transformation. Colonies isolated on a selective
plate were PCR screened and plasmid purified. The purified plasmids were verified via Sanger
sequencing before being transformed into E. coli BL21 (DE3). Site-directed mutagenesis was
performed using the QuickChange™ site-directed mutagenesis protocol with reduced overlap
length90 or Gibson assembly method89.

2.2.7 In vivo characterization of CATsa and its variants in E. coli
For in vivo characterization of CATsa and its variants in E. coli, high-cell density cultures were
performed with an addition of 2 g/L of various alcohols91. For in-situ extraction of esters, each
tube was overlaid with 25% (v/v) hexadecane. To confirm the protein expression of CATsa and its
variants, 1% (v/v) of stock cells were grown overnight at 37℃ and 200 rpm in 15 mL culture tubes
containing 5 mL of LB media and antibiotics. Then, 4% (v/v) of the overnight cultures were
transferred into 1 mL of LB media containing antibiotics in a 24-well microplate. The cultures
were grown at 37℃ and 350 rpm using an incubating microplate shaker (Fisher Scientific, PA,
USA) until OD reached to 0.4~0.6 and then induced by 0.1 mM isopropyl β-D-1thiogalactopyranoside (IPTG) for 4 hours with a Breathe-Easy Sealing Membrane to prevent
evaporation and cross contamination (cat# 50-550-304, Research Products International Corp., IL,
USA). The protein samples were obtained using the B-PER complete reagent (cat# 89822, Thermo
Scientific, MA, USA), according to the manufacturer’s instruction and analyzed by SDS-PAGE.
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Table 2-2: A list of primers used in this study. The bold and underlined letters indicate restriction
and site-directed mutation sites, respectively.
Primers
Primer sequence (5’ to 3’)
Site-saturation mutagenesis of CATsa F97
CATsa_F BamHI
CTCTGGATCCAATGAACTTTAATAAAATTGATTTAG
CATsa_R SacI
CTCTGAGCTCTTATAAAAGCCAGTCATTAGGCCTA
F97R_F
TGATGGTGTATCTAAAACACGTTCTGGTATTTGGACTC
F97R_R
GTCCAAATACCAGAACGTGTTTTAGATACAC
F97K_F
TGATGGTGTATCTAAAACAAAATCTGGTATTTGGACTC
F97K_R
GTCCAAATACCAGATTTTGTTTTAGATACAC
F97L_F
TGATGGTGTATCTAAAACACTGTCTGGTATTTGGACTC
F97L_R
GTCCAAATACCAGACAGTGTTTTAGATACAC
F97W_F
TGATGGTGTATCTAAAACATGGTCTGGTATTTGGACTC
F97W_R
GTCCAAATACCAGACCATGTTTTAGATACAC
F97I_F
TGATGGTGTATCTAAAACAATTTCTGGTATTTGGACTC
F97I_R
GTCCAAATACCAGAAATTGTTTTAGATACAC
F97G_F
TGATGGTGTATCTAAAACAGGTTCTGGTATTTGGACTC
F97G_R
GTCCAAATACCAGAACCTGTTTTAGATACAC
CATsa_F
TGTTTAACTTTAAGAAGGAGATATACCAT
BB_CATsa_R
TGGATCCTGGCTGTGG
CATTCTTTACAGGAGTCCAAATACCAGAGGCTGTTTTAGATACACC
F97A_R
ATCAAAAATTGTAT
BB_F97A_F
GCCTCTGGTATTTGGACTCCTGTA
CATTCTTTACAGGAGTCCAAATACCAGAATTTGTTTTAGATACACC
F97N_R
ATCAAAAATTGTAT
BB_F97N_F
AATTCTGGTATTTGGACTCCTGTA
CATTCTTTACAGGAGTCCAAATACCAGAGTCTGTTTTAGATACACC
F97D_R
ATCAAAAATTGTAT
BB_F97D_F
GACTCTGGTATTTGGACTCCTGTA
CATTCTTTACAGGAGTCCAAATACCAGAACATGTTTTAGATACACC
F97C_R
ATCAAAAATTGTAT
BB_F97C_F
TGTTCTGGTATTTGGACTCCTGTA
CATTCTTTACAGGAGTCCAAATACCAGATTGTGTTTTAGATACACC
F97Q_R
ATCAAAAATTGTAT
BB_F97Q_F
CAATCTGGTATTTGGACTCCTGTA
CATTCTTTACAGGAGTCCAAATACCAGACTCTGTTTTAGATACACC
F97E_R
ATCAAAAATTGTAT
BB_F97E_F
GAGTCTGGTATTTGGACTCCTGTA
CATTCTTTACAGGAGTCCAAATACCAGAGTGTGTTTTAGATACACC
F97H_R
ATCAAAAATTGTAT
BB_F97H_F
CACTCTGGTATTTGGACTCCTGTA
CATTCTTTACAGGAGTCCAAATACCAGACATTGTTTTAGATACACC
F97M_R
ATCAAAAATTGTAT
BB_F97M_F
ATGTCTGGTATTTGGACTCCTGTA
CATTCTTTACAGGAGTCCAAATACCAGATGGTGTTTTAGATACACC
F97P_R
ATCAAAAATTGTAT
BB_F97P_F
CCATCTGGTATTTGGACTCCTGTA
CATTCTTTACAGGAGTCCAAATACCAGAGCTTGTTTTAGATACACC
F97S_R
ATCAAAAATTGTAT
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Table 2-2 Continued.
Primers
BB_F97S_F
F97T_R
BB_F97T_F
F97Y_R
BB_F97Y_F
F97V_R
BB_F97V_F
Y20W F
Y20W R
Y20H F
Y20H R
G194K F
G194K R
Y20D F
Y20D R
T88Y F
T88Y R
T88D F
T88D R
T88F F
T88F R
Y20T F
Y20T R
Y20F F
Y20F R
G194R F
G194R R
T88L F
T88L R
G194Y F
G194Y R
G194V F
G194V R
Y20L F
Y20L R
T88M F
T88M R
L116R F
L116R R
L116K F
L116K R
F49Y F
F49Y R
F49W F

Primer sequence (5’ to 3’)
AGCTCTGGTATTTGGACTCCTGTA
CATTCTTTACAGGAGTCCAAATACCAGACGTTGTTTTAGATACACC
ATCAAAAATTGTAT
ACGTCTGGTATTTGGACTCCTGTA
CATTCTTTACAGGAGTCCAAATACCAGAGACTGTTTTAGATACACC
ATCAAAAATTGTAT
GTCTCTGGTATTTGGACTCCTGTA
CATTCTTTACAGGAGTCCAAATACCAGAGTATGTTTTAGATACACC
ATCAAAAATTGTAT
TACTCTGGTATTTGGACTCCTGTA
TTAATCAT TGG TTGAACCAACAAACGAC
GTTCAA CCA ATGATTAAATATCTCTTTTCTC
TTAATCAT CAT TTGAACCAACAAACGAC
GTTCAA ATG ATGATTAAATATCTCTTTTCTC
GTTTGTGAT AAA TATCATGCAGGATTG
TGCATGATA TTT ATCACAAACAGAATGATG
TTAATCAT GAT TTGAACCAACAAACGAC
GTTCAA ATC ATGATTAAATATCTCTTTTCTC
ACTTTAT TAT ATTTTTGATGGTGTATC
CAAAAAT ATA ATAAAGTGGCTCTAAC
ACTTTAT GAT ATTTTTGATGGTGTATC
CAAAAAT ATC ATAAAGTGGCTCTAAC
ACTTTAT TTT ATTTTTGATGGTGTATC
CAAAAAT AAA ATAAAGTGGCTCTAAC
TTAATCAT ACC TTGAACCAACAAACGAC
GTTCAA GGT ATGATTAAATATCTCTTTTCTC
TTAATCAT TTT TTGAACCAACAAACGAC
GTTCAA AAA ATGATTAAATATCTCTTTTCTC
TGTGAT CGT TATCATGCAGGATTG
TGATAA ACG TCACAAACAGAATGATGTA
ACTTTAT CTG ATTTTTGATGGTGTATC
CAAAAAT CAG ATAAAGTGGCTCTAAC
TGTGAT TAT TATCATGCAGGATTG
TGATAA ATA TCACAAACAGAATGATGTA
TGTGAT GTT TATCATGCAGGATTG
TGATAA AAC TCACAAACAGAATGATGTA
TTAATCAT CTG TTGAACCAACAAACGAC
GTTCAA CAG ATGATTAAATATCTCTTTTCTC
ACTTTAT ATG ATTTTTGATGGTGTATC
CAAAAAT CAT ATAAAGTGGCTCTAAC
TATAC CGT TCTGATGTAGAGAAATA
ATCAGA ACG GTATAAATCATAAAAC
TATAC AAA TCTGATGTAGAGAAATA
ATCAGA TTT GTATAAATCATAAAAC
CATTTAT TAT CTTAGTGACAAGGGTG
CTAAG ATA ATAAATGCAGGGTAAAATT
CATTTAT TGG CTTAGTGACAAGGGTG
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Table 2-2 Continued.
Primers
F49W R
G92R F
G92R R
K48R F
K48R R
Y112K F
Y112K R
K48I F
K48I R
T88I F
T88I R
T88R F
T88R R
S140L F
S140L R
A138T F
A138T R
CATec3 mutagenesis
ec3 F97W F
ec3 F97W R
ec3 Y20F F
ec3 Y20F R
CATec1 mutagenesis
ec1 F102W F
ec1 F102W R

Primer sequence (5’ to 3’)
CTAAG CCA ATAAATGCAGGGTAAAATT
TTTGAT CGT GTATCTAAAACATTCTCTGG
GATACA ACG TCAAAAATTGTATAAAGTGG
GCATT CGT TTTCTTAGTGACAAGGGTGA
AGAAA ACG AATGCAGGGTAAAATTTATATCC
AGTTT AAA GATTTATACCTTTCTG
AATC TTT AAACTCTTTGAAGTCAT
GCATT AAT TTTCTTAGTGACAAGGGTGA
AGAAA ATT AATGCAGGGTAAAATTTATATCC
ACTTTAT ATT ATTTTTGATGGTGTATC
CAAAAAT AAT ATAAAGTGGCTCTAAC
ACTTTAT CGT ATTTTTGATGGTGTATC
CAAAAAT ACG ATAAAGTGGCTCTAAC
CTTTT CTG CTTTCTATTATTCCATGGAC
AGAAAG CAG AAAAGCATTTTCAGGTATAGG
GAAAAT ACC TTTTCTCTTTCTATTATTC
AGAAAA GGT ATTTTCAGGTATAGGTG
AGACG TGG AGCGCGTTATCGTGCC
GCGCT CCA CGTCTCTGTTTCCTGATG
AATTT TTT CGCCACAGACTGCCAT
TGGCG AAA AAATTCGAAATGTTCG
AAACC TGG AGCTCATTATGGAGTGAA
GAGCT CCA GGTTTCCGTTTGTTC
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2.2.8 Enzyme characterization
For enzyme expression, an overnight culture was inoculated with a 1:50 ratio in fresh LB medium
containing 1 mM IPTG and antibiotics, followed by 18oC overnight incubation (up to 20 hours) in
a shaking incubator at 200 rpm. The induced cells were harvested by centrifugation at 4℃, and
4,700 x g for 10 minutes. The cell pellet was then washed once with Millipore water and
resuspended in the B-PER complete reagent. After 30 min incubation at room temperature, the
mixture was centrifuged at 17,000 x g for 2 minutes. The supernatant was collected and designated
as crude extract. For his-tag purification, the crude extract was incubated with HisPur Ni-NTA
superflow agarose in a batch as the manufacturer recommends. Then, the resin was washed with
at least three volumes of wash buffer, consisting of 50 mM Tris-HCl (pH 8.0), 300 mM NaCl, 10
mM imidazole, and 0.1 mM EDTA. The resin bound proteins were eluted by 300 L elution buffer
containing 50 mM Tris-HCl (pH 8.0), 50 mM NaCl, 300 mM imidazole, and 0.1 mM EDTA. The
eluted sample was then desalted and concentrated via an Amicon filter column with 10 kDa
molecular weight cutoff. Finally, the protein sample was suspended in 200 L of 20 mM Tris-HCl
buffer (pH 8.0). Protein concentration was measured by the Bradford assay92 with bovine serum
albumin (BSA) as the reference protein.
To measure protein melting temperature (Tm), a thermofluor assay was employed with
SYPRO Orange93. About 10 to 250 g of His-tag purified protein was mixed with 5x SYPRO
Orange in a 50 L final volume in a 96-well qPCR plate. The plate was sealed with PCR caps
before running the assay. The StepOne real-time PCR machine (Applied Biosystems, CA, USA)
was used to run the assay with the following parameters: ROX reporter, 1℃ increment per cycle,
one-minute hold at every cycle, and temperature range from 20℃ to 98℃. The data were collected,
exported, and manually processed to calculate Tm.
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Reaction rate for each CAT was determined by a DTNB assay94 in a 384-well plate. Total
reaction volume was 50 L with the reaction buffer comprising of 50 mM Tris-HCl (pH 8.0).
Concentrations of acetyl-CoA (CoALA Biosciences, TX, USA) and alcohols were varied as
specified in each experiment. Final enzyme concentrations of 0.05 g/mL and 10 g/mL were
used for the reactions towards chloramphenicol and alcohols, respectively. Reaction kinetics were
collected by measuring absorbance at 412 nm every minute for one hour at 50℃ in a microplate
reader (Synergy HTX microplate reader, BioTek). The reaction rate was calculated using the
extinction coefficient from a standard curve of free coenzyme A (MP Biomedicals, OH, USA)
under the same condition. It should be noted that since the maximum operating temperature
recommended for the plate reader is 50℃, the high throughput enzyme assay for CAT at elevated
temperature was only performed to determine enzyme kinetics parameters.
The parameters of Michaelis-Menten rate law (eqn. 1) were calculated for each enzyme as
follows. First, linear regression was performed on data collected from a microplate reader to
identify initial reaction rates, 𝑦𝑖 , at different initial substrate concentrations, 𝑠𝑖 , where i= 95n is the
number of data points collected. Then, these initial reaction rates and associated initial substrate
concentrations for all replicates were simultaneously fit to the Michaelis-Menten model (eqn. 1)
using robust non-linear regression (eqn. 2) with a soft-L1-loss estimator (eqn. 3) as implemented
in the SciPy numerical computing library v1.2.096, 97.
𝑣𝑖 =

𝑣𝑚𝑎𝑥 𝑠𝑖

[1]

𝐾𝑀 +𝑠𝑖

𝑚𝑖𝑛𝑘𝑚,𝑣𝑚𝑎𝑥 ∑𝑛𝑖=1 𝜌((𝑣𝑖 (𝑠𝑖 , 𝐾𝑀 , 𝑣𝑚𝑎𝑥 ) − 𝑦𝑖 ) 2 )

[2]

𝜌(𝑧) = 2(√1 + 𝑧) − 1

[3]

The least squares problem determines the parameters 𝐾𝑀 and 𝑣𝑚𝑎𝑥 by minimizing the difference
between the model predicted reaction rates 𝑣𝑖 and measured reaction rates 𝑦𝑖 (eqn. 2). A
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smoothing function 𝜌(𝑧) is used to make the least square problem resistant to outliers (eqn. 3).
Due to the unbiased resistance to outliers and the avoidance of errors resulting from conventional
linearization methods, robust non-linear regression provides the most precise parameter estimate
for the Michaelis-Menten model98.

2.3 Developing a robust alcohol acyltransferase for designer ester
biosynthesis
2.3.1 Chloramphenicol acetyltransferase is a potential candidate for a robust alcohol
acyltransferase
To develop a robust microbial ester production platform, a stable AAT is required. Unfortunately,
the AATs known to date are isolated from mesophilic yeasts or plants, and none of them has been
reported to be active at a temperature above 50℃. To explore any of the eukaryotic AATs are
thermostable, we screened 12 AATs by measuring activity after heat incubation. The results
showed that all the AATs were vulnerable to heat and lost the activity after one hour of incubation
at 50℃, agreeing that the AATs have poor thermostability (Table 2-3). Recent studies inferred that
another class of acetyltransferase, chloramphenicol acetyltransferase (CAT), might have the AAT
activity producing short chain esters50. CAT is one of the widespread proteins implying a broad
host compatibility. For example, the CAT from Staphylococcus aureus (CATsa) has also been
used in genetic engineering of thermophilic microbes as a marker99, 100, which suggest the enzyme
can serve as an alternative thermostable AAT (Table 2-3, Figure 2-1).
We confirmed substrate promiscuity of CATsa by measuring conversion of various alcohols into
acetate esters when feeding the alcohols to an E. coli overexpressing CATsa (Figure 2-2A).
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Therefore, we chose CATsa to investigate their potential functions as a thermostable AAT because
some thermostable CATs have been successfully used as a selection marker in thermophiles100-104
and others have been shown to perform the acetylation for not only chloramphenicol but various
alcohols like AATs75, 105-107. As a proof-of-study, we investigated CATsa, classified as Type A-9,
from the plasmid pNW33N for a broad range of alcohol substrates as it has been widely used for
genetic engineering in C. thermocellum at elevated temperature (≥ 50℃)100-102.
We first conducted alcohol docking simulations using the homology model (Figure 2-2B).
Remarkably, the model predicted binding affinities of short-to-medium chain length alcohols (e.g.,
ethanol, propanol, isopropanol, butanol, and isobutanol) and aromatic alcohols (e.g., benzyl
alcohol and phenethyl alcohol) to the binding pocket. The change in the protein’s Gibbs free energy
upon the substrate binding was ordered as follows: 2-phenethyl alcohol > benzyl alcohol >
isobutanol > butanol > propanol > ethanol > isopropanol (Figure 2-2A).
To quickly evaluate the in silico docking simulation results experimentally, we next
performed in vivo characterization of a CATsa-overexpressing E. coli strain and screened for
acetate esters production. Acetyl-CoA was derived from glycolysis while various alcohols were
externally supplied to the media. Remarkably, the results exhibited the same trends of specificities
of CATsa towards alcohols as predicted by the in silico docking simulation (Figure 2-2A). The
CATsa-overexpressing E. coli produced all the expected acetate esters including ethyl acetate,
propyl acetate, isopropyl acetate, butyl acetate, isobutyl acetate, benzyl acetate, and 2-phenethyl
acetate at titers of 1.12  0.07, 2.30  0.28, 0.08  0.02, 9.75  1.57, 17.06  6.04, 152.44  29.50,
and 955.27  69.50 mg/L and specific ester production rates of 0.02  0.00, 0.05  0.01, 0.00 
0.00, 0.19  0.03, 0.34  0.12, 3.02  0.57, and 19.27  1.32 mg/gDCW/h, respectively. We
observed that the specific ester production titers and rates are higher for aromatic alcohols than
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Figure 2-1: Acetylation by chloramphenicol acetyltransferase and alcohol acetyltransferase.
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linear, short-chain alcohols likely because the hydrophobic binding pocket of CATsa has been
evolved towards chloramphenicol 108, an aromatic antibiotic (Figure 2-2A). Specifically, the bulky
binding pocket of CATsa likely contributes to more interaction with the aromatic substrates than
the short, linear-chain alcohols.
Overall, thermostable CATs, (e.g., CATsa) can have broad range of substrate promiscuity
towards linear, short-chain, and aromatic alcohols and hence can be harnessed as AATs for novel
ester biosynthesis at elevated temperatures.

2.3.2 Rational design of CATsa to improve catalytic activity towards isobutanol and
thermostability
Since the in vivo activity of CATsa is more than 50-fold higher for the aromatic alcohols than
isobutanol, we asked whether its activity could be improved for isobutyl acetate biosynthesis.
Using the in silico analysis, we started by examining whether any modification of the binding
pocket of CATsa could improve the activity towards isobutanol. According to the homology
model, the binding pocket consists of Tyr-20, Phe-27, Tyr-50, Thr-88, Ile-89, Phe-90, Phe-97, Ser140, Leu-141, Ser-142, Ile-143, Ile-144, Pro-145, Trp-146, Phe-152, Leu-154, Ile-166, Ile-167,
Thr-168, His-189, Asp-193, Gly-194, and Tyr-195, where the His189 and Asp193 are the catalytic
sites (Figure 2-3A). Since chloramphenicol resistance is likely a strong selective pressure
throughout evolution, we expected all CATs to exhibit a common binding pocket structure.
Unsurprisingly, conserved sequences in the binding pocket were observed by protein sequence
alignment of CATsa with other CATs of Type A. Especially, Pro-85 and Phe-97 were highly
conserved in CATs of not only Type-A but also Type-B (Figure 2-3B).
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Table 2-3: Bioprospecting of AATs by heat incubation at 50℃ for 1 hour. -: negative, +: positive
AATs

Origin

Activity after 1hr
incubation at 50℃

Alcohol preference

ATF1

Saccharomyces cerevisiae

-

Heptanol,
Isobutanol

KmATF

Kluyveromyces marxianus

-

Ethanol

CsAAT1

Citrus sinensis (Orange)

-

N.A.

CmAAT1

Cucumis melo (Muskmelon)

-

(E)-2-hexen-1-ol

CmAAT3

Cucumis melo

-

Benzyl Alcohol

CmAAT4

Cucumis melo

-

Benzyl Alcohol

CcAAT1

Citrus clementina

-

N.A.

CcAAT2

Citrus clementina

-

N.A.

VpAAT

Vasconcellea pubescens

-

Benzyl Alcohol

BanAAT

Musa acuminate

-

Cinnamyl Alcohol

MdAAT

Golden delicious

-

2-methyl butanol

pNW33N (Staphylococcus sp.)

+

Chloramphenicol

CAT

Figure 2-2: Broad substrate specificity of CATsa. (A) Comparison of predicated binding free
energies of various alcohols to the binding pocket of CATsa and the titer of esters produced in E.
coli carrying CATsa with an exogenous alcohol doping. (B) Structure of the CATsa homology
model. The red arrows indicate the binding pockets formulated by the trimeric structure.
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Based on the binding pocket identified, we performed docking simulation with alanine
scans using the acetyl-CoA-isobutanol-CATsa complex and calculated Stability upon isobutanol
binding (Figure 2-3C). Remarkably, the simulation suggested that Phe-97 residue is a promising
target for mutagenesis. This residue is involved in the formation of a tunnel-like binding pocket108.
Motivated by the analysis, Phe-97 was chosen for site saturated mutagenesis, and the variants were
screened in E. coli for isobutyl acetate production by external supply of isobutanol.
Among the variants characterized, the F97W variant exhibited the best performance
(Figure 2-4A), with the similar protein expression levels in E. coli (Figure 2-4B). As compared to
the wild-type, the F97W variant enhanced the isobutyl acetate production by 4-fold. Subsequent
in silico analysis showed that the mutation created a CH-π interaction between the hydrogen of
isobutanol and the indole ring of F97W (Figure 2-4C). The model also indicated no change in
distance between the isobutanol and active site (His-189) in F97W. Therefore, the CH-π interaction
is likely responsible for the improved activity of F97W variant towards isobutyl acetate
biosynthesis.
Next, we checked whether the F97W mutation affected thermal stability of the enzyme.
We overexpressed and purified both the wildtype CATsa and CATsa F97W variant (Figure 2-5A).
The SDS-PAGE analysis confirmed the expression and purification of the enzymes by bands with
the expected monomer size (25.8 kDa). Thermofluor assay revealed that the F97W variant slightly
lowered the wildtype melting point from 72℃ to 68.3℃ (Figure 2-5B).
Table 2-4 shows the in vitro enzymatic activities of both the wildtype CATsa and CATsa
F97W at 50℃. The turnover number (kcat) of CATsa F97W was two times higher than that of the
wildtype. The increased turnover number of CATsa F97W led to 1.9-fold increase in enzymatic
efficiency (kcat/KM, 4.08 ± 0.62, 1/M/sec) while the mutation did not result in significant change
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in KM. The improved enzymatic efficiency of CATsa F97W agrees with the enhanced isobutanol
production observed in the in vivo characterization using the CATsa-overexpressing E. coli (Figure
2-4A).
Based on the rigidity of the binding pocket, we originally presumed that mutagenesis on
the binding pocket would result in activity loss towards chloramphenicol. Surprisingly, CATsa
F97W retained the activity towards chloramphenicol (Table 2-4). The F97W mutation decreased
kcat but also lowered KM, resulting in a compensation effect. Turnover number of CATsa (kcat,
202.97 ± 3.36, 1/sec) was similar to the previously reported value by Kobayashi et al.109, but KM
(0.28 ± 0.02, mM) was about 1.75-fold higher. The difference might attribute to the experimental
condition and analysis performed. Kobayashi et al. used chloramphenicol in a range of 0.05-0.2
mM for the assay and the Lineweaver-Burk method for analysis, while we used a 0-1.0 mM range
with a nonlinear regression analysis method. Interestingly, affinity towards acetyl-CoA was
independent of the alcohol co-substrates (Table 2-5), suggesting that the alcohol affinity would be
likely the main bottleneck for microbial production of isobutyl acetate.
We further hypothesized that the thermostable CATsa could be repurposed to function as
an AAT with higher catalytic efficiency towards a broad range of substrates and microbes
including thermophiles. To test this hypothesis, we further aimed to engineer CATsa for enhanced
melting temperature and catalytic efficiency towards smaller chain alcohols different from the
native substrate chloramphenicol. To guide CAT engineering, we created a protein homology
model of CATsa58 from the available protein structures108. From the constructed homology model,
we calculated its stability and affinity scores with small chain alcohols and acetyl-CoA required
for ester biosynthesis.
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Figure 2-3: Docking simulation and consensus analysis of CATsa. (A) A binding pocket of CATsa
and comprised amino acid residues. (B) Alanine scan of 23 identified residues in the binding
pocket of the CATsa-isobutanol-acetyl-CoA complex. ∆Stability (kcal/mol) represents the relative
stability of each variant with respect to its wild type. Positive ∆Stability values indicate that the
structural stability of the protein-ligands complex is reduced if a specific residue is replaced with
alanine, suggesting the significance of that specific residue in the protein-ligands complex. (C)
Protein sequence alignment of CATsa with different CATs. The highly conserved regions, F97
and P85, are red highlighted.
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Figure 2-4: Mutagenesis study of CATsa to improve activity towards isobutanol. (A) SDS-PAGE
analysis of E. coli crude extracts expressing CATsa F97 variants. The overexpressed CATsa F97
variants are shown in the red box. The alphabets annotate the amino acid variants. LD; protein
ladder. (B) Screening of F97 site-saturated mutagenized variants for enhanced isobutyl acetate
production in E. coli. The letters indicate amino acids substituting F in the wildtype CATsa. (C)
Superposed binding pocket structure of the wildtype and CATsa F97W mutant. The red arrow
indicates a CH-π interaction between the hydrogen of isobutanol and the indole ring of F97W.

Figure 2-5: In vitro characterization of CATsa and CATsa F97W. (A) SDS-PAGE of purified
CATsa WT and F97W. The black arrow indicates expected size of expressed target proteins,
CATsa and CATsa F97W. 1; crude extract of IPTG induced E. coli BL21(DE3) harboring
pET_CATsa, 2; His-tag purified CATsa, 3; crude extract of IPTG induced E. coli BL21(DE3)
harboring pET_CATsa F97W, 4; His-tag purified CATsa F97W, M; protein ladder. (B) Melting
curve of CATsa WT and F97W. The intensity was normalized by each maximum value. (C)
Michaelis-Menten plots of CATsa wild type and F97W toward isobutanol at 50℃. 2 mM of acetylCoA was supplemented as the saturated cosubstrate. The error bars represent standard deviation
of three biological replicates.
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As a representative small alcohol, isobutanol was chosen for docking simulation and experimental
characterization of CAT variants for thermostability and catalytic efficiency because this alcohol
is much smaller and very different from chloramphenicol and can be efficiently produced by
microorganisms110. Affinity and stability screening via in silico mutagenesis of selected CATsa
binding pocket residues suggested some candidates potentially altering the isobutanol binding
(Figure 2-6A, B). By experimentally constructing and characterizing the top 26 CATsa variants
using an in vivo microbial screening assay111, we identified the CATsa Y20F variant to exhibit the
most significant increase in conversion of isobutanol to isobutyl acetate, about 43-fold higher than
its wild-type enzyme (Table 2-6).
We next characterized robustness and efficiency of CATsa Y20F in vitro by measuring
melting temperatures and kcat/KM values towards isobutanol. Since a previous study demonstrated
that CATsa A138T increased thermostability109, we also investigated whether the combinatorial
mutagenesis CATsa variants enhanced the enzyme performance (Figure 2-6C). We found that
CATsa Y20F improved the catalytic efficiency over the wild-type CATsa and CATsa F97W 5.0and 2.5-fold, respectively, while the melting temperature slightly decreased from 71.2 to 69.3℃
(Figure 2-6D). Among the combinatorial mutagenesis, CATsa Y20F A138T exhibited both the
highest melting temperature (76 ± 0.0℃) and catalytic efficiency towards isobutanol (10.3 ± 1.2,
1/M/s), respectively.
Unfortunately, the combinatorial mutation of F97W and Y20F did not further improve the
catalytic efficiency and rather lowered the melting temperatures (Fig. 2-6D). It has been suggested
that the hydrogen bonds between chloramphenicol, catalytic His-189, and Tyr-20 at the transition
state are critical for high catalytic efficiency of the CAT, specifically by constraining the binding
of chloramphenicol in the correct orientation112.
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Table 2-4: Kinetic parameters of the wildtype CATsa and mutant CATsa F97W.The reactions
were performed at 50℃. The co-substrate, acetyl-CoA, was supplied at the saturated concentration
of 2 mM. Melting temperature (Tm) of CATsa and CATsa F97W are 72.0 ± 0.8, and 68.3 ± 1.2℃,
respectively.
CATsa
CATsa F97W
Substrates
Chloramphenicol
Isobutanol
Chloramphenicol
Isobutanol
KM (mM)
0.28 ± 0.02
138.66 ± 28.92
0.18 ± 0.01
144.77 ± 23.65
kcat (1/sec)
202.97 ± 3.36
0.30 ± 0.03
102.63 ± 2.04
0.59 ± 0.05
kcat/KM (1/M/sec) 7.37 ± 0.48 x 105
2.16 ± 0.45
5.77 ± 0.49 x 105
4.08 ± 0.62

Table 2-5: KM values of CATsa and CATsa F97W towards acetyl-CoA.
Co-substrates
KM (mM)

CATsa
Chloramphenicol
Isobutanol
0.08 ± 0.01
0.06 ± 0.01
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CATsa F97W
Chloramphenicol
Isobutanol
0.09 ± 0.01
0.08 ± 0.02

Since the Y20F mutation retains the aromatic ring that contributes to tautomeric stabilization of
His-189, the catalytic imidazole can still interact with the smaller chain alcohols stably and
flexibly, likely contributing to the enhanced enzymatic activity observed for isobutyl acetate
biosynthesis.

2.3.3 Bioprospecting CATs
The CAT is one of the most widespread enzymes in nature but only a few were discovered to have
the AAT activity towards small alcohols. To explore whether high thermostability and alcohol
promiscuity of CATs occurred in nature, we selected a library of 27 structurally distinctive typeA and type-B CATs71 for characterization because influence of the protein structure differences
on the small alcohol promiscuity was unknown. Since CATs are commonly found in various
organisms with similar or identical protein sequences, we annotated the CAT origins based on the
Uniprot and NCBI databases. We synthesized these CATs, expressed, purified, and characterized
their melting temperatures and promiscuous activities towards isobutanol (Figure 2-7). Most of the
CATs showed melting temperatures higher than 60℃ except CAT_GEO (Tm = 43.5℃) (Table 27). Among these CATs, CAT1_ECOLX (CATec1), CAT3_ECOLX (CATec3), CATsa,
CAT_KLEPS (CATkl), CAT2_ECOLX (CATec2), CAT_HAEIF (CATha), and CAT_CLOBU
(CATcb) exhibited the highest specific activities towards isobutanol at 50℃. Five out of these
seven most isobutanol-active CATs were evolutionarily related, suggesting that their activities
towards isobutanol might be influenced by their unique structural features. We further evaluated
kinetic thermostability of these seven most isobutanol-active CATs by measuring their activity
losses after one-hour incubation at elevated temperatures of 50, 55, 60, 65, and 70℃ (Figure 28A).
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Table 2-6: Screening of CATsa variants for isobutyl ester synthesis in E. coli. Ethyl ester is a
byproduct since E. coli produced ethanol endogenously. Each value represents mean ± 1 standard
deviation (stdev) from at least three biological replicates.

CATsa variants
WT
Y20W
Y20H
G194K
Y20D
T88Y
T88D
T88K
Y20T
Y20F
G194R
T88L
G194Y
G194V
Y20L
T88M
L116R
L116K
F49Y
F49W
G92R
K48R
Y112K
K48I
T88I
T88R
S140L

Ethyl acetate
(mg/L)
2.88 ± 0.24
2.12 ± 0.30
1.98 ± 0.45

Isobutyl acetate
(mg/L)
4.16 ± 1.23
5.25 ± 3.51
3.75 ± 1.56

1.83 ± 0.36

1.33 ± 1.12

1.98 ± 0.44
1.72 ± 0.17
2.52 ± 0.83

1.71 ± 1.44
1.72 ± 1.03
1.81 ± 1.54

2.16 ± 0.66

1.14 ± 0.61

1.92 ± 0.29

4.07 ± 0.95

1.56 ± 0.15

181.80 ± 32.38

2.07 ± 0.59

4.09 ± 3.89

1.95 ± 0.16

0.58 ± 0.23

2.06 ± 0.24

2.30 ± 0.69

2.03 ± 1.29

2.85 ± 2.47

2.00 ± 0.45
2.33 ± 0.83
2.30 ± 0.75
2.36 ± 0.11
2.13 ± 0.39

12.88 ± 1.17
3.52 ± 2.00
7.99 ± 1.39
12.62 ± 4.38
4.51 ± 2.92

2.28 ± 0.20

3.04 ± 2.60

2.75 ± 0.87
2.20 ± 0.35
2.40 ± 0.52
2.65 ± 1.36
2.86 ± 0.72
2.92 ± 1.23
2.60 ± 1.08

3.66 ± 2.50
6.01 ± 0.86
2.85 ± 2.03
9.11 ± 3.64
3.43 ± 1.04
4.54 ± 1.71
4.46 ± 0.84
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Figure 2-6: Protein engineering of CATsa to improve efficiency and robustness towards
isobutanol. (A) Residue scan of binding pocket residues interacting with isobutanol of the CATSaisobutanol-acetyl-CoA complex. Selected candidates are based on the ∆Affinity values. (B)
Residue scan of residues interacting with acetyl-CoA of the CATsa-isobutanol-acetyl-CoA
complex. Selected candidates are based on the ∆Affinity values. (C) Catalytic efficiencies of
CATsa and its variants towards isobutanol. Student’s t-test: *p-value = 1.20E-07 (df = 5), **pvalue = 3.94E-04 (df = 8), NS = not significant (df = 6). (D) Melting temperatures of CATsa and
its variants. Student’s t-test: *p-value = 0.016 (df = 7), **p-value = 4.49E-05 (df = 8). In panels
C-D, each value represents mean ± 1 stdev from at least three biological replicates. For each in
vitro assay, 2 mM acetyl-CoA was used as a co-substrate.
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Figure 2-7: Screening of CATs for activity towards isobutanol. (A) SDS-PAGE of His-tag
purified CATs. The protein samples were loaded at 500 ng per lane. From 1 to 27; CATsa,
CAT_STRAC, CAT2_ECOLX, CAT_THEACI, CAT_BACI, CAT4_STAAU, CAT_BAOCI,
CAT3_STAAU, CAT_PROMI, CAT_BACPU, CAT1_ECOLIX, CAT_KLEPS, CAT_CLOBU,
CAT_GEO, CAT_CAMCO, CAT4_ECOLIX, CAT4_PSEAE, CAT_CLODI, CAT_LYSI,
CAT4_MORMO, CAT1_CLOPF, CAT5_STAAU, CAT3_ECOLX, CAT4_KLEAE,
CAT_STRAG, CAT2_HAEIF, and CAT_VIBAN. The red arrow indicates the average size of the
CATs (24.9kDa). CAT_STAIN was not included because of unsuccessful expression. (B) Specific
activity of CATs towards 100 mM isobutanol (mean ± 1 stdev from two biological replicates).

Figure 2-8: Thermostability of the seven selected CATs. (A) Kinetic thermostability of the
selected CATs. Residual activity after the heat incubation at 50℃ was used for the normalization.
Each value represents mean ± 1 stdev from three biological replicates. (B) Melting curves of the
seven selected CATs. The signal intensity was normalized by each maximum value.
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Table 2-7: Melting temperatures of a set of 28 chloramphenicol acetyltransferases (CATs). Each
value represents mean ± 1 stdev. Note that CAT1_ECOLX and CAT3_ECOLX are also denoted
as CATec1 and CATec3, respectively.
No

Type

CATs

Origins

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28

A
A
A
A
A
A
A
A
A
A
A
A
A
A
B
B
B
A
A
A
A
A
B
A
A
A
A
A

CATsa
CAT_STRAC
CAT2_ECOLX
CAT_THEACI
CAT_BACI
CAT4_STAAU
CAT_BAOCI
CAT_CLOBU
CAT3_STAAU
CAT5_STAAU
CAT_BACPU
CAT1_ECOLX
CAT_KLEPS
CAT_GEO
CAT4_ECOLX
CAT4_PSEAE
CAT4_MORMO
CAT_LYSI
CAT_VIBAN
CAT1_CLOPF
CAT_PROMI
CAT3_ECOLX
CAT4_KLEAE
CAT_STRAG
CAT2_HAEIF
CAT_CAMCO
CAT_CLODI
CAT_STAIN

Staphylococcus aureus
Streptomyces acrimycini
Escherichia coli
Thrmoactinomyces sp.
Bacillus sp.
Staphylococcus aureus
Bacillus oceanisediminis
Clostridium butyricum
Staphylococcus aureus
Staphylococcus aureus
Bacillus pumilus
Escherichia coli
Klebsiella sp.
Geomicrobium sp.
Escherichia coli
Pseudomonas aeruginosa
Morganella morganii
Lysinibacillus boronitolerans
Vibrio anguillarum
Clostridium perfringens
Proteus mirabilis
Escherichia coli
Klebsiella aerogenes
Streptococcus agalactiae
Haemophilus influenzae
Campylobacter coli
Clostridioides difficile
Staphylococcus intermedius
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Uniprot (or NCBI)
protein entry
WP_001010387.1
P20074
P22615
WP_037996077.1
A0A3N9QXS5
P36882
A0A160M771
Q02736
P06135
P36883
P00487
P62577
P58777
WP_042419141.1
P26838
P26841
P50869
A0A0A3IEC4
P49417
P26825
P07641
P00484
P50868
Q03058
P22616
P22782
P11504
P25309

Tm
(℃)
71.2 ± 1.1
77.5 ± 4.3
81.6 ± 0.8
81.0 ± 0.0
70.7 ± 0.9
71.0 ± 0.0
65.0 ± 0.0
70.0 ± 0.0
68.7 ± 2.4
82.0 ± 0.0
72.0 ± 0.0
71.2 ± 0.7
67.7 ± 0.9
43.3 ± 0.8
71.8 ± 1.3
71.0 ± 1.6
57.0 ± 0.0
76.0 ± 0.0
71.5 ± 0.5
65.0 ± 0.0
81.0 ± 0.0
80.2 ± 1.5
70.5 ± 0.9
66.3 ± 5.8
82.0 ± 1.8
69.0 ± 0.0
n.a.
n.a.

Replicates
6
4
11
2
3
2
3
3
3
2
2
6
3
4
12
4
2
2
2
2
2
6
4
4
6
3
2
2

Remarkably, CATec3 and CATec2 could retain more than 95% of the activity at 70℃ while the
residual activity of CATsa rapidly decreased. The high kinetic thermostability of CATec3 agrees
with a previous study113. We also found that CATec1, previously employed to demonstrate some
ester biosynthesis in E. coli50, is less thermostable and efficient than CATec3 (Table 2-7).
Particularly, CATec1 showed relatively poor kinetic thermostability although it showed similar
thermodynamic stability as compared to CATsa (Figure 2-8B).
Overall, CATec3 was the most thermostable CAT with the highest promiscuous activity
towards isobutanol (Figure 2-9A).

2.3.4 Engineering alcohol promiscuity of CATec3
Discovery of high thermostability and promiscuity of CATec3 towards the small alcohol
(i.e., isobutanol) prompted us to investigate whether the beneficial mutations discovered in CATsa
could be introduced into CATec3 to further improve its performance. We constructed CATec3
variants harboring single and combinatorial mutations of F97W and Y20F. Since the homolog
residue of A138 does not exist in CATec3, its mutation was not constructed and characterized.
Interestingly, the results showed that the CATec3 Y20F variant improved not only the catalytic
efficiency (13.0 ± 0.2, 1/M/s), about 3.3-fold higher than wild-type, but also the melting
temperature (87.5 ± 0.5℃) (Figure 2-9B, C). Among all the CATs characterized, CATec3 Y20F
is the most thermostable and isobutanol-active (Table 2-8). Motivated by the improved catalytic
efficiency introduced by the Y20F mutation towards various alcohols, we further examined
whether CATec3 Y20F exhibited enhanced compatibility towards a library of 16 linear, branched,
saturated, unsaturated, and aromatic alcohols with acetyl-CoA as a co-substrate (Table 2-9). We
found that CATec3 Y20F was more efficient towards bulky and long-chain alcohols that are more
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hydrophobic than short-chain alcohols, likely due to a stronger binding affinity. As compared to
the wild-type CATec3 against a representative set of six alcohols that can be naturally synthesized
by organisms, we found that the CATec3 Y20F variant exhibited higher catalytic efficiency
towards butanol by 4.0-fold (Figure 2-10A), pentanol by 8.8-fold (Figure 2-10B), benzyl alcohol
by 6.9-fold (Figure 2-10C), and phenylethyl alcohol by 6.2-fold (Figure 2-10D), respectively.
In addition, we found that CATec3 Y20F could catalyze acetylation of fatty alcohols (i.e.,
octanol and decanol) to produce long-chain wax esters for drop-in biodiesel applications (Figure
2-11A, B). Note that kinetic parameters were not reported for these fatty alcohols due to low
substrate solubility. The alcohol compatibility of CATec3 Y20F expanded from ethanol to
terpenoid alcohols such as geraniol and nerol. Due to high KM value (>1M) towards ethanol (Figure
2-11C), CATec3 Y20F is more favorably applied for biosynthesis of higher-chain alcohol esters.
This characteristic is potentially beneficial to produce designer esters rather than ethyl esters in
organisms since ethanol is a common fermentative byproduct that can act as a competitive
substrate. In comparison to CATsa Y20F A138T, CATec3 Y20F displayed higher activity towards
not only isobutanol, but also most of other alcohols (Figure 2-12). It is noteworthy that these
engineered CATs exhibited different alcohol specificities. For example, CATsa Y20F A138T was
relatively more specific to phenylethyl alcohol than terpenoid alcohols as compared to CATec3
Y20F (Figure 2-12).

2.3.5 Acyl-CoA promiscuity of CATec3
We next examined whether CATec3 Y20F was also compatible with longer-chain acylCoAs.
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Figure 2-9: Bioprospecting and protein engineering of CATs. (A) A phylogenetic tree of 28 CATs
and heat map of their melting temperatures (Tm) and activities towards isobutanol (IBOH). The
numbers in the phylogenetic tree represent bootstrapping values (%) from 1000 bootstrap
replicates. (B) Melting temperatures of CAT3_ECOLX (CATec3) variants. Student’s t-test: *pvalue = 4.34E-08 (df = 13), **p-value = 3.43E-06 (df = 13). Each value represents mean ± 1 stdev
from at least three biological replicates. (C) Catalytic efficiencies of CATec3 and its variants
towards isobutanol. Student’s t-test: *p-value = 4.46E-05 (df = 6). Each value represents mean ±
1 stdev from at least three biological replicates.
Table 2-8: Melting temperatures and kinetic parameters of CAT variants towards isobutanol. The
co-substrate, acetyl-CoA, was supplemented at the saturated concentration of 2 mM. Kinetic
parameters were determined at 50℃. Each value represents mean ± 1 stdev from at least three
biological replicates.
CATs
CATec1
CATec1 F102W
CATsa
CATsa F97W
CATsa Y20F
CATsa Y20F F97W
CATsa Y20F A138T
CATsa Y20F F97W A138T
CATec3
CATec3 F97W
CATec3 Y20F
CATec3 Y20F F97W

Tm
(℃)
71.2 ± 0.7
68.0 ± 0.0
71.2 ± 1.1
68.3 ± 1.2
69.3 ± 0.5
68.7 ± 0.5
76.0 ± 1.2
73.0 ± 0.6
80.2 ± 1.5
81.2 ± 0.4
87.5 ± 0.5
85.5 ± 0.5

kcat
(1/s)
0.4 ± 0.1
1.2 ± 0.1
0.3 ± 0.05
0.6 ± 0.05
1.5 ± 0.06
1.4 ± 0.1
2.0 ± 0.09
1.4 ± 0.06
0.7 ± 0.1
0.5 ±0.1
2.3 ± 0.1
0.53 ± 0.1
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KM
(mM)
375.9 ± 121.7
259.3 ± 59.2
164.1 ± 29.6
144.8 ± 23.7
146.3 ± 13.8
212.3 ± 32.4
189.2 ± 19.8
205.7 ± 17.8
171.4 ± 24.6
250.2 ± 84.3
180.1 ± 21.7
156.7 ± 58.5

kcat/KM
(1/M/s)
1.0 ± 0.4
4.7 ± 1.2
2.1 ± 0.4
4.1 ± 0.7
10.5 ± 1.1
6.4 ± 1.1
10.3 ± 1.2
6.7 ± 0.6
4.2 ± 0.1
1.8 ± 0.1
13.0 ± 0.2
3.4 ± 0.1

Table 2-9: Catalytic efficiency of CATec3 Y20F towards multiple alcohol substrates. The
catalytic efficiency was measured from the kinetic reactions performed at 50℃. The co-substrate,
acetyl-CoA, was supplemented at the saturated concentration of 2 mM. The values represent
average ± standard deviation from at least three biological replicates. *Calculation of the
parameters against methanol was not statistically practical due to the low affinity. # 10% of DMSO
was supplemented due to low substrate solubility.
Alcohol substrates

kcat (1/s)

KM (mM)

kcat/KM (1/M/s)

Ethanol*

0.8 ± 1.0

1232.5 ± 1986.3

0.6 ± 1.3

Butanol

1.9 ± 0.4

195.7 ± 87.3

10.5 ± 5.1

Isobutanol

2.3 ± 0.1

180.1 ± 21.7

13.0 ± 1.7

Prenol

2.7 ± 0.3

101.0 ± 21.6

26.4 ± 6.6

Furfuryl alcohol

1.1 ± 0.1

37.1 ± 9.8

29.1 ± 8.4

Pentanol

3.9 ± 1.0

64.7 ± 33.6

59.1 ± 19.3

Isoamyl alcohol

2.8 ± 0.3

59.9 ± 26.6

46.0 ± 11.9

Benzyl alcohol

1.6 ± 0.1

12.2 ± 1.6

130.3 ± 17.8

Hexanol

6.4 ± 0.4

29.2 ± 4.0

219.5 ± 33.5

3-cis-Hexen-1-ol

2.3 ± 0.2

6.4 ± 2.2

360.1 ± 129.4

Phenylethyl alcohol

6.1 ± 0.1

10.6 ± 0.4

577.1 ± 26.2

3-Methoxybenzyl alcohol#

18.8 ± 0.9

10.0 ± 1.2

1,891.6 ± 248.8

Geraniol#

8.0 ± 0.2

4.1 ± 0.4

1,975.7 ± 186.8

Citronellol#

7.7 ± 0.2

3.2 ± 0.3

2,400.9 ± 247.9

Nerol#

2.2 ± 0.04

4.1± 0.8

4,119.5 ± 753.0

Chloramphenicol

105.5 ± 6.9

0.2 ± 0.05

491,901.5 ± 115,286.2
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Figure 2-10: Comparison of catalytic efficiencies of CATec3 and CATec3 Y20F towards (A)
butanol (Student’s t-test: *p-value = 8.22E-04 (df = 5), (B) pentanol (Student’s t-test: *p-value =
2.77E-06, df = 5), (C) benzyl alcohol (*p-value = 4.70E-03, df = 3), (D) 2-phenylethyl alcohol
(Student’s t-test: *p-value = 1.45E-04, df = 2, and (E) chloramphenicol (Student’s t-test: *p-value
= 1.22E-04, df = 5). Each value represents mean ± 1 stdev from at least three biological replicates.
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We analyzed the relative activities of CATec3 Y20F against a set of 10 linear, branched, and
aromatic acyl-CoAs that can be synthesized in organisms together with isobutanol as a co-substrate
(Fig. 2-13A). CATec3 Y20F has the highest activity towards the native substrate acetyl-CoA,
which is the most abundant and critical precursor metabolite for cell biosynthesis. As compared to
acetyl-CoA, CATec3 Y20F achieved 46%, 28%, 15%, 12%, 11%, and 9% of activity towards
isobutyl-CoA, propionyl-CoA, butyryl-CoA, valeryl-CoA, phenylethyl-CoA, and isovaleryl-CoA,
respectively. No activity was detected against linear fatty acyl-CoAs longer than valeryl-CoA.
Interestingly, CATec3 Y20F also exhibited activity towards an uncommon lactyl-CoA for lactate
ester biosynthesis. Since lactyl-CoA is not commercially available for in vitro assay, we
determined the activity in vivo by using a recombinant E. coli co-expressing CATec3 Y20F and a
propionyl-CoA transferase (PCT) derived from different microbes including Thermus
thermophilus (PCTtt) that transfers CoA from acetyl-CoA to lactate114, 115 (Figure 2-13B). By cofeeding the recombinant E. coli with 2 g/L of isoamyl alcohol and lactate, isoamyl lactate could
be produced at a level of about 66.6 mg/L (Figure 2-13C), which is at least 2.5-fold higher than
the use of the eukaryotic AATs reported previously61. Since PCTtt is derived from a thermophile,
the lactate ester biosynthesis pathway is likely thermostable and compatible with thermophilic
hosts. Like eukaryotic AATs, CATs are also known to have weak thioesterase activities that
hydrolyze acyl-CoAs; however, their turnover rates (kcat) are significantly lower for thioesterases
than for alcohol acetyltransferases116. Taken together, we have shown unequivocally that
promiscuity of CATs can be engineered for de novo thermostable AATs for esterification of small
alcohols. The engineered CATec3 Y20F likely has a higher modularity than other eukaryotic
AATs because it is a robust and efficient ester biosynthesis module compatible with a wide range
of alcohols and acyl-CoA substrates.
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Figure 2-11: Michaelis-Menten plots of CATec3 Y20F towards octanol, decanol, and ethanol. (A)
octanol, (B) decanol, and (C) ethanol. Each data represents mean ± 1 stdev from at least three
biological replicates.

Figure 2-12: Specific activity of CATec3 Y20F and CATsa Y20F A138T towards various
alcohols. The specific activity was measured at 20mM of alcohol substrates (mean ± 1stdev from
three biological replicates).
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2.4 Conclusion
Robust and efficient AATs are essential enzyme modules to expand biological routes for
sustainable and renewable production of designer bioesters with useful applications. Although
metabolic engineering and synthetic biology strategies expanded ester biosynthesis of short-chain
volatile esters in well-studied microbes such as E. coli50, 65, 66, 117, harnessing broader range of
microbial metabolic networks for an efficient ester production has been largely limited due to the
lack of compatible AATs known to have poor solubility and thermostability (e.g., even for ATF1
of S. cerevisiae, one of the best performing AATs known to date118-120). This chapter addressed
the AAT problems by elucidating the promiscuity of CATs and exploiting this unique property to
create novel biomanufacturing microbial platforms for designer ester biosynthesis.
Prior to our study, promiscuous activity of CATs was accidentally discovered from an
unexpected production of esters by the engineered alcohol-producing recombinant E. coli strains
50, 75

; however, CATs were not efficient enough to convert alcohols to esters and hence utility of

CATs as a catalyst was underestimated. Furthermore, fundamental understanding of CATs’
enzymatic characteristics for designer ester biosynthesis was lacking. To fill this knowledge gap,
we identified and engineered the promiscuity of CATs to function as robust and efficient AATs
compatible with multiple alcohols and acyl-CoAs through screening of CAT diversity, modelguided protein engineering, and comprehensive enzyme characterization. A single mutation of
Y20F, weakening the interaction between chloramphenicol, catalytic H189, and Y20 at the
transition state, can enhance its promiscuity. In addition to discover the Y20F role, we engineered
F97W and A138T for improving promiscuity of CATs towards smaller alcohols and
thermostability, but the combinatorial mutations did not result in beneficial effects synergistically.
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Figure 2-13: Substrate promiscuity of CATec3 Y20F towards acyl-CoAs. (A) Relative activity of
CATec3 Y20F towards acyl-CoAs as compared to acetyl-CoA. 400mM of isobutanol was
supplemented as the co-substrate. Each value represents mean ± 1 stdev from six biological
replicates. (B) Microbial biosynthesis of isoamyl lactate by co-feeding the recombinant E. coli coexpressing CATec3 Y20F and propionate CoA transferases (PCTs) with isoamyl alcohol and
lactate. (C) Effect of expressing various PCTs on isoamyl lactate production after 48 h. The initial
M9 medium contained 10 g/L glucose, 5 g/L yeast extract, 2 g/L of isoamyl alcohol, 2 g/L lactate,
and 0.1mM of IPTG to induce the protein expression. 1 mL of hexadecane was overlaid to extract
the isoamyl lactate produced during the fermentation. Each value represents mean ± 1 stdev from
three biological replicates. Origin of PCTs: PCTpt, Pelotomaculum thermopropionicum; PCTme,
Megasphera elsdenii; PCTtt, Thermus thermophilus, PCTcp, Clostridium propionicum; PCTre,
Ralstonia eutropha.
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We found that CATsa Y20F A138T mutant achieved both the improved catalytic efficiency
and thermostability while CATec3 Y20F was the best performer among the library of variants
characterized. We believe that additional rounds of mutagenesis of the best enzyme CATec3 Y20F
with a larger library screening could potentially identify other beneficial mutants that can further
improve its catalytic efficiency towards a target substrate, which is an interesting future research
topic. Overall, the repurposed CAT is a useful platform to synthesize designer bioesters in multiple
microorganisms (Fig. 2-14). Theoretically, at least 168 esters can be synthesized by CATec3 Y20F
in combination of the 21 alcohols and 8 acyl-CoAs. Since expressing the functional CAT does not
require post-translational modifications and/or localization, a wider range of organisms can
employ the repurposed CAT for ester production.
In summary, this study created a new direction for programmable ester production by
repurposing CATs rather than bioprospecting AATs for designer ester biosynthesis. The CAT can
serve a useful platform of the protein engineering towards a specific target alcohol and/or acylCoA. While this study presented a robust and efficient platform for diverse classes of ester
biosynthesis, further optimization is required to control specificity. Relative short amino acid
length and well identified protein structures of CATs as compared to other eukaryotic AATs are
favorable for the protein engineering. The high stability and promiscuity of CATs also offer a
better protein evolvability76-78 than other AATs. Metabolic engineering strategies can also
facilitate a specific ester production by controlling metabolic flux towards targeted alcohol and
acyl-CoA precursors.
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Figure 2-14: Repurposing chloramphenicol acetyltransferase (CAT) for an efficient and robust
designer ester biosynthesis. The repurposed CAT can serve as a robust, efficient, and promiscuous
AAT that is compatible with multiple microbial hosts, expanding biological routes for various
ester production.
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3. Chapter 3. Engineering metabolic network/cellular level
modularity of ester biosynthesis in a model microorganism
This chapter focuses on metabolic engineering of E. coli to engineer modularity of ester
biosynthesis at metabolic network/cellular level. The engineered CATec3 Y20F was expressed in
E. coli for conversion of various alcohols using intracellular acetyl-CoA, demonstrating
compatibility of the engineered ester biosynthesis module to the metabolic network. Further,
engineered isoamyl acetate production was demonstrated by manipulating precursor pathway
modules. Parts of the studies are under review for publication59.

3.1 Motivation
Cellular system comprises thousands of different enzymes that build up a metabolic network. The
metabolic pathways catalyze sequential metabolic reactions converting sugars into alcohols and
acyl-CoAs, the two key precursors for ester biosynthesis. Therefore, expressing a functional AAT
in a cell introduces a heterologous ester biosynthesis pathway on top of the endogenous
metabolism.
Since the engineered CATec3 Y20F is robust and compatible with various substrates
(Table 2-9), metabolic engineering strategies using the CATec3 Y20F can harness metabolic
network of a microorganism to produce esters. At metabolic network/cellular level, ideal
phenotypes are efficient production (e.g., titer, yield, productivity), robustness (e.g., cell growth,
stable fermentation), and metabolic compatibility (e.g., metabolic balance, soluble protein
expression).
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Model organisms are relatively well characterized, and many genetic engineering tools and
parts (e.g., plasmids, promoters, and terminators) are available, suitable as platform cell factories
for proof-of-principle. Escherichia coli is one of the most well studied a facultative anaerobic and
mesophilic gram-negative microorganism that has been largely deployed as a workhorse industrial
host. Especially, many favorable characteristics (e.g., fast growth, broad sugar assimilation
capability, trackable genetic elements) make the E. coli appropriate for engineering modularity of
ester biosynthesis at cellular level.

3.2 Materials and methods
3.2.1 Bacterial strains and plasmids
E. coli BL21(DE3) was used as a host strain for alcohol conversion and fermentative ester
production. The strains and plasmids used in this chapter were listed in Table 3-1.

3.2.2 Media and cultivation
E. coli strains were grown in lysogeny broth (LB) medium or M9 hybrid medium80 containing
glucose as a carbon source and 5 g/L yeast extract supplemented with 100 µg/mL ampicillin and/or
50 µg/mL kanamycin when appropriate.

3.2.3 Recombineering
E. coli gene deletions were carried out using recombineering121. A temperature sensitive low-copy
plasmid that contains exo, bet and gam in their native phage operon, pL, under λ CI repressor
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Table 3-1: A list of plasmids and strains used in this study.
Name
Plasmids

Descriptions

Source

pET29a

pBR322 ori, KanR, lacI, T7lac promoter

Novagen

pET_CATec3
Y20F

CATec3 Y20F encoding gene in pET29a, 6X His-tag at CThis study
terminus

pACYCDuet-1

p15A ori, CmR, lacI, T7lac promoter

Novagen

pCDFDuet-1

CloDF ori, SmR, lacI, T7lac promoter

Novagen

pRSFDuet-1

RSF ori, KanR, lacI, T7lac promoter

Novagen

pET23a

pBR322 ori, AmpR, T7 promoter

Novagen

pSIM6
pCP20

pSC101 repAts, Gam, Beta, Exo under the control of a
temperature sensitive promoter
repA101ts, CmR, AmpR, FLP recombinase under the control
of a temperature senstivie protmoer.

122

123

pHM46

pCDFDuet-1::alsS::kivD

124

pHM47

pET23a::ilvC, ilvD, yqhD

124

pHS121

pRSFDuet-1::alsS::kivD

This study

pHS122

pACYCDuet-1::alsS::kivD

This study

pHS133

pRSFDuet-1:: alsS, catec3 Y20F::kivD

This study

pHS144

pCDFDuet-1::LeuABCD

This study

pHS155

pCDFDuet-1:: LeuABCD:: catec3 Y20F

This study
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Table 3-1 Continued.
Name

Descriptions

Source

E. coli
Top10

BL21(DE3)

Host for molecular cloning, mcrA, ∆(mrr-hsdRMS- Invitrogen
mcrBC), Phi80lacZ(del)M15, ∆lacX74, deoR, recA1,
araD139, ∆(ara-leu)7697, galU, galK, rpsL(SmR), endA1,
nupG
F– ompT gal dcm lon hsdSB(rB–mB–) λ(DE3 [lacI Novagen
lacUV5-T7p07 ind1 sam7 nin5]) [malB+]K-12(λS)

HSEC01

BL21(DE3) harboring pET_CATec3 Y20F

This study

HSEC0501

BL21(DE3) harboring pHM47 and pHS122

This study

HSEC0502

BL21(DE3) harboring pHM46 and pHS47

This study

HSEC0503

BL21(DE3) harboring pHM47 and pHS121

This study

HSEC0201

BL21(DE3) ΔadhE, Δdld

This study

HSEC0302

BL21(DE3) ΔadhE, Δdld, ΔldhA

This study

HSEC0403

BL21(DE3) ΔadhE, Δdld, ΔldhA, ΔackA-pta

This study

HSEC0504

BL21(DE3) ΔadhE, Δdld, ΔldhA, ΔackA-pta, ΔilvE

This study

HSEC0605

BL21(DE3) ΔadhE, Δdld, ΔldhA, ΔackA-pta, ΔilvE, ΔtyrB

This study

HSEC1006

BL21(DE3) harboring pHM47, pHS133, and pHS144

This study

HSEC1207

HSEC0201 harboring pHM47, pHS133, and pHS144

This study

HSEC1208

HSEC0201 harboring pHM47, pHS133_kivD V461A,
F381L, and pHS144
HSEC0201
harboring
pHM47,
pHS133,
and
pHS144_LeuA G462D
HSEC0201 harboring pHM47, pHS133_kivD V461A,
F381L, and pHS144_LeuA G462D
HSEC0605 harboring pHM47, pHS133_kivD V461A,
F381L, and pHS155_LeuA G462D

This study

HSEC1209
HSEC1210
HSEC1614
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This study
This study
This study

control (pSIM6) was used to induce homologous recombination of double strand DNA into the
genome122. Briefly, E. coli strains harboring pSIM6 was cultured in 3 mL LB medium at 30℃
overnight. The grown cells were transferred to fresh 20 mL LB medium in a 250 mL flask with 1%
inoculum size (200 L) and cultured for 2-3 hours in a water bath shaking incubator at 200 rpm
and 32℃. At OD600nm of 0.4~0.6, the cell culture flask was transferred to a preheated 42℃ water
bath shaking incubator at 200 rpm for 15 mins. Them the cells were immediately cooled down in
ice for 10 mins and centrifuged at 4,700 rpm for 10 mins. The cell pellets were washed twice with
50 mL ice-cool sterile Millipore water and then suspended in the 200 L ice-cool sterile Millipore
water. 80 L of the concentrated cells were mixed with ~100 ng of linear double-stranded DNA
containing FRT-Kan-FRT cassette, amplified by PCR. Then, the cells were transferred to an icechilled 1-mm gap electroporation cuvette (BTX Harvard Apparatus, MA, USA) followed by an
exponential decay pulse with 1.8 kV, 350 Ω, and 25 F, which gave usual pulse duration of 4.56.0 ms. The cells were immediately mixed with 700 L LB medium and recovered in a shaking
incubator at 30℃ for two hours. The recovered cells were plated on LB solid medium with 25
g/mL kanamycin and incubated at 30℃ for 2 days. Successful gene deletion was confirmed by
colony PCR using multiple combinations of primers specifically binding at upstream and/or
downstream of the target location and/or Kan in the FRT-Kan-FRT cassette. The kanamycin
resistance marker was subsequently disrupted by FLP mediated recombination of FRT by
pCP20125.

3.2.4 Plasmid construction
Plasmids were constructed by ligation-dependent cloning and/or Gibson DNA assembly.
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Briefly, DNA fragments were amplified using the Phusion DNA polymerase (cat# F530S, Thermo
Fisher Scientific, MA, USA) and then purified by DNA purification and gel extraction kits (Omega
Biotek, GA, USA). For the ligation-dependent cloning, the vectors and inserts were digested by
restriction enzymes and ligated together using a T4 DNA ligase. In the case of Gibson DNA
assembly cloning, the purified DNA fragments of the vector and insert were mixed together with
the Gibson master mix126 and assembled at 50℃ for one hour. Using the DNA mixtures, E. coli
TOP10 was transformed by heat-shock transformation and selected on LB agar plates (15 g/L agar)
with appropriate antibiotics. All the constructed plasmids were checked by PCR amplification
and/or restriction enzyme digestion, and Sanger sequencing. The primers used in this chapter were
listed in Table 3-2.

3.2.5 Conversion of alcohols to esters in E. coli.
For batch cultures, tube-scale alcohol conversions were performed in 4 mL M9 medium containing
10 g/L glucose with addition of 1 mL of hexadecane for in situ extraction at 37℃. 0.1 mM
isopropyl β-D-1-thiogalactopyranoside (IPTG) was added to the initial medium to induce
expression of CATec3 Y20F. Alcohols were supplemented in the initial medium, and the product
yield and titer were measured by esters collected in hexadecane layers and residual alcohols in
culture media. Samples were analyzed after 24h for experiments with supplementation of single
alcohols and after 12h, 24h, and 48h for the experiments simulating rose ester profiles. For
fedbatch cultures designed to achieve high-level conversion of alcohols (i.e., isoamyl alcohol,
phenylethyl alcohol), cells were grown microaerobically in a 125 mL screw capped shake flask
with a working volume of 20 mL M9 medium containing 25 g/L glucose and 10 mL hexadecane.
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Table 3-2: A list of primers used in this study. The bold and underlined letters indicate restriction
and site-directed mutation sites, respectively.
Primer
name
HS677
HS678
HS683
HS684
HS802
HS785
HS786

Primer sequence (5’ to 3’)

Description

CTCT GTCGAC
TTAAGAAGGAGATATAGATATGAATTATACTAA
CTCTAA GCGGCCGC
TTACTTCAATTTCGAATTGCAGAGC
CTCT GAGCTC
TATGAGCCAGCAAGTCATTATTTTCGATAC
CTCTAA CTCGAG
TTAATTCATAAACGCAGGTTGTTTTGC
CTCTAA GCGGCCGC
TTAATTCATAAACGCAGGTTGTTTTGC
AGTATAAGAAGGAGATATACATATGAATTATACT
AAATTCGATG
TTGCTCAGCGGTGGCAGCAGCCTAGGTTAATTTA
CTTCAATTTCGAATTGC

CAT cloning at
MCS1 forward
CAT cloning at
MCS1 reverse
LeuABCD cloning
forward
LeuABCD cloning
reverse
LeuABCD cloning
at MCS1 reverse
CAT clonging at
MCS2 forward
CAT clonging at
MCS2 reverse
LeuA G462D
mutation forward
LeuA G462D
mutation reverse
kivD V461A
mutation forward
kivD V461A
mutation reverse
kivD F381L
mutation forward
kivD F381L
mutation reverse
adhE deletion
forward
adhE deletion
reverse
adhE deletion check
upstream
adhE deletion check
downstream

HS701

ATGCGCTG GAC CAGGTGGATATCGTCGC

HS702

CACCTG GTC CAGCGCATCTTTACCGTGG

HS703

TTATACA GCG GAAAGAGAAATTCATGG

HS704

TCTTTC CGC TGTATAACCATCATTATTG

HS705

GGACATCA CTG TTTGGCGCTTCATCA

HS706

CGCCAAA CAG TGATGTCCCTTGTTCAG

HS117
HS118

ATTTACTAAAAAAGTTTAACATTATCAGGAGAGC
ATTATG GTGTAGGCTGGAGCTGCTTC
GCCCAGAAGGGGCCGTTTATGTTGCCAGACAGCG
CTACTGA CATATGAATATCCTCCTTA

HS372

CTATACTCTCGTATTCGAGCAGATG

HS373

GGCCGTTTATATTGCCAGACAG

HS31
HS32

TTTGTGATATTTTTTCGCCACCACAAGGAGTGGA
AAATGGTGTAGGCTGGAGCTGCTTC
TAAGTGAATTCGGATGGCGATACTCTGCCATCCG
TAATTTCATATGAATATCCTCCTTA
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dld deletion forward
dld deletion reverse

Table 3-2 Continued.
Primer
name

Primer sequence (5’ to 3’)

HS39

CAGTTTATTGTCTGAATTTTCAAAATA

HS40

AGCTATAAAAAACAAAAAGCCGC

HS863
HS864

Description

GCTTAAATGTGATTCAACATCACTGGAGAAAGTC
TTATGGTGTAGGCTGGAGCTGCTTC
TCCCCTGCAACCCAGGGGAGCTGATTCAGATAAT
CCCCAATCATATGAATATCCTCCTTA

HS865

CCCGAGCGTCATCAGCAGCG

HS866

GGTCATTGCCAGCCCTTTGGCTG

HS713
HS714
HS717
HS718
HS715
HS716
HS720
HS873

dld deletion check
upstream
dld deletion check
downstream
ldhA deletion
forward
ldhA deletion
reverse
ldhA deletion check
upstream
ldhA deletion check
downstream
ilvE deletion
forward

CAAATCCGCGCCTGAGCGCAAAAGGAATATAAA
AATGGTGTAGGCTGGAGCTGCTTC
AATGGGACGGTGCGTGCCGTCCCATTTTTTGTATC
ilvE deletion reverse
ATATGAATATCCTCCTTA
ilvE deletion check
AGTCAGTTAAATAAACTG
upstream
ilvE deletion check
GCCATGGGTGGTGGTGGC
downstream
TAACCACCTGCCCGTAAACCTGGAGAACCATCGC tyrB deletion
GTGGTGTAGGCTGGAGCTGCTTC
forward
GCTGGGTAGCTCCAGCCTGCTTTCCTGCATTACA
tyrB deletion reverse
CATATGAATATCCTCCTTA
tyrB deletion check
GTTGCTAATTGCCGTTC
upstream
tyrB deletion check
TAGAACGATGGCATCAAAA
downstream

60

A volume of 25-50 L of the alcohols (≥ 98% purity) were added to the culture at 6h, 9h, 12h,
15h, and 24h time points with a working concentration of 2 g/L per addition.

3.2.6 Fermentative isoamyl acetate production
For fermentative isoamyl acetate production, cells were microaerobically cultured in a 125 mL
screw capped shake flask with a working volume of 20 mL M9 medium containing 40 g/L glucose
and 5 g/L yeast extract. For production performance comparison of the engineered strains, cells
were cultured at 37℃ for 48 hours. 10 mL of hexadecane (50% v/v) were overlaid to extract the
isoamyl acetate during the fermentation. For the glucose fed-batch fermentation, cells were first
cultured to OD 0.4~0.6 at 37℃ followed by the 0.1mM IPTG induction and subsequently cultured
at 30℃. pH was adjusted by intermittent addition of 5M KOH.

3.2.7 Analytical methods
HPLC system (Shimadzu Inc., MD, USA) was used to quantify alcohols and sugars. 800 L of
samples were centrifuged at 17,000 x g for 3 minutes followed by filtering through 0.2 micron
filters. The samples were run with 5 mM H2SO4 at 0.6 mL/min on an Aminex HPX-87H (Biorad
Inc., CA, USA) column at 50℃. Refractive index detector (RID) and ultra-violet detector (UVD)
at 220 nm were used to determine concentrations of sugars, organic acids, and alcohols.
Esters were measured by GC (HP 6890, Agilent, CA, USA) equipped with a MS (HP 5973,
Agilent, CA, USA). For the GC system, the Zebron ZB-5 (Phenomenex, CA, USA) capillary
column (30 m x 0.25 mm x 0.25 m) was used to separate analytes, and helium was used as the
carrier with a flow rate of 0.5 mL/min. The oven temperature program was set as follows: 50℃
initial temperature, 1℃/min ramp up to 58℃, 25℃/min ramp up to 235℃, 50℃/min ramp up to
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300℃, and 2-minutes bake-out at 300oC. 1 L of sampled hexadecane layer was injected into the
column in the splitless mode with an injector temperature of 280℃. For the MS system, selected
ion mode (SIM) was used to detect and quantify esters with the following parameters: (i) ethyl
acetate, m/z 45.00 and 61.00 from 4.2 to 4.6 minute retention time (RT), (ii) isopropyl acetate, m/z
45 and 102 from 4.7 to 5.0 minute RT, (iii) propyl acetate, m/z 59 and 73 from 5.2 to 5.8 minute
RT, (iv) ethyl isobutyrate, m/z 73 and 116 from 6.1 to 6.6 minute RT, (v) isobutyl acetate, m/z 61
and 101 from 6.6 to 7.6 minute RT, (vi) butyl acetate, m/z 61 and 116 from 7.7 to 9.2 minute RT,
(vii) isobutyl isobutyrate, m/z 89 and 129 from 10.1 to 12.5 minute RT, (viii) benzyl acetate, m/z
108 and 150 from 13.1 to 13.8 minute RT, and (ix) 2-phenethyl acetate, m/z 104 and 121 from
13.8 to 15.5 minute RT. As an internal standard, 10 mg/L n-decane were added in initial
hexadecane layer and detected with m/z 85, 99, and 113 from 12 to 15-minute retention time range.
The esters were identified by RT and quantified by the peak areas and standard curves. Standard
curves were determined by using pure esters diluted into hexadecane at concentrations of 0.01 g/L,
0.05 g/L, 0.1 g/L, 0.5 g/L, and 1 g/L.

3.3 Efficient alcohol conversion by E. coli whole-cell biocatalyst
3.3.1 Microbial conversion of alcohols to esters
Microbial conversion presents a renewable and sustainable route to synthesize chemicals.
Specifically, utilizing AATs for microbial ester production is most desirable because acyl-CoAs
are very expensive for cell-free ester synthesis. Even though CATec3 Y20F is compatible with a
broad range of alcohols and acyl-CoAs as presented in Chapter 2, its performance in whole-cell
biocatalyst is unknown due to complicated reaction environments (e.g., intracellular enzyme
abundance, precursor availability, intracellular pH, and temperature). Here, we characterized how
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efficient and compatible the engineered CATec3 Y20F is to enable biosynthesis of designer esters
in an E. coli whole-cell biocatalyst, a workhorse for industrial biotechnology.

3.3.2 Harnessing the engineered CAT for designer ester biosynthesis in E. coli.
To demonstrate the biosynthesis of designer acetate esters, we engineered HSEC01, a recombinant
E. coli BL21 (DE3) harboring CATec3 Y20F under the control of a T7lac promoter that uses its
native metabolism to convert fermentable sugars into the precursor acetyl-CoA and characterized
the engineered strain in the growth media supplemented with representative linear, branched,
saturated, unsaturated, and/or aromatic alcohols and with hexadecane for in situ ester extraction
(Figure 3-1A). The result showed that the recombinant CATec3 Y20F-expressing E. coli produced
all the expected acetate esters with relatively high conversion efficiency. In batch cultures,
conversion of all alcohols to their respective acetate esters achieved more than 50% (mol/mol)
yield within 24 h (Figure 3-1B). Noticeably, yields of phenylethyl and geranyl acetate reached up
to 80% (mol/mol). The recombinant E. coli produced and secreted the acetate esters at final titers
of 2.6 g/L butyl acetate, 2.3 g/L of isobutyl acetate, 3.1 g/L pentyl acetate, 2.9 g/L isoamyl acetate,
2.6 g/L 3-hexenyl acetate, 0.9 g/L benzyl acetate, 1.2 g/L 2-phenylethyl acetate, and 0.3 g/L
geranyl acetate (Figure 3-1C). To further increase ester production, we performed fed-batch
fermentation using the representative branched isoamyl alcohol and aromatic phenylethyl alcohol.
With the intermittent feeding of up to 10 g/L alcohols, the recombinant E. coli produced the
expected esters at a relatively high efficiency, achieving titers of 13.9 g/L and 10.7 g/L and yields
of 95% (mol/mol) and 80% (mol/mol) for isoamyl acetate and phenylethyl acetate, respectively
(Figure 3-2A). We did not observe any noticeable growth inhibition at this high level of ester
production in the fed batch mode due to the in situ ester extraction with hexadecane (Figure 3-2B,
63

C), even though both alcohols and esters are known to be toxic to microbial health at relatively
low concentrations (< 2 g/L)127. The turnover numbers of CATec3 Y20F were similar or better for
biosynthesis of isobutyl acetate and isoamyl acetate as compared to a widely used AAT from
Saccharomyces cerevisiae (ATF1), in engineered E. coli strains50, 66, 117, 128. Unlike ATF1, CATec3
Y20F is thermostable and compatible with broader range of alcohols and acyl-CoAs. As the
heterologous pathways for higher alcohols have been metabolically engineered in recombinant
organisms (e.g., E. coli)55, 110, 129, designer bioesters can be produced by using the engineered CAT
and either co-feeding fermentable sugars and alcohols as demonstrated here or via natural
fermentative processes which produce alcohols natively.

3.3.3 Naturally reconstituting an ester profile of roses in E. coli
To demonstrate the high efficiency and substrate compatibility of the engineered CAT for designer
ester biosynthesis in the E. coli whole-cell biocatalyst, we explored whether CATec3 Y20F could
be harnessed as an efficient AAT to create ester profiles exhibited by floral plants. In nature,
eukaryotic AATs in floral plants formulate a mixture of volatile esters that contribute to their
beneficial interactions with the environment. For example, roses (Rosa hybrida) utilize AATs,
regulated within their developing stages130, to synthesize and emit volatile esters attracting
pollinators together with other aromatic molecules (Figure 3-2A). To mimic an ester profile of R.
hybrida, we fed HSEC01 with a mixture of alcohols at a total working concentration of 1 g/L,
consisting of 0.2 g/L hexanol, 0.2 g/L 0.15 g/L 3-cis-hexen-1-ol, benzyl alcohol, 0.15 g/L
phenylethyl alcohol, 0.1 g/L geraniol, 0.1 g/L nerol, and 0.1 g/L citronellol at a mid-log phase
(OD600nm~1.0).
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Figure 3-1: Alcohol conversion by E. coli overexpressing CATec3 Y20F. (A) Microbial ester
biosynthesis by a CATec3 Y20F-expressing E. coli at 37℃. (B) Alcohol conversion efficiencies
and (C) Final titer of acetate esters from alcohol conversion by E. coli. Each value represent mean
± 1 stdev from three biological replicates. Supplemented alcohol concentrations were 3 g/L for
butanol, isobutanol, pentanol, and isoamyl alcohol, 1 g/L for benzyl alcohol, and phenylethyl
alcohol, and 0.3 g/L for geraniol. (D) Fed-batch conversion of isoamyl alcohol to isoamyl acetate.
Each value represent mean ± 1 stdev from three biological replicates. (E) Fed-batch conversion of
2-phenylethyl alcohol to 2-phenylethyl acetate. Each value represent mean ± 1 stdev from three
biological replicates. (F) Titers of isoamyl acetate and 2-phenylethyl acetate by the CATec3 Y20Fexpressing E. coli BL21(DE3) strain HSEC01 from the alcohol feeding conversion after 48 hours.
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Figure 3-2: Reconstituting an ester profile of roses. (A) Ester biosynthesis in developing rose
petals. Roses (Rosa hybrida) synthesize volatile esters by alcohol acyltransferases (AATs),
contributing to its unique aroma. (B) Simulated ester profile of roses by HSEC01 harboring
CATec3 Y20F. Each value represents mean ± 1 stdev from three biological replicates. (C) Cell
growth during the alcohol mixture Each value represents mean ± 1 stdev from three biological
replicates. The arrow indicates the point when the alcohol mixture was added to the medium.
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The recombinant E. coli could rapidly and completely convert the alcohol mixture into the
desirable acetate ester profiles with a yield of 97.1 ± 0.7 % (mol/mol) and a titer of ~1.5 g/L within
12 h (Figure 3-2B). For high production of esters, the in situ extraction using hexadecane overlay
is very critical to mitigate the toxicity of esters (Figure 3-2C).

3.4 Engineered isoamyl acetate production in E. coli
3.4.1 Microbial isoamyl acetate production
Motivated by the efficient conversion of various alcohols to acetate esters, we next questioned
whether the E. coli metabolism can be engineered to overproduce an acetate ester from glucose
fermentation without the alcohol doping. As a proof of concept, we engineered isoamyl acetate
production pathway that is a branched medium chain length ester.
Isoamyl acetate, also known as isopentyl acetate or 3-methyl-1-butyl acetate, is a versatile ester
with broad industrial applications as solvents and/or flavoring agents in food and beverage,
cosmetic, textile, aerospace, and pharmaceutical industries. Also, an isomer of isoamyl acetate,
ethyl valerate, is fully compatible for blending with gasoline or diesel62, suggesting potential
application of isoamyl acetate as drop-in biofuel. Global market of isoamyl acetate was about 5
billion USD in 2019, and it is expected to continuously grow by 2026131, 132. Like other ester
manufacturing, isoamyl acetate is synthesized by Fisher esterification of isoamyl alcohol and
acetic acid in the presence of strong acids. The process is thermodynamically unfavorable that
necessitates a large amount of alcohol and strong acid to push forward the reversible reaction.
Also, the water should be removed during the process to prevent retardation of the reaction. In
contrast, alcohol acyltransferase (AAT) dependent biological process synthesizes isoamyl acetate
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by condensing an isoamyl alcohol and acetyl-CoA. Because the reaction is thermodynamically
favorable, esters can be synthesized through fermentation under mild aqueous condition.
Recently, metabolic engineering strategies employing the AATs enabled high production
of short to medium chain esters such as ethyl acetate 69, butyl acetate 133, and isobutyl acetate 66.
However, most of the AATs have poor substrate specificity50, 65, 66, 134 and therefore, a long chain
ester pathway involving intermediate alcohol pathways can potentially produce undesired short
chain ester byproducts. Especially, isoamyl acetate pathway is so similar with isobutyl acetate
pathway that requires precise metabolic control to reduce byproducts and enhance titer and yield.
Microbial isoamyl acetate production was actively studied in early 2000s with highlights
on relationship between intracellular CoA and acetyl-CoA pool with isoamyl acetate production135138

. However, due to the limited knowledge on the AAT and pathway engineering, production titer

was relatively low (<250 mg/L). Progresses of metabolic engineering could achieve high levels of
isoamyl alcohol production139, 140, a key precursor of isoamyl acetate, suggesting that bridging the
alcohol production platform with an appropriate ester biosynthesis platform can potentially
produce isoamyl acetate at high titer. A critical is to manipulate pathway specificity within multiple
gene overexpression for an efficient isoamyl acetate production.
In this study, we engineered E. coli to produce isoamyl acetate from glucose fermentation.
We investigated specificity control by engineering isobutanol and isoamyl alcohol pathway
modules to achieve a high titers and specificity of isoamyl acetate production. The optimized strain
produced isoamyl acetate at titers of 8g/L with reduced isobutyl acetate byproduct. The flux shift
and amplification by stepwise engineering suggests metabolic bottlenecks in engineered isoamyl
acetate production.
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3.4.2 Optimization of isobutanol production module
Isoamyl acetate production pathway starts from pyruvate (Figure 3-3). Pyruvate is converted to 2ketoisovalerate (2-KIV) which is elongated to 2-ketoisocaproate (2-KIC) via the L-leucine
biosynthesis pathway facilitated by LeuABCD operon. The Ehrilch pathway driven by ketoacid
decarboxylase (KDC) converts the 2-KIC to isovaleraldehyde which is reduced to isoamyl alcohol
by alcohol dehydrogenases. Finally, the isoamyl alcohol is condensed with acetyl-CoA to isoamyl
acetate via the AAT pathway. To maximize the flux, strong metabolic drive from pyruvate to 2KIV is important. Since the pathway has been well studied for isobutanol production141, we first
aimed to construct an efficient isobutanol pathway that can be latter rewired to isoamyl acetate
production.
It has been suggested that heterologous expression of AlsS (2-acetolactate synthase) from
Bacillus subtilis and KivD (2-ketoisovalerate decarboxylase) from Lactococcus lactis is critical
for high level isobutanol production141. We constructed three different plasmids harboring alsS
and kivD with different plasmid copy numbers from a previously reported plasmid pHM46124, and
introduced to wild type BL21 (DE3). For a sufficient flux, ilvC (ketoacid reductoisomerase), ilvD
(Dihydroxy-acid dehydratase), and yqhD (alcohol dehydrogenase) were overexpressed under the
control of T7 promoter (Figure 3-4A). Then, isobutanol production by the recombinant E. coli
strains were measured to identify the most efficient combination of the production modules (Figure
3-4B). Interestingly, the higher copy number of alsS and kivD achieved the higher isobutanol titer.
HSEC0503 harboring the pRSFDuet-1 backbone plasmid with >100 plasmid copy number (PCN)
produced 5.9 g/L of isobutanol within 48 hours, yet alsS and kivD in a relatively low copy number
plasmid (pACYCDuet-1) produced only 0.03 g/L of isobutanol. Therefore, we started from the
production modules with alsS and kivD in the high copy number plasmid.
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Figure 3-3: A map of metabolic pathway for isoamyl acetate production. Gene deletion targets are
presented as the red cross marks.
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Figure 3-4: Optimization of isobutanol production module. (A) Operon architecture of production
modules, (B) Isobutanol production by E. coli BL21(DE3) harboring the production modules.
Plasmid copy number of pRSF, pCDF, pET, and pACYC are >100, 20~40, 15~20, and 10~12,
respectively.
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3.4.3 Push and pull engineering
When metabolic flux is balanced, combination of deletion or downregulation of competitive
upstream pathways and overexpression of metabolite-forming upstream pathways can achieve
large flux amplification142. Starting from the isobutanol production module, we employed the
“push-and-pull” metabolic engineering strategy to shift the flux towards isoamyl acetate.
Because KivD, YqhD are promiscuous, overexpression of LeuABCD can rewire the
isobutanol pathway to isoamyl alcohol, which can be converted to isoamyl acetate by expressing
an AAT (Figure 3-3). We constructed a leuABCD operon in pCDFDuet-1 plasmid to complete the
isoamyl alcohol production pathway (Figure 3-5A). Theoretically, expressing an AAT on top of
the isoamyl alcohol production modules can produce isoamyl acetate. However, due to the high
similarity of intermediate metabolites of the isobutyl acetate and isoamyl acetate pathways,
choosing an isoamyl alcohol specific AAT was important for specific isoamyl acetate production.
Previously, we engineered a chloramphenicol acetyltransferase CATec3 Y20F to produce a broad
range of esters in microbes59. The use of CATec3 Y20F capitalizes 3.5-folds higher catalytic
efficiency (kcat/KM) towards isoamyl alcohol than isobutanol (Table 2-9). It should be noted that
other AATs have similar catalytic efficiency towards isobutyl acetate and isoamyl acetate66.
Because the acetate esters are toxic to cell growth, hexadecane was overlaid on the culture to
extract the produced esters in situ. Wild type BL21(DE3) expressing the isoamyl acetate
production modules (HSEC1006) produced 0.29 g/L isoamyl acetate and 0.32 g/L isobutyl acetate.
We hypothesized that improving flux to isoamyl alcohol is required to leverage the isoamyl
acetate titers and specificity. Therefore, we implemented three strategies: 1) deletion of pyruvate
and acetyl-CoA pool related genes, adhE (aldehyde-alcohol dehydrogenase) and dld (quinonedependent D-lactate dehydrogenase), 2) expression of a feedback insensitive LeuA G462D

72

mutant143, and 3) expression of longer chain keto-acid specific KivD V461A, F381L55 (Figure 35B). The engineered strains produced less isobutyl acetate down to 0.07 g/L while isoamyl acetate
titers reached to 0.8 g/L (Figure 3-5B). Although the engineering strategies could improve the
isoamyl acetate specificity, isoamyl acetate titers were not further improved. Interestingly, more
than 1 g/L of isobutanol and isoamyl alcohol were accumulated that likely inhibited HSEC1210
growth (Figure 3-5C, D, E). Especially, 2.5-3 g/L level of isoamyl alcohol inhibits 50-80% of cell
viability139, 144. Therefore, we hypothesized that AAT activity should be improved to prevent the
alcohol accumulation.
Gene arrangement in an operon affects expression level of the individual genes145. Because
CATec3 Y20F was cloned at the downstream of alsS (Figure 3-5A), expression level of CATec3
Y20F could be compromised. To improve the CATec3 Y20F, we simply cloned additional
monocistronic CATec3 Y20F operon in the pCDF plasmid under the control of T7lac promoter
(Figure 3-6A). The additional expression of CATec3 Y20F significantly reduced isoamyl alcohol
accumulation and improved isoamyl acetate production (Figure 3-6B, C), suggesting that high
expression level of the AAT is important to avoid the accumulation of the toxic precursor alcohols.
Although HSEC1311 produced 4.1g/L of isoamyl acetate, glucose consumption was significantly
inhibited after 36 hours of the culture (Figure 3-6D), suggesting that there is another bottleneck(s)
causing the fermentation cessation. The fermentation cessation was similarly observed from an
engineered E. coli strain producing isoamyl alcohol (3-methyl-1-butanol), reasoning toxicity of
isoamyl alcohol140. However, our system did not accumulate isoamyl alcohol higher than 0.2 g/L
(Figure 3-6B), and isoamyl acetate was efficiently extracted to hexadecane layer during the
fermentation at 94 ± 2% (w/w) efficiency.
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Figure 3-5: Engineered strain comparison. (A) Architecture of synthetic operons to produce
isoamyl acetate. PCN: plasmid copy number. (B) Titers of isobutyl acetate and isoamyl acetate by
engineered E. coli strains. (C-E) Characterization of the engineered strains. (C) Isobutanol and
isobutyl acetate titers, (D) Isoamyl alcohol and isoamyl acetate titers, (E) Cell growth. The star (*)
denotes mutant leuA and kivD. All data are presented as means ± stdev of three biological
replicates.
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We hypothesized that the growth condition might be the reason of the fermentation
cessation because the pH after 48 hours of the culture was as low as 5.5. Therefore, we next deleted
genes relevant to the organic acid formulation, ldhA (L-lactate dehydrogenase) and ackA-pta (An
operon of acetate kinase and phosphate acetyltransferase), which have been commonly deleted to
reduce the lactate and acetate formulation15,

146

. To improve ketoacid availability, we also

subsequently deleted ilvE (branched chain amino acid aminotransferase) and tyrB (aromaticamino-acid aminotransferase)139.
Unfortunately, additional deletions did not significantly improve isoamyl acetate titers and
yields (Figure 3-7A, B), suggesting that the upstream competitive pathways were not major
bottlenecks of the system. The production yield reached up to 0.21 (g/g) that corresponds to 59%
of the theoretical maximum yield (0.36 g/g). The yield is higher than a previously reported isoamyl
alcohol producing E. coli that reported 0.11 (g/g) corresponding to 33% of the theoretical
maximum yield140. Theoretically, one mole of isoamyl acetate requires two moles of glucose that
supplies two acetyl-CoAs and one isoamyl alcohol. The pathway necessitates production of five
mole excess NAD(P)H that could hamper the fermentation under the microaerobic condition
without an appropriately coupled electron sink pathway.

3.4.4 Glucose fed-batch fermentation
The comparable production yield prompted us to investigate glucose-fed batch
fermentation with pH control for higher isoamyl acetate production titer. We employed HSEC1614
(BL21 (DE3) ∆adhE ∆dld ∆ldhA ∆ackA-pta ∆ilvE ∆tyrB harboring the isoamyl acetate production
modules) to produce isoamyl acetate over 120 hours of glucose fed-batch fermentation.
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Figure 3-6: Increasing the AAT activity by additional clone of CATec3 Y20F. (A) A diagram of
production module combination in HSEC1210 and HSEC1311. (B) Accumulated isoamyl alcohol
concentration in the medium. (C) Produced isoamyl acetate in the hexadecane layer. (D) A time
dependent profile of glucose, isoamyl acetate, and isobutyl acetate of HSEC1311 culture.
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Figure 3-7: Isoamyl acetate production by deletion strains. (A) Isoamyl acetate titers after 48 hours.
(B) Isoamyl acetate production yield and corresponding maximum theoretical yield percentage.
The yield was measured at between 24 and 36 hours, the middle of production phase. All the data
presents mean ± 1 stdev from three biological replicates.
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The pH was adjusted with 5M KOH every 12 hours after 36 hours until 96 hours, maintained at
between 6.0 and 7.5 (Figure 3-8). Final isoamyl acetate titers reached to 8.0 g/L corresponding to
overall yield of 0.16 (g/g), from 51 g/L of consumed glucose over the 120 hours with volumetric
productivity of 2.6 (g/L/day). The intermittent pH adjustment could maintain the fermentation
process over the 120 hours, suggesting that pH control is important to prevent the fermentation
cessation. Isobutyl acetate, a major byproduct, increased from 36 hours to 72 hours up to final
concentrations of 1.0 g/L. A possible explanation of the isobutyl acetate is promiscuous KDC
activity of the AlsS. The AlsS enables isobutanol production without KivD when IlvCD are
overexpressed in E. coli147.Overall, pH adjusted glucose fed-batch fermentation of the engineered
E. coli could produce isoamyl acetate up to 8.0 g/L.

3.5 Conclusion
In this chapter, modularity of ester biosynthesis at metabolic network level was engineered in a
model mesophilic bacterium E. coli, demonstrating high alcohol conversion and ester titer. The
metabolic engineering of E. coli for isoamyl acetate production articulated strategies to control the
product specificity by pathway module engineering. With non-toxic hexadecane overlay, the
engineered E. coli produced isoamyl acetate above than solubility limit (2 g/L), suggesting that
higher chain esters with low solubility can be produced at high titers and yield. Acylation of
alcohols generally increases hydrophobicity that allows in situ product recovery via hybrid
extraction-distillation process which can recover the ester products at high concentration and
purity followed by distillation with a lower energy requirement148. Because long chain esters are
much less toxic than their precursor alcohols149-151, esterification of the toxic alcohols will be
advantageous for overall bioprocessing.
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Figure 3-8: Fed-batch isoamyl acetate production by HSEC1614(∆adhE ∆dld ∆ldhA ∆ackA-pta
∆ilvE ∆tyrB harboring the isoamyl acetate production modules).
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The detoxification by esterification was recently demonstrated for geranyl acetate production in
engineered E. coli150. Acylation of alcohols generally increases hydrophobicity that allows in situ
product recovery via hybrid extraction-distillation process which can recover the ester products at
high concentration and purity followed by distillation with a lower energy requirement148.
Engineering specificity of LeuA, KivD, and AAT can further exploit the production
pathways for a longer chain branched acetate esters such as isohexyl acetate (C8) and isoheptyl
acetate (C9) with controlled metabolic flux as described here. Protein engineering of LeuA from
E. coli and KivD from L. lactis can increase the binding pocket size for higher chain alcohol
production55, and indolepyruvate decarboxylase (IPDC) having higher specificity towards long
chain ketoacids exists152. Therefore, microbial production of the long-branched chain esters at high
titers will be feasible with a combination of metabolic engineering and process engineering.
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4. Chapter 4. Engineering metabolic network/cellular level
modularity of ester biosynthesis in non-model organisms
This chapter focuses on engineering modularity of ester biosynthesis at metabolic network/cellular
level in a non-model cellulolytic and thermophilic bacterium, Clostridium thermocellum. Parts of
this chapter are slightly modified from published papers58, 59, 153.

4.1 Motivation
More than 80% of metabolic engineering research have employed model-organisms such as
Escherichia coli and Saccharomyces cerevisiae because they are well characterized, and many
genetic engineering tools and parts are available. Although the model organisms are useful to
develop a novel metabolic pathway, it is often difficult to obtain desirable phenotypes even with
extensive engineering. A representative example is to engineer model microbes to efficiently
utilize recalcitrant lignocellulose, the most abundant carbon source in the planet, and produce
valuable chemicals as well. Degradation and utilization of the polysaccharide usually require
multiple enzymes in a concerted action154, 155, which is challenging to accomplish by engineering
a non-cellulolytic microbe. Heterologous engineering of cellulose utilization necessitates effective
expression and secretion of multiple cellulases and therefore, building a production pathway on
top of an engineered cellulose assimilation system usually results in metabolic burden and
imbalance compromising production efficiency and/or the cellulose fermentation capability156, 157.
Domesticating a non-model cellulolytic bacterium is another approach to develop
bioprocesses utilizing lignocellulose for valuable chemical production. Cellulolytic bacteria have
been evolved to efficiently degrade and consume cellulose with robust enzyme systems such as
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cellulosome154. Therefore, cellulolytic bacteria have increasingly become attractive for direct
conversion of lignocellulosic biomass into esters in a consolidated bioprocessing (CBP)
configuration where biomass degradation and fermentation simultaneously take place in a single
step and hence reduce the production cost158.
A

gram-positive

and

thermophilic

anaerobe

Clostridium

thermocellum

(Hungateiclostridium thermocellum) is an ideal cellulolytic bacterium for CBP because it is the
best biomass degrader known to date and has endogenous metabolic pathways for synthesizing
various alcohols including ethanol and isobutanol159-161. Also, due to high volatility of esters, the
bioprocess at elevated temperatures can benefit downstream product separation and hence reduce
the process cost. However, most of the AATs known to date are isolated from mesophilic microbes
or plants162-165, and none of them has been reported to be active at elevated temperatures (> 50oC).
The highest temperature reported for ester production is 42℃ in a thermotolerant yeast68.
Therefore, engineering C. thermocellum can attain a milestone for CBP ester production from
lignocellulose at elevated temperatures.
In this chapter, we engineered C. thermocellum to produce ester from cellulose
fermentation by harnessing the engineered robust ester biosynthesis module. We screened
esterases responsible for ester hydrolysis and disrupted the two critical esterases that helped
alleviate the isobutyl acetate degradation in C. thermocellum while not affecting cellulose
utilization. By introducing the engineered CATec3 Y20F, the engineered esterase-deficient C.
thermocellum strain could convert various alcohols into esters by cellulose fermentation. In
combination with gene expression and fermentation optimization, we demonstrated the firstgeneration of engineered C. thermocellum capable of producing 0.34 g/L of C4-derived esters by
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direct cellulose fermentation and 1 g/L of C4-derived esters with an isobutanol supplemented
cellulose fermentation.

4.2 Materials and methods
4.2.1 Bacterial strains and plasmids
Strains and plasmids are listed in Table 4-1. C. thermocellum DSM 1313 ∆hpt (M1354)166 was
used as the parent strain because the hpt deletion allows counter-selection for markerless gene
deletion167. Escherichia coli TOP10 and BL21(DE3) were used for molecular cloning and dam
methylation of plasmids for C. thermocellum transformation168, respectively. For characterization
of carbohydrate esterases, E. coli BL21 CodonPlus (DE3)- RIPL (Agilent, CA, USA) was used as
an expression host to avoid potential expression problems caused by codon bias.

4.2.2 Bioinformatics
The homology model of Clo1313_0613 was generated using the Swiss-Model software169 and
visualized using the Molecular Operating Environment software (MOE, version 2019.01). The 3D
structure was energy minimized with the Amber10: EHT force, and the binding pocket was
searched using the ‘Site Finder’ tool in MOE.
Identified esterases were sequence aligned with the homolog proteins from different
organisms. The representative homologous proteins of Clo1313_0613 and Clo1313_0693 were
identified from the Carbohydrate Active Enzymes (CAZy) database (http://www.cazy.org/) along
with BLAST search170, 171 and their sequences were retrieved from the NCBI protein sequence
repository. Their domain sequences were aligned by ClustalW172 in Mega781.
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Table 4-1: A list of plasmids and strains used in this study.
Name
Plasmids
pETDuet-1
pET_1424t

Descriptions

Source

pBR322 ori, AmpR, lacI, T7lac promoter
Clo1313_1424t cloned at MCS1 site. Original signal peptides
removed and tagged with 6x His at N-terminus
pET_1139
Clo1313_1139 cloned at MCS1 site. Original signal peptides
removed and tagged with 6x His at N-terminus
pET_1680
Clo1313_1680 cloned at MCS1 site. Original signal peptides
removed and tagged with 6x His at N-terminus
pET_0521
Clo1313_0521 cloned at MCS1 site. Original signal peptides
removed and tagged with 6x His at N-terminus
pET_0613
Clo1313_0613 cloned at MCS1 site. 6x His at N-terminus
pET_0693
Clo1313_0693 cloned at MCS1 site. Original signal peptides
removed and tagged with 6x His at N-terminus
pHS005
pNW33N derivative, The backbone plasmid for gene deletions
pHS0024_F97W
pNW33N derivative, CATsa_F97W under C. thermocellum
gapDH promoter
pNW33N derivative, CATsa_F97W under C. thermocellum
pHS0024_CATec3
gapDH promoter
pHS0024_Y20F
pNW33N derivative, CATsa Y20F under C. thermocellum
gapDH promoter
pHS0024_Y20F
pNW33N derivative, CATsa_Y20F A138T under C.
A138T
thermocellum gapDH promoter
pHS0059
pHS0024 harboring CATec3 replacing with CATsa
pHS0059_Y20F
CATec3 Y20F under C. thermocellum gapDH promoter
pHS0070
pHS0059_Y20F with truncated GapDH promoter
Strains
E. coli
Top10
Host for molecular cloning, mcrA, ∆(mrr-hsdRMS-mcrBC),
Phi80lacZ(del)M15, ∆lacX74, deoR, recA1, araD139, ∆(araleu)7697, galU, galK, rpsL(SmR), endA1, nupG
BL21 (DE3)
Host for plasmid in vivo methylation, E. coli B dcm, ompT,
hsdS(rB-mB-), gal
Host for heterologous esterase expression, E. coli B F- ompT
BL21-CodonPlus
hsdS(rB- mB-) dcm+ gal λ(DE3) endA Hte [argU proL] [argU
(DE3)- RIPL
ileY leuW], TetR , CmR, Strep/SpecR
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Novagen
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study

Invitrogen
Invitrogen
Agilent

Table 4-1 Continued.
Name

Descriptions

Source

M1354

C. thermocellum DSM1313 ∆hpt

166

HSCT1003
HSCT1004
HSCT2005

M1354 ∆clo1313_0613
M1354 ∆clo1313_0693
M1354 ∆clo1313_0613 ∆clo1313_0693
M1354 ∆clo1313_0613 ∆clo1313_0693 ∆clo1313_1160
(ldhA)
HSCT2005 harboring pHS0024_F97W
M1354 harboring pHS0024_F97W
HSCT2005 harboring pHS0024_Y20F
HSCT2005 harboring pHS0059
HSCT2005 harboring pHS0059_Y20F
HSCT2005 harboring pHS0024_Y20F A138T
HSCT3009 harboring pHS0070

This study
This study
This study

C. thermocellum

HSCT3009
HSCT2105
HSCT0102
HSCT2106
HSCT2107
HSCT2108
HSCT2113
HSCT3110
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This study
This study
This study
This study
This study
This study
This study
This study

Phylogenetic trees were built based on the aligned sequences using the maximum likelihood
method with 1,000 bootstrap replicates. A 40% bootstrap confidence level cutoff was selected.

4.2.3 Genetic engineering of C. thermocellum
The primers used in this chapter are listed in Table 4-2. C. thermocellum cells were transformed
by electroporation58, 167. Electroporation was performed outside of the anaerobic chamber followed
by cell recovery and plating inside the chamber. A series of two consecutive exponential pulses
were applied using the electroporation system (cat # 45-0651, BTX Technologies Inc., MA, USA)
set at 1.8 kV, 25 F, and 350 Ω, which usually resulted in a pulse duration of 7.0-8.0 ms. For
markless gene deletions, 500 bp to 750 bp length of upstream (5’) and downstream (3’) fragments
of the target gene were assembled by overlapping PCR and cloned in the MCS1 of pHS005. In the
MCS2, 500 bp to 750 bp intermediate fragments (int) were cloned. The dam methylated plasmid
was introduced to C. thermocellum and selected in CTFuD agar supplemented with Thm. A colony
from successful transformation was selected and cultured in the liquid CTFuD-NY medium
supplemented with Thm until the cell culture reached mid-log growth phase (OD ~ 0.2- 0.6). Cells
were then serially diluted 100-fold and plated on a CTFuD-NY agar plate supplemented with Thm
and 30 µg/mL 5-fluoro-2′-deoxyuridine (FuDR) followed by 3-5 days of incubation at 55℃. The
colonies were PCR screened using the primers, HS252 and HS253 (Table 4-2), to check for
plasmid loss. A colony without a PCR product was selected and streaked on the CTFuD-NY agar
plate containing Thm and FuDR followed by incubation at 55℃ for 3-5 days. Colonies were PCR
screened again to ensure plasmid loss and then cultured in the liquid CTFuD-NY medium without
selection. The cultured cells were serial diluted 100-fold and plated on the CTFuD-NY agar
supplemented with 500 µg/mL 8-azahypoxanthine (8-AZH).
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Table 4-2: A list of primers used in this study. The restriction enzyme sites were underlined.
Primer
name

Primer sequence (5’ to 3’)

HS302

CTCTGGATCCAATGGCCCCGAATGAATACAAG

HS230
HS304
HS234
HS306
HS238
HS229
HS230
HS303
HS232
HS305
HS236
HS307
HS240
HS186
HS473
HS474
HS475
HS441
HS442

Description

Clo1313_0693 cloning
forward
CTCTGAGCTCTTAATTGGTTTTCAAATACTTCG Clo1313_0693 cloning
C
reverse
CTCTGGATCCAATGGATGTGGTAATTACGTCA
Clo1313_0521 cloning
AACC
forward
Clo1313_0521 cloning
CTCTGAGCTCTTACGGTACAGAGTTATAC
reverse
CTCTGGATCCAATGTCCCGGGAAGACGTTGTA Clo1313_1680 cloning
GG
forward
Clo1313_1680 cloning
CTCTGAGCTCTTACTGTTTTTTTATCTGTCTTC
reverse
Clo1313_0613 cloning
CTCTGGATCCAATGGCACAATTATATGATATGC
forward
Clo1313_0613 cloning
CTCTGAGCTCTTACGGATTCAGCTCATCC
reverse
Clo1313_0500 cloning
CTCTGGATCCAATGGCAGCGGTCAATGCG
forward
Clo1313_0500 cloning
CTCTGAGCTCTTATACAGGCAATTGTGTAATTG
reverse
CTCTGGATCCAATGACAAGAGAGCAGGAAAAT Clo1313_1139 cloning
CTC
forward
Clo1313_1139 cloning
CTCTGAGCTCTCATTTCTCAAGTATAAGG
reverse
CTCTGGATCCAATGAAAACGATAAAAATCATG Clo1313_1424 cloning
CCTG
forward
Clo1313_1424 cloning
CTCTGAGCTCCTAATTTCTAAGAAGTATTC
reverse
Clo1313_0613 deletion
CTCTGAGCTCAGAATTGCAACAAACATTTC
upstream forward
CCATATATAGCATTTTCAAAACCCCTTTTTATT Clo1313_0613 deletion
C
upstream reverse
AAAAGGGGTTTTGAAAATG
Clo1313_0613 deletion
GTATATATGGATGCGGTTCG
downstream forward
CTCTGGATCCTTACGGATTCAGCTCATCCATAA Clo1313_0613 deletion
G
downstream reverse
TTGTACACGGCCGCATAATCTGCAAATATTGA
Clo1313_0613 deletion
AGGGTG
intermediate forward
GCAGCCTAGGTTAATTAAGCTGCGCTTACGGA Clo1313_0613 deletion
TTCAGCTCATCCATAAGTATC
intermediate reverse
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Table 4-2 Continued.
Primer
name

Primer sequence (5’ to 3’)

HS370

GGTTTACTGTACAGGGCTTC

HS371

GCTCGACTTGCATGTGTTAG

HS452

CTCTGAGCTCCCGGAAGATATGCCTGC

HS453
HS454
HS455
HS456
HS457

Description

GAAAAGGAGAACTT
ATTCCTTCCTCCTTTATCAATAAC
ATAAAGGAGGAAGGAAT
AAGTTCTCCTTTTCTTTTATGA
CTCTGGATCCATCTTGACAGTATTTCGGATTC
TTGTACACGGCCGCATAATC
GCCAACCAAAAAGAAGGCG
GCAGCCTAGGTTAATTAAGCTGCGC
TCATATATCTAGTGTTTTTATTATTTC

HS83

AGCATCGGCATCATCTC

HS86

CAAGGGGTTTTCGTCGTG

HS476

CTCTGAGCTCGTGCGGAAAAGAAAATTAGG

HS477
HS478
HS479
HS480
HS481

TGATAACGTTATTCCCAAATTGGCCTGATGAA
GCCATATTTC
CATCAGGCCAATTTGGGAATAACGTTATCAGG
GCAACAGC
CTCTGGATCCTTAATTGGTTTTCAAATACTTCG
C
TTGTACACGGCCGCATAATCGGAAGCAACGCT
TGCATTATATATGCC
GCAGCCTAGGTTAATTAAGCTGCGCTTGATTA
AGATTTGCCACTATACC

HS53

ATTGTGTATCATTTGCATAAACAATG

HS56

GTTTTTGTCCAGCCACTTAAGCAC

HS252

TTTTACGGTGTAAACCTTCCTC

HS253

AAAAGAAAATCGCTAATGTTGATTAC
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Clo1313_0613 deletion
check primer
Clo1313_0613 deletion
check primer
Clo1313_1160 deletion
upstream forward
Clo1313_1160 deletion
upstream reverse
Clo1313_1160 deletion
downstream forward
Clo1313_1160 deletion
downstream reverse
Clo1313_1160 deletion
intermediate reverse
Clo1313_1160 deletion
intermediate reverse
Clo1313_1160 deletion
check primer
Clo1313_1160 deletion
check primer
Clo1313_0693 deletion
upstream forward
Clo1313_0693 deletion
upstream reverse
Clo1313_0693 deletion
downstream forward
Clo1313_0693 deletion
downstream reverse
Clo1313_0693 deletion
intermediate forward
Clo1313_0693 deletion
intermediate reverse
Clo1313_0693 deletion
check primer
Clo1313_0693 deletion
check primer
Plasmid ori RepB check
primer
Plasmid ori RepB check
primer

After three days, colonies were PCR screened using the primers binding at genome-specific
upstream and downstream sites of the target knockout gene. A colony was streaked on a new
CTFuD-NY plate up to three transfers to isolate a single genotype. Finally, the markerless gene
deletion was confirmed by negative cell growth in CTFuD medium supplemented with Thm.

4.2.4 Media and cultivation
E. coli strains were grown in lysogeny broth (LB) medium supplemented with 30 µg/mL
chloramphenicol (Cm) and/or 50 µg/mL kanamycin (Kan) when appropriate. All C. thermocellum
strains were cultivated in an anaerobic chamber (Sheldon manufacturing, OR, USA) with a gas
mixture (90% N2, 5% CO2, 5% H2) or rubber stopper sealed Balch tubes outside the chamber. For
genetic engineering, C. thermocellum strains were grown in rich media, CTFuD or CTFuD-NY167
supplemented with 10 µg/mL thiamphenicol (Thm) as needed. The CTFuD medium contained 2
g/L yeast extract while CTFuD-NY contained vitamins and trace elements167 without yeast extract.
Except for isobutyl acetate production from cellulose, C. thermocellum strains were grown in a
defined MTC medium with 5 g/L cellobiose as previously described
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. To produce isobutyl

acetate from cellulose, a modified MTC medium (C-MTC) was used as previously described
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.

The C-MTC medium contained (per liter): 2 g urea, 1.5 g ammonium chloride, 10 g 3-(Nmorpholino)propanesulfonic acid (MOPS), 2 g sodium citrate tribasic dihydrate, 1.5 g citric acid
monohydrate, 1 g sodium sulfate, 0.5 g potassium phosphate monobasic, 1 g cysteine-HCl, 0.2 g
calcium chloride, 1 g magnesium chloride hexahydrate, 0.1 g iron (II) chloride tetrahydrate, 2.5 g
sodium bicarbonate, 0.02 g pyridoxamine dihydrochloride, 0.004 g p-aminobenzoic acid, 0.002 g
biotin, and 0.002 g vitamin B12. The medium was adjusted to pH of 7.5 and autoclaved for
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sterilization. Solid LB and CTFuD media additionally contained 15 g/L and 10 g/L of agar,
respectively.

4.2.5 Esterase and thioesterase assay
To screen esterase activity towards isobutyl acetate, seven putative esterases from C. thermocellum
were heterologously expressed in E. coli BL21 CodonPlus-RIPL(DE3) strains under a control of
T7lac promoter. The recombinant E. coli strains were cultured overnight in 3 mL of LB medium
at 37℃, transferred to 25 mL of fresh LB medium with 100-fold dilution, and cultured at 37℃
until OD reached 0.3~0.4. Then, protein expression was induced by adding isopropyl β-D-1thiogalactopyranoside (IPTG) at final concentration of 0.1 mM. The IPTG-induced cells were
cultured in a water bath orbital shaker (MaxQ7000, Thermo Fisher Scientific, MA, USA) at 19℃
and 200 rpm up to 16 hours and harvested by centrifugation at 4,700 xg for 5 minutes. The cell
pellets were washed with Milli-Q water once and suspended in a B-PER complete bacterial protein
extraction reagent (cat# 89821, Thermo Fisher Scientific, MA, USA) to disrupt cell wall. Crude
cell extract was collected by 5 minutes of centrifugation at 17,000 xg for further experiments.
Deacetylation activity of the seven O-deacetylases was screened by a colorimetric pNPA assay on
a 96-well plate. The reaction buffer contained 50 mM Tris-HCl at pH 6.8 and 10 mM pNPA in
200 L of total reaction volume. The reaction started by adding crude cell extracts at 2X, 4X, and
8X dilutions and then an absorbance at 405nm was monitored in a microplate reader at 50℃ for
10 minutes.
The 6xHis tagged enzymes were purified by Ni-NTA agarose (cat# 25214, Thermo Fisher
Scientific, MA, USA) using a mini spin column (cat# 6572, BioVision Inc., CA, USA), based on
the manufacturer’s recommendation. The eluted enzyme was desalted by a centrifugal filter unit
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(cat# C7719, MilliporeSigma, MA, USA) before the enzyme reaction. The reaction assay
contained 20 mM Tris-HCl at pH 7.4 and 20 mM of isobutyl acetate in 1 mL total volume. The
reaction started by adding 5 g/mL of the His-tag purified enzymes, followed by 10 hours
incubation at 55℃ in an oven. pH change was measured with a pH meter (Hach, CO, USA) before
and after the reaction to screen for esterase activity. In addition, HPLC analysis was used to verify
the hydrolysis of isobutyl acetate into isobutanol and acetate.
Thioesterase activities of Clo1313_0613 and Clo1313_0693 were measured by DTNB
assay using isobutyl-CoA as a substrate94. The reaction solution consisted of 50 mM Tris-HCl at
pH 6.8, 0.5 mM of isobutyl-CoA, and 1 mg/mL DTNB in 100% DMSO in 50 L of total reaction
volume. 10 g/mL of the His-tag purified enzymes were added to the reaction solution and
immediately incubated at 50℃ in a plate reader followed by kinetic measurement at 412nm for 30
mins. The reaction rate and specific activity were calculated using the extinction coefficient from
a standard curve of free coenzyme A (MP Biomedicals, OH, USA) under the same condition.

4.2.6 Proteomics
For proteomics, cell cultures were sampled at 48h in the middle of stationary growth phase and
stored in -80℃ before the analysis. Two milliliters of a slurry containing C. thermocellum cells
growing on Avicel was pelleted by centrifugation (5000 x g for 10 min), supernatant discarded,
and pellet resuspended in 350 µl of lysis buffer (4% SDS, 5 mM DTT, 100 mM Tris-HCl, pH 8.0).
Cells were lysed by sonication (Branson Sonifier; 20% amplitude, 2 s pulses, 30 s total), precleared
by centrifugation (21000 x g for 10 min) and crude protein supernatant with a Nanodrop OneC
spectrophotometer (Thermo Scientific). Samples were then adjusted 15 mM iodoacetamide (20
min at room temperature in the dark) and 300 µg cleaned up via protein aggregation capture174.
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Aggregated protein (on 1-micron magnetic Sera-Mag beads; GE Healthcare) was then digested
with proteomics-grade trypsin (1:75 w/w; Promega) in 100 mM Tris-HCl, pH 8.0 overnight at
37°C, and again for 3 h at 37°C the following day. Released tryptic peptides were then acidified
to 0.5% formic acid, filtered through a 10 kDa MWCO spin filter (Vivaspin 2; Sartorius), and
quantified by Nanodrop OneC. Three micrograms of peptides were then analyzed by 1D LCMS/MS using a Vanquish uHPLC coupled directly to an Orbitrap Q Exactive mass spectrometer
(Thermo Scientific) as previously described 175. Peptides were separated across a 180 min organic
gradient using an in-house pulled nanospray emitter packed with 15 cm of 1.7-micron Kinetex
reversed-phase resin (Phenomenex). Peptide fragmentation spectra were analyzed/sequenced by
Proteome Discoverer software (Thermo Scientific) and peptides quantified by chromatographic
area-under-the-curve. Peptide abundances were log2 transformed, distributions normalized by
LOESS, and rolled up to their respective proteins via RRollup InfernoRDN176. Protein abundance
distributions were then median centered and statistical analyses performed in Perseus177. Manual
determination of CATec3 abundance across strains was performed by comparing log2 peptide
abundance trends across orthologs as only one AA difference differentiate the two protein forms.
All LC-MS/MS raw data have been deposited into the MassIVE and ProteomeXchange
repositories with the following accession numbers: MSV000086201 (MassIVE) and PXD021695
(ProteomeXchange).

Data

can

be

downloaded

directly

via

ftp://massive.ucsd.edu/MSV000086201/

4.2.7 Conversion of alcohols to esters in C. thermocellum
Tube-scale cellulose fermentation was performed in the batch mode. Briefly, 19 g/L of Avicel PH101 was used as a sole carbon source in a 16 mL culture volume. 0.8 mL of overnight cell culture
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was inoculated in 15.2 mL of C-MTC medium, and 4 mL hexadecane was added in the anaerobic
chamber. Each tube contained a small magnetic stirrer bar to homogenize cellulose, and the culture
was incubated in a water bath connected with a temperature controller and a magnetic stirring
system. Alcohols were fed to the culture at 36h time point when cells entered early stationary
growth phase. pH was adjusted to between 6.4 and 7.8 with 5 M KOH injection.

4.2.8 Fermentative ester production
Ester production from cellobiose in C. thermocellum strains was performed by the two-step
bioconversion configuration. Cells were first cultured in MTC minimal medium167 containing 5
g/L cellobiose in a rubber capped Balch tube until OD reached 0.8~1.0. The cells were cooled
down at room temperature for 20 minutes and centrifuged at 4,700 x g and 4℃ for 20 minutes.
After removing the supernatant, cells were resuspended in the same volume of fresh MTC minimal
media containing 2 g/L isobutanol in an anaerobic chamber. The cell suspension was then divided
into 800 L in a 2.0 mL screw cap microcentrifuge tube with a 200 L hexadecane overlay. The
cells were incubated at 55℃ for 24 hours followed by analysis of gas chromatography coupled
with a mass spectrometer (GC/MS) to quantify the amount of isobutyl acetate produced.
For the cellulose fermentation, modified MTC medium (C-MTC medium) was used. 20
g/L of Avicel PH-101 was used as a sole carbon source instead of cellobiose, and 10 g/L of MOPS
was added to increase buffer capacity. Initial pH was adjusted to 7.5 by 5M KOH and autoclaved.
In an anaerobic chamber, 0.8 mL of overnight cell culture was inoculated in 15.2 mL of C-MTC
medium (1:20 inoculation ratio) with 4 mL of overlaid hexadecane. Each tube contained a small
magnetic stirrer bar to homogenize cellulose. The rubber capped Balch tube was incubated in a
water bath connected with a temperature controller set at 55℃ and a magnetic stirring system.
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Following pH adjustment with 70 L of 5 M KOH injection, 800 L of cell culture and 200 L of
hexadecane layer were sampled every 12 hours. Culture pH was maintained within a range of 6.47.8 during the fermentation.
Cell growth was monitored by measuring pellet protein. The cell-cellulose pellet from 800
L sampling volumes was washed twice with Milli-Q water and suspended by 200 L lysis buffer
(0.2 M NaOH, 1% SDS) followed by an hour incubation at room temperature. Then, the solution
was neutralized with 50 L 0.8 M HCl and diluted by 550 L water. The mixture was centrifuged
at 17,000 x g for 3 minutes. Protein concentration from the supernatant was analyzed by the
detergent-compatible Bradford assay (Thermo Scientific, WA, USA). The residual pellet was
boiled in a 98℃ oven for an hour before quantifying residual cellulose.
Residual cellulose was quantified by the phenol-sulfuric acid method178 with some
modifications. The boiled sample was washed twice with Milli-Q water and suspended in 800 L
water to make equivalent volume to the original. The sample was homogenized by pipetting and
vortexing for 10 seconds, and 20 L of the homogenized sample was transferred to a new 2.0 mL
microcentrifuge tube or 96-well plate and dried overnight in a 55℃ oven. The dried pellet was
suspended in 200 uL of 95% sulfuric acid and incubated for an hour at room temperature. After
the pellet was dissolved completely, 20 L of 5% phenol was added and mixed with the sulfuric
acid solution. After 30 min incubation at room temperature, 100 L of the sample was transferred
to a new 96-well plate, and the absorbance at 490 nm was measured. The absorbance was converted
to cellulose concentration by the standard curve of Avicel PH-101 treated by the same procedure.
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4.2.9 Analytical methods
HPLC system (Shimadzu Inc., MD, USA) was used to quantify extracellular metabolites. 800 L
of samples were centrifuged at 17,000 x g for 3 minutes followed by filtering through 0.2 micron
filters. The samples were run with 5 mM H2SO4 at 0.6 mL/min on an Aminex HPX-87H (Biorad
Inc., CA, USA) column at 50℃. Refractive index detector (RID) and ultra-violet detector (UVD)
at 220 nm were used to determine concentrations of sugars, organic acids, and alcohols. GC (HP
6890, Agilent, CA, USA) equipped with a MS (HP 5973, Agilent, CA, USA) was used to quantify
esters. A Zebron ZB-5 (Phenomenex, CA, USA) capillary column (30 m x 0.25 mm x 0.25 m)
was used with helium as the carrier gas at a flow rate of 0.5 mL/min. The oven temperature
program was set as follows: 50℃ initial temperature, 1℃/min ramp up to 58℃, 25℃/min ramp
up to 235℃, 50℃/min ramp up to 300℃, and 2-minutes bake-out at 300℃. 1 L sample was
injected into the column with the splitless mode at an injector temperature of 280oC. For the MS
system, selected ion mode (SIM) was used to detect and quantify esters. As an internal standard,
10 mg/L n-decane were added in initial hexadecane layer and detected with m/z 85, 99, and 113
from 12 to 15-minute retention time range.

4.3 Disruption of carbohydrate esterases hydrolyzing isobutyl
acetate from C. thermocellum
4.3.1 Endogenous esterase activities as a bottleneck for CBP ester production
Ester production in cellulolytic bacteria such as C. thermocellum has never studied before and
bottlenecks for CBP ester production is widely unknown. One of the potential bottlenecks is ester
degradation caused by endogenous esterases. For example, by disrupting an esterase that
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hydrolyzes volatile esters from Saccharomyces cerevisiae179, 180, biosynthesis of medium chain
esters was increased 181, suggesting that balance of AAT and esterase activity of brewer yeasts is
important for the ester accumulation in wine and distillates 181-183. Cellulolytic bacteria including
C. thermocellum possess multiple carbohydrate esterases (CEs) whose expression helps
deconstruct lignocellulosic biomass in a concerted enzyme reaction

184-186

. However, it is widely

unknown which CEs hydrolyze the medium chain esters. Therefore, identification of the CEs
degrading the medium chain esters is important to develop an efficient CBP platform for ester
biosynthesis from lignocellulosic biomass.
The esterase- and AAT-dependent pathways have different reaction chemistry for ester
biosynthesis (Figure 4-1A, B). The pathway driving force depends on the equilibrium constant and
species concentrations. For isobutyl acetate biosynthesis by an esterase in an aqueous solution, the
equilibrium constant (Keq =1.3x10-5 1/M) at the standard condition (T = 25℃, P = 1 atm, pH 7, [C]
= 1M) is relatively low, yielding a positive standard ∆Go of 27.8 ± 4.2 kJ/mol187. This reaction is
not thermodynamically favorable for ester biosynthesis but for degradation (or ester hydrolysis)188,
and therefore, relatively high substrate concentrations are required to push the reaction forward
(Table 4-3). In contrast, the AAT-dependent pathway is thermodynamically favorable with Keq of
2.42 1/M and a negative standard ∆Go of -2.4 ± 4.1 kJ/mol187, hence only relatively low substrate
concentrations are needed for ester biosynthesis to occur. In short, esterases play a critical role in
ester degradation under aqueous fermentation conditions while AATs are essential for ester
biosynthesis182, 183, 189, 190.
It is challenging to determine which CEs cause ester degradation because C. thermocellum
possesses a large number of CEs to deacetylate O-acetyl groups of hemicelluloses critical for
lignocellulosic biomass deconstruction184-186 and the functional roles of these CEs responsible for
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ester degradation are largely unknown. Here, we aimed to identify which endogenous CEs of C.
thermocellum could be disrupted to reduce ester degradation while not interfering biomass
deconstruction.

4.3.2 Putative carbohydrate esterases degrading isobutyl acetate
To identify endogenous CEs of C. thermocellum hydrolyzing isobutyl acetate, we thoroughly
searched the CAZy database170. We found C. thermocellum has 14 CEs that are classified as either
N-deacetylase or O-deacetylase, based on the domains and putative substrates of CEs (Table 4-4).
Since isobutyl acetate is an O-acetyl ester that can be deacylated by an O-acetyl esterase, we
focused on investigating the seven putative O-acetyl esterases, Clo1313_1424, Clo1313_1139,
Clo1313_1160, Clo1313_0521, Clo1313_0613, Clo1313_0500, and Clo1313_0693. Based on the
sequence motifs, only Clo1313_0613 is a cytosolic enzyme while others are likely secreted and/or
anchored to the cell membrane (Figure 4-2A). To characterize these seven CEs for ester hydrolysis,
we cloned and heterologously expressed them in E. coli. We first removed the signal peptides of
these proteins except Clo1313_0613 and tagged all proteins with 6x His residues at their N-termini
(Figure 4-2A). For Clo1313_1424 that has two identical DNA sequences encoding a Xyn_B like
domain, we built a truncated version of Clo1313_1424 (Clo1313_1424t) with only one Xyn_B
like domain and without the N-terminus signal peptide for expression in E. coli. Successful
expression of the seven modified esterases in E. coli was confirmed as shown in Figure 4-2B.

4.3.3 Clo1313_0613 and Clo1313_0693 are potential deletion targets
To evaluate the CE activities for ester hydrolysis, we incubated isobutyl acetate with the purified
enzymes at 55℃ for 10 hours and monitored the pH change.
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Table 4-3: Gibbs free energy change (∆G, KJ/mol) for isobutyl acetate biosynthesis by the
esterase- and AAT-dependent pathways. Substrate concentrations are varied while the
concentration of isobutyl acetate is fixed to be 10-6 mM.
Pathways

Esterase

Alcohol acyltransferase (AAT)

Isobutanol (mM)

Acetic acid (mM)

∆G (kJ/mol)

0.01

1

22.1 ± 4.2

0.1

1

16.4 ± 4.2

1

1

10.7 ± 4.2

100

1

-0.7 ± 4.2

100

10

-12.2 ± 4.2

Isobutanol (mM)

Acetyl-CoA (mM)

∆G (kJ/mol)

0.01

0.01

-47.8 ± 4.1

0.1

0.01

-53.5 ± 4.1

1

0.01

-59.2 ± 4.1

10

0.01

-64.9 ± 4.1

100

0.01

-70.7 ± 4.1
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Figure 4-1: Two representative ester biosynthesis pathways and metabolic pathway of C.
thermocellum for isobutyl acetate synthesis. (A) A reaction scheme of esterase/lipase associated
ester synthesis pathway and equation of equilibrium constant. Water is necessarily involved in the
reaction. (B) A reaction scheme of alcohol acyltransferase (AAT) and equation of equilibrium
constant. (C) A scheme of isobutyl acetate production from lignocellulose via AAT pathway in C.
thermocellum.
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Table 4-4: Carbohydrate esterases (CEs) in C. thermocellum.
Class Locus tag and description
Clo1313_2635, glycoside hydrolase family 10, putative N-deacetylase, endoglucanase included
CE-1
Clo1313_1305, glycoside hydrolase family 10, putative N-deacetylase, endoglucanase included
Clo1313_2858, carbohydrate binding family 6, putative N-deacetylase, endoglucanase included
CE-2

Clo1313_1425, glycoside hydrolase family 5, endoglucanase included

CE-3

Clo1313_1424, lipolytic protein G-D-S-L family, putative O-deacetylase
Clo1313_1139, glycoside hydrolase family 11, putative N-, O-deacetylase

CE-4
Clo1313_1680, delta-lactam-biosynthetic de-N-acetylase, putative N-, O-deacetylase
Clo1313_0521, glycoside hydrolase family 11, putative N-, O-deacetylase
CE-7

Clo1313_0613, cephalosporin-C deacetylase, putative O-deacetylase

CE-8

Clo1313_0500, pectinesterase, putative O-deacetylase

CE-9

Clo1313_2853, N-acetylglucosamine-6-phosphate deacetylase, putative N-deacetylase

CE-12 Clo1313_0693, carbohydrate binding family 6, putative O-deacetylase
CE-14 Clo1313_2896, GlcNAc-PI de-N-acetylase, putative N-deacetylase
CENC Clo1313_0420, dockerin type 1
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Figure 4-2: Identification of esterases responsible for isobutyl acetate hydrolysis in C.
thermocellum. (A) Seven O-deacetylases in C. thermocellum and their domain architectures. The
locations tagged with the histidine residues were marked as 6xHis in red. Clo1313_1424t is a
truncated version of Clo1313_1424 which is derived from removal of the signal peptide and one
XynB_like domain located at 36-225 residues that is identical to the other located at 252-441
residues. Abbreviation − SP: signal peptide, DCN: dockerin, CDA: carbohydrate deacetylase
family, GH: glycosyl hydrolases family, CBD: cellulose binding domain, AXE: acetyl xylan
esterase, and TesA: thioesterase A (lysophospholipase L1 or related esterase). (B) SDS-PAGE of
purified His-tagged proteins expressed in the recombinant E. coli strains. Abbreviations − M:
protein marker ladder and C: E. coli harboring an empty backbone plasmid. (C) In vitro screening
of isobutyl acetate hydrolysis activities by endogenous CEs of C. thermocellum. The error bars
represent standard deviation of three biological replicates.
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If the enzymes hydrolyze isobutyl acetate, pH of the reaction solution will decrease because
hydrolysis of isobutyl acetate (pKa ~25) by an esterase into isobutanol and acetic acid (pKa ~4.75)
lowers pH (Figure 4-2C). The screening discovered three most active CEs, Clo1313_0693,
Clo1313_0613, and Clo1313_1424 (Figure 4-2C). The hydrolysis was further confirmed with
detection of isobutanol and acetate by HPLC analysis (data not shown). The other CEs showed
insignificant pH changes, suggesting that they might have little or no activity towards isobutyl
acetate. Taken together, we identified the three esterases, Clo1313_0613 and Clo1313_0693, and
Clo1313_1424 that can hydrolyze isobutyl acetate.
Since CEs are important for lignocellulose deconstruction, it is critical to eliminate CEs
that alleviate ester hydrolysis but do not affect lignocellulose fermentation in C. thermocellum.
The key question is which of the three esterases identified above should be chosen for disruption
in C. thermocellum. Bioinformatic analysis revealed that Clo1313_0613 (cephalosporin C
deacetylase) shares 59% protein sequence identity with a well-studied homo-hexamer
cephalosporin C deacetylase from Bacillus subtilis. Similarly, the homology model of
Clo1313_0613 was also presented as a homo-hexamer structure. This deacetylase has a broad
substrate range with high specificity towards short substrates including p-nitrophenyl acetate
(pNPA) and short-chain or pre-processed xylans191. Our in vitro assay indeed confirmed that
Clo1313_0613 exhibited activity towards pNPA (Figure 4-3). Based on the constructed
phylogenetic tree of Clo1313_0613, we found homolog proteins exist in a wide spectrum of
bacteria, regardless of their cellulolytic capability (Figure 4-4A). Most of the bacteria identified
are gram-positive including Actinomyces sp. while a small group of gram-negative bacteria such
as Mesorhizobium sp are also found. Taken together, Clo1313_0613 was expected to be a nondetrimental deletion target.
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Figure 4-3: p-nitrophenyl (pNPA) assay of the seven O-acetyl esterases.
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The catalytic domain of Clo1313_0693, annotated as a carbohydrate binding family 6,
shares the highest sequence similarity (68%) with an uncharacterized protein YxiM from B.
subtilis (locus tag: BSU_39120). YxiM has not yet been characterized experimentally, but its
homolog proteins deacetylate broad substrates including apple pectin rhamnogalacturonan192,
pNPA192,

193

, and cephalosporin C193. Clo1313_0693 possesses two rhamnogalacturan

acetylesterase-like domains that are likely responsible for the hydrolysis activity of isobutyl acetate
as experimentally observed (Figure 4-3C). The gene encoding Clo1313_0693 is located
downstream of a promoter regulated by the σI3 RNA polymerase194, 195, which is related to a
membrane-associated anti-sigma factor (Rsigl3) that specifically binds to pectin196. Another
pectinesterase under the control of σI3 regulon is Clo1313_1983, a rhamnogalacturonan lyase195.
Note that Clo1313_0693 includes a signal peptide and dockerin (Figure 4-2A), which is proposed
to be a component of extracellular cellulosome197. Interestingly, we found that homolog proteins
broadly exist in both cellulolytic and non-cellulolytic bacteria (Figure 4-4B), suggesting that
Clo1313_0693 might not be detrimental for lignocellulose fermentation.
Lastly, the catalytic domain of Clo1313_1424 shares 30% amino acid sequence identity
with a well-studied XynB domain of xylanase from Ruminococcus flavefaciecns198, 199. The XynB
deacetylates xylan that is important for hemicellulose deconstruction200. Even though wild type C.
thermocellum is not capable of assimilating C5 sugars for growth, it possesses enzymes to
deconstruct xylan to enhance accessibility of cellulolytic enzymes to the recalcitrant
lignocellulosic biomass201. Remarkably, most of the homologs of XynB were observed in
cellulolytic microorganisms (Figure 4-4C). Therefore, we reasoned that Clo1313_1424 is not a
good target for disruption to alleviate ester hydrolysis in C. thermocellum due to its functional role
important for lignocellulose deconstruction.
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Figure 4-4: Phylogenetic analysis of Clo1313_0613, Clo1313_0693, and Clo1313_1424. (A) A
phylogenetic tree of AXE1 domain in Clo1313_0613. The red triangle indicates Clo1313_0613.
(B) A phylogenetic tree of TesA domain in Clo1313_0693. The red triangle indicates
Clo1313_0693. (C) A phylogenetic tree of the catalytic domain in Clo1313_1424. The red triangle
indicates Clo1313_1424.
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4.3.4 Disruption of clo1313_0613 and clo1313_0693 is not detrimental to cellulose
fermentation capability of C. thermocellum
To genetically disrupt the targeted esterases, we first constructed a markerless gene deletion
platform that utilizes two counter-selection genetic parts167. pHS005 (Figure 4-5) was constructed
by assembling the required genetic parts using pNW33N as a backbone plasmid58. The markless
gene deletion platform pHS005 contains two multiple cloning sites (MCS) that allows use of
restriction enzyme and ligation for constructing deletion plasmids (Figure 4-5B).
Transcriptomic analysis of C. thermocellum shows that both Clo1313_0613 and
Clo1313_0693 are expressed in C. thermocellum197, 202. To test their in vivo activities for isobutyl
acetate degradation, we disrupted these esterase genes through homologous recombination. We
generated three esterase-deficient strains including HSCT1003 with Clo1313_0613 deletion,
HSCT1004 with Clo1313_0693 deletion, and HSCT2005 with both Clo1313_0613 and
Clo1313_0693 deletion (Figure 4-6A). HSCT1003 (0.271 ± 0.017 1/h) and HSCT2005 (0.270 ±
0.031 1/h) grew about 20% slower than the parent strain (M1354, 0.341 ± 0.013 1/h) while
HSCT1004 (0.352 ± 0.018 1/h) did not exhibit significant change in growth rate (Table 4-5).
Interestingly, the cellulose degradation profiles were similar among the engineered strains, with
the similar growth (Figure 4-6B, Table 4-5). Therefore, we concluded that the esterase disruptions
did not inhibit cellulose consumption in C. thermocellum.

4.3.5 Alleviated isobutyl acetate degradation by the esterase deficient C.
thermocellum
We next compared the hydrolysis of isobutyl acetate among the parent and esterase-deficient
strains (Figure 4-6C). To estimate the in vivo esterase activity, we externally supplemented 1 g/L
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Table 4-5: Specific growth rate of C. thermocellum strains. Cells were cultured in the defined
MTC medium with 5 g/L of cellobiose at 55oC. The values are presented as mean ± 1 standard
deviation of six biological replicates.
Strains
M1354 (∆hpt)
HSCT1003 (∆hpt ∆0613)
HSCT1004 (∆hpt ∆0693)
HSCT2005 (∆hpt ∆0613 ∆0693)

Specific growth rate (1/h)
0.341 ± 0.013
0.271 ± 0.017
0.352 ± 0.018
0.270 ± 0.031
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Figure 4-5: Schematic of gene deletion in C. thermocellum. (A) Steps of markless gene deletion.
(B) Structure of pHS005 for markerless gene deletion.
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Figure 4-6: Disruption of esterases in C. thermocellum and characteristics of the esterase-deficient
mutants. (A) Confirmation of gene disruption. Abbreviation − L: DNA marker ladder, C: control
strain (M1354), 1: HSCT1003 (∆Clo1313_0613), 2: HSCT1004 (∆Clo1313_0693), and 3:
HSCT2005 (∆Clo1313_0613, ∆Clo1313_0693). (B) Comparison of residual cellulose by the
engineered C. thermocellum strains during 20 g/L cellulose fermentation. The error bar represents
standard deviation of three biological replicates. (C) Hydrolysis of isobutyl acetate by the
engineered strains. The error bars represent standard deviation of three biological replicates.
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(8.61 mM) of isobutyl acetate and monitored the changes in ester concentrations by a gas
chromatography coupled with mass spectrometry (GC/MS). After 72 h, the parent strain M1354
degraded 74.0 ± 2.4% of isobutyl acetate while HSCT1003 and HSCT1004 exhibited only 40.0 ±
1.5% and 45.1 ± 8.4% of isobutyl acetate degradation, respectively. Remarkably, HSCT2005 with
double esterase disruption exhibited the least ester degradation (17.6 ± 3.6%) (Figure 4-6C).
Interestingly, we also observed that 13.3 ± 6.8% of isobutyl acetate decreased even without the
cells (negative control), likely due to spontaneous hydrolysis and/or experimental loss. The results
clearly showed that both Clo1313_0613 and Clo1313_0693 were the major esterases responsible
for isobutyl acetate degradation in C. thermocellum. Furthermore, we observed that double esterase
disruption in HCST2005 helped alleviate degradation of isobutyl isobutyrate but not ethyl esters
(i.e., ethyl acetate and ethyl isobutyrate), as compared to the parent strain M1354 (Table 4-6).
Taken together, we identified and disrupted two endogenous CEs, Clo1313_0613 and
Clo1313_0693, that could significantly alleviate hydrolysis of isobutyl acetate without potential
inhibition on lignocellulose deconstruction in C. thermocellum.

4.4 Designer ester biosynthesis in engineered C. thermocellum
4.4.1 Conversion of alcohols to esters by CATec3 Y20F expressing C. thermocellum
In Chapter 2, we screened and engineered CATs for higher thermostability and catalytic efficiency
towards a wide range of alcohols. Here, we investigated performance of the engineered CATs in
C. thermocellum by comparing isobutanol conversion to the in vitro characteristics. By harnessing
the high thermostability of CATec3 Y20F, we investigated whether CATec3 Y20F-harboring C.
thermocellum could catabolize cellulose and convert various alcohols to designer bioesters
efficiently at an elevated temperature of 55oC (Figure 4-7A).
110

Table 4-6: Degradation of various esters by M1354 and HSCT2005 after 72 hour fermentation.
The cells were cultured in the MTC medium with external supply of esters. Esters were added at
initial concentrations of 1 g/L except for isobutyl isobutyrate at 0.5 g/L due its low solubility. The
values represent means ± standard deviation of three biological replicates.
Esters
Ethyl acetate
Ethyl isobutyrate
Isobutyl acetate
Isobutyl isobutyrate

M1354
10.06 ± 2.04%
17.75 ± 2.28%
81.25 ± 0.70%
67.35 ± 6.68%
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HSCT2005
13.91 ± 3.00%
15.51 ± 9.13%
17.99 ± 0.88%
9.34 ± 5.59%

We chose the engineered C. thermocellum Δclo1313_0613, Δclo1313_0693 as the host because its
two carbohydrate esterases was disrupted to alleviate ester degradation. By co-feeding cellulose
and each higher alcohol, the recombinant C. thermocellum could produce all respective acetate
esters (Figure 4-7B, D). Since C. thermocellum has the endogenous isobutyl-CoA pathway160, we
also observed the production of isobutyrate esters such as butyl isobutyrate and isobutyl
isobutyrate as byproducts (Figure 4-7C). Many of these esters, such as n-butyl, n-pentyl, isoamyl,
and geranyl esters, have never been reported to be feasibly synthesized in a thermophile since
eukaryotic AATs are not thermostable. Among the esters, isoamyl acetate was produced at the
highest conversion yield of > 30% (mol/mol) and titer of 1.2 g/L. Ester production in C.
thermocellum was not as high as observed in E. coli likely due to the metabolic burden required to
make cellulolytic enzymes for cellulose degradation along with overexpression of the heterologous
gene. An increased titer of isobutyl esters was achieved when feeding a higher concentration of
isobutanol (Figure 4-7E) below the lethal concentration (Figure 4-7F), indicating that the enzyme
expression and/or alcohol availability were likely unsaturated in C. thermocellum. Further strain
engineering and/or optimization of medium and operating conditions might help boost the
production of designer bioesters by the CBP technology.

4.4.2 Thermostability of CAT is critical for efficient designer ester biosynthesis at
elevated temperatures
Functional expression of a heterologous protein in thermophiles requires high thermostability,
which is not well understood and often presents a significant bottleneck in metabolic engineering
of these organisms.
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Figure 4-7: Conversion of alcohols by C. thermocellum. The error bars represent ±1 stdev from
three biological replicates. (A) Microbial ester biosynthesis by a CATec3 Y20F-expressing C.
thermocellum at 55℃. (B) Time dependent alcohol conversion to acetate esters by CATec3 Y20Fexpressing strain C. thermocellum HSCT2108. (C) Time dependent alcohol conversion to
isobutyrate esters by CATec3 Y20F-expressing strain C. thermocellum HSCT2108. (D) Alcohol
conversion efficiencies. Each value represents mean ± 1 stdev from three biological replicates. (E)
Toxicity of isobutanol to C. thermocellum. M1342 (C. thermocellum DSM1313 Δhpt) was cultured
in MTC medium containing 5g/L cellobiose and isobutanol. Optical density (OD600nm) was
measured over 48 hours. (F) Isobutyl ester titers of CATec3 Y20F-expressing strain C.
thermocellum HSCT2108 upon different isobutanol feeding concentration.
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Inspired by the differences in the catalytic efficiency and melting temperatures among the
engineered CATs (Table 2-9), we investigated how thermostability of the CATs affected ester
production in C. thermocellum. We characterized the recombinant C. thermocellum
Δclo1313_0613 Δclo1313_0693 (HSCT2005) harboring various CATs with distinctive melting
temperatures and catalytic efficiency for in vivo isobutyl ester production by co-feeding cellulose
and isobutanol at 55℃ (Figure 4-8A). Among the recombinant C. thermocellum strains,
HSCT2108 harboring CATec3 Y20F, which has the highest catalytic efficiency and melting
temperature, produced the highest level of isobutyl esters (892 mg/L), about 14-fold higher than
the CATsa F97W-expressing C. thermocellum HSCT2105. Even though CATsa Y20F A138T has
similar catalytic efficiency but higher melting temperature relative to CATsa Y20F, the CATsa
Y20F A138T-expressing strain HSCT2113 produced 46% more esters than the CATsa Y20Fexpressing strain HSCT2106. Similarly, we also observed higher ester production in the CATec3expressing strain HSCT2107 than the CATsa F97W-expressing strain HSCT2105, where CATec3
has similar catalytic efficiency but higher melting temperature. Both HSCT2107 and HSCT2113
produced esters at very similar level, although CATsa Y20F A138T has higher catalytic efficiency
but about 10℃ lower melting temperature than CATec3. These results strongly suggested that
CAT robustness with enhanced thermostability plays a critical role for efficient ester production
in C. thermocellum at elevated temperatures.
To further elucidate the effect of thermostability of CATs on ester production, we
characterized the performance of HSCT2113 and HSCT2108 at various elevated temperatures
(Figure 4-8B, C) compatible with C. thermocellum growth. Interestingly, HSCT2113 increased the
ester production up to 220 mg/L at 50℃, about 2-fold higher than 55℃ (Figure 4-8B). In contrast,
HSCT2108 produced esters at relatively similar level of about 1 g/L at 50 and 55℃, while the
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production was reduced to 74 mg/L at 60℃ (Figure 4-8C). Proteolysis is a common cellular
process to degrade and remove denatured or misfolded proteins203. If the cell growth temperature
affected integrity of the CATs, their intracellular abundances would be altered. To quantify
statistically meaningful changes in the intracellular abundance of CATs, we analyzed and
compared proteomes across the two representative strains expressing CATec3, the wildtype
(HSCT2107) versus the Y20F mutant (HSCT2108). Since the only difference between these two
strains is one amino acid substitution, we could reliably quantify the relative abundance of each
CAT by comparing tryptic peptide fragments. The result showed that CATec3 Y20F was 2.2-fold
(average difference between peptide abundances) more abundant than CATec3 (Figure 4-8D).
Because CATec3 Y20F has a 7℃ higher melting temperature than CATec3 (Table 2-8), the
intracellular protein abundance change might imply a lesser degree of denaturation or misfolding
due to higher protein thermostability. Taken altogether, CAT thermostability is critical for robust
and efficient ester production in thermophiles by maintaining its intracellular protein abundance.

4.5 Metabolic engineering of C. thermocellum for C4-derived
ester production
4.5.1 Consolidated bioprocessing of ester production from cellulose
The conversion of isobutanol to isobutyl esters at g/L scale by C. thermocellum overexpressing
the engineered CATs suggested that improving isobutanol flux will guarantee higher ester
production from cellulose fermentation (Figure 4-8). Therefore, metabolic engineering strategies
to improve alcohol and acyl-CoA flux would enable the ester production from cellulose
fermentation without supplementing the alcohols.
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Figure 4-8: Effect of CAT thermostability on robust and efficient of microbial biosynthesis esters
at elevated temperatures. (A) Isobutyl ester production of the recombinant C. thermocellum strains
harboring various CATs. (B-C) Effect of temperatures on isobutyl ester production by the (B)
CATec3-expressing strain HSCT2107 and (C) CATec3 Y20F-expressing strain HSCT2108. In
panels a-c, each data represents mean ± 1 stdev from three biological replicates. An amount of 5
g/L of isobutanol was fed at the early stationary phase of the culture to avoid cell growth inhibition.
(D) Box-whisker plot of protein level difference between HSCT2108 and HSCT2107. The data
represent mean ± 1 stdev from three biological replicates (p-value: 0.0049).
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A recent study engineered isobutanol production in C. thermocellum by overexpressing
heterologous ketoisovalerate decarboxylase (KDC) and endogenous valine pathway160. However,
the KDC from Lactococcus lactis (KivDLL) has unsatisfactory thermostability that could
potentially reduce the pathway efficiency over prolonged fermentation at elevated temperatures
higher than 50℃204. Also, the process necessitated high cell density at OD above 16 which is an
unfavorable configuration because the usual maximum OD of C. thermocellum under common
culture conditions is lower than 1.5173, 205.
Another possible strategy is to harness endogenous ferrodoxin-dependent ketoisovalerate
oxidoreductase (KOR) pathway that catalyzes isobutyl-CoA synthesis from 2-ketoisovalerate160,
206

, a key precursor of valine biosynthesis. The isobutyl-CoA serves a key building block for C4-

derived esters (e.g., ethyl isobutyrate, isobutyl acetate, isobutyl isobutyrate). The pathway is
normally activated under high cellulose loading fermentation associated overflow metabolism159,
207

, resulting from promiscuous PFORs that primarily catalyze conversion of pyruvate to acetyl-

CoA206. Among the PFORs, two PFORs (Clo1313_1353-1356 and Clo1313_0020-0023) were
previously suggested to encode for the main PFOR complexes in C. thermocellum208. Especially,
Clo1313_1353-1356 is responsible for the isobutanol production in C. thermocellum due to the
detrimental effect of Clo1313_1353-1356 deletions on isobutanol production206. However, it has
been largely unknown how to harness the endogenous pathway to overproduce C4-derived esters.
Here, we engineered the endogenous metabolism of C. thermocellum for ester biosynthesis
from cellulose fermentation. We discovered that deletion of two carbohydrate esterases,
Clo1313_0613, and Clo1313_0693, improves isobutanol by reducing endogenous thioesterase
activity against isobutyl-CoA. Overexpression of a thermostable ester biosynthesis enzyme,
CATec3 Y20F59, synergistically enhanced isobutanol production with the esterase deletion,
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improving isobutyl ester production 100-folds compared to a precedent strain. An engineered C.
thermocellum strain produced 340 mg/L of isobutyl-CoA derived esters (i.e., ethyl isobutyrate,
isobutyl acetate, and isobutyl isobutyrate) from one-step cellulose fermentation at 55℃.

4.5.2 Expression of CATsa F97W for endogenous ester production in C.
thermocellum
As a starting point, we investigated whether C. thermocellum overexpressing CATsa F97W could
produce esters at elevated temperatures. Previous studies have demonstrated that the wild type C.
thermocellum has native metabolism capable of endogenously producing precursor metabolites for
ester biosynthesis, such as acetyl-CoA, isobutyryl-CoA, as well as ethanol209 and higher alcohols
(e.g., isobutanol) under high cellulose loading fermentation159,

160, 207

. Therefore, functional

expression of the engineered CAT would produce esters using the endogenous pathways.
We first tested whether an engineered CATsa F97W can produce isobutyl acetate, a
medium chain ester. We started by generating two isobutyl acetate-producing strains, HSCT0101
and HSCT0102, by introducing the plasmids pHS0024 (harboring the wildtype CATsa) and
pHS0024_F97W (harboring the mutant CATsa F97W) into C. thermocellum DSM1313 (Table 41). Colonies were isolated on antibiotics selective plates at 55℃. Successful transformation clearly
indicated that CATsa F97W conferred the thiamphenicol resistance and hence maintained CAT
activity.
Next, we evaluated whether the C. thermocellum strains could synthesize isobutyl acetate
directly from cellobiose. Since the endogenous isobutanol production from a typical cellobiose
concentration (5 g/L) is low159, we supplemented the media with 2 g/L isobutanol. Both
HSCT0101 and HSCT0102 could produce isobutyl acetate at 55℃ as expected. HSCT0102
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outperformed HSCT0101 with 3.5-fold increase in isobutyl acetate production (Figure 4-9A).
Interestingly, we also observed the parent C. thermocellum M1354 produced a trace amount of
isobutyl acetate (< 0.1 mg/L) even though this strain does not harbor a CAT (Figure 4-9B). This
phenomenon was only observed when hexadecane overlay was used during fermentation for ester
extraction. One possible explanation is the endogenous activity of esterases in C. thermocellum
might have been responsible for low isobutyl acetate production while the organic phase overlay
helps extract the target ester. It should be noted that the esterase reaction is reversible and more
thermodynamically favorable for ester degradation than biosynthesis.
Finally, we tested whether HSCT0102 could endogenously produce isobutyl acetate
directly from cellulose at elevated temperature (55℃). After 72 hours, cell mass, containing 550
mg/L of pellet protein, reached 1.04 g/L, and 17 g/L of cellulose were consumed (Figure 4-9C).
About 103 mg/L of isobutanol were produced for the first 48 hours, and further increased up to
110 mg/L for additional 24 hours. Besides isobutanol, C. thermocellum also produced other
fermentative metabolites, including ethanol, formate, acetate, and lactate, as expected (Figure 49A, B). For the target isobutyl acetate production, HSCT0102 did not produce isobutyl acetate for
the first 24 hours but started accumulating the target product for the next 48 hours. The observed
profile of isobutyl acetate production could be attributed to the low substrate affinity of CATsa
F97W (Table 2-4). The final titer of isobutyl acetate reached 1.9 mg/L.
Besides the production of the desirable ester isobutyl acetate, we also observed that
HSCT0102 produced other detectable esters such as ethyl acetate, ethyl isobutyrate, and isobutyl
isobutyrate (Figure 4-10B, C). Endogenous biosynthesis of these esters could be explained from
the complex redox and fermentative metabolism of C. thermocellum207, 210. C. thermocellum can
endogenously synthesize the precursor metabolites, acetyl-CoA and ethanol via the ethanol
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biosynthesis pathway while C. thermocellum can endogenously produce the precursor metabolites,
isobutyryl-CoA and isobutanol via the valine biosynthesis (Figure 4-10A). With the availability of
four precursor metabolites, C. thermocellum could produce ethyl acetate, ethyl isobutyrate,
isobutyl acetate, and isobutyl isobutyrate as observed experimentally (Figure 4-10C).
Taken altogether, C. thermocellum overexpressing CATsa successfully produced the target
isobutyl acetate from cellulose at elevated temperature (55oC).

4.5.3 Employing the esterase-deficient C. thermocellum for ester production
To evaluate whether the esterase-deficient C.thermocellum can improve isobutyl acetate
production, we introduced the thermostable ester production module CATsa F97W into
HSCT2005 to generate the esterase-deficient, ester-producing strain HSCT2105. Strain
characterization showed that HSCT2105 produced 3.1 mg/L of isobutyl acetate (Figure 4-11A)
after the 72-hour cellulose fermentation. In comparison to HSCT0102, harboring the identical
production module without the esterase disruption, HSCT2105 achieved 1.6-fold higher titer
(Figure 4-11B). Since both strains yielded the same maximal pellet protein (~520 mg/L) and
consumed cellulose (~17 g/L), it further supports that the esterase disruptions did not interfere with
cellulose utilization. HSCT2105 produced isobutyl isobutyrate 10-fold higher than HSCT0102
(Figure 4-11B). This result correlates with decreased lactate and increased isobutanol production
(Table 4-7), implying a higher metabolic flux was directed towards isobutyl-CoA, a precursor for
isobutanol and isobutyl isobutyrate biosynthesis. Since some esterases exhibit versatile activities
such as thioesterases211-214, double deletion of esterases in HSCT0102 might have alleviated
degradation of not only isobutyl isobutyrate but also isobutyl-CoA.
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Figure 4-9: Isobutyl acetate production in the engineered C. thermocellum. (A) A simplified
isobutyl acetate production pathway from cellulose in C. thermocellum. (B) Biosynthesis of
isobutyl acetate of the wildtype and engineered C. thermocellum strains at 55℃ from MTC
medium with 5 g/L cellobiose and external supply of 2 g/L isobutanol. Isobutyl acetate was
measured after 24 hours from the hexadecane layer of cell cultures. Initial OD of each cell culture
was in a range of 0.8−1.0. The error bars represent standard deviation of five biological replicates.
Statistical analysis: t-test, “*” p value < 4 × 10−4, t = -6.475, df = 7. (C) Kinetic profiles of cell
growth and residual cellulose of HSCT0102. HSCT0102 was cultured in C-MTC medium with 20
g/L Avicel PH-101. The error bars represent standard deviation of three biological replicates. (D)
Kinetic profiles of isobutanol and isobutyl acetate production by HSCT0102 in C-MTC medium
with 20 g/L Avicel PH-101. The error bars represent standard deviation of three biological
replicates. Abbreviation: KOR, 2-ketoisovalerate ferredoxin oxidoreductase; ADH, alcohol
dehydrogenase.
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Figure 4-10: Fermentative products from cellulose fermentation of HSCT0102. (A) Simplified
metabolic pathways of C. thermocellum for biosynthesis of native fermentative metabolites and
heterologous esters. (B) Kinetic profile of biosynthesis of other esters besides isobutyl acetate,
including ethyl acetate, ethyl isobutyrate, and isobutyl butyrate. (C) An overlaid GC/MS
chromatogram demonstrating ester biosynthesis. (D) Kinetic profile of other fermentative
metabolites. Abbreviation: IS, internal standard.
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Figure 4-11: Comparison of ester production by HSCT0102 and HSCT2105. (A) A time
dependent profile of isobutyl acetate production from cellulose by HSCT2105. The error bars
indicate standard deviation of three biological replicates. (B) Ester concentrations by HSCT0102
and HSCT2105 after fermentation. The esters were quantified after 72 hours of cellulose
fermentation. The error bars indicate standard deviation of three biological replicates.
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Even though esterase deletion resulted in higher isobutyl ester production in HSCT2005
than HSCT0102, the ester titer was relatively low. Therefore, we hypothesize that other
bottlenecks need to be tackled for more efficient ester production. One critical bottleneck is the
availability of an efficient thermostable AAT used to construct the ester production module50, 61,
65, 66, 190

. Based on the thermodynamics (Figure 4-1A), it is anticipated that the beneficial

contribution from disrupting esterases to alleviate ester hydrolysis will become more significant
for enhanced ester production as observed in Figure 4-8B when the esterase-deficient phenotype
is tested in an ester overproducing C. thermocellum harboring a more efficient ester production
module.
Overall, the esterase-deficient, ester-producing C. thermocellum HSCT2105 showed a
higher metabolic capacity for isobutyl acetate biosynthesis. This strain can serve as a starting host
for metabolic engineering to enhance ester production in future studies.

4.5.4 Overexpression of CATec3 Y20F and the esterase deletion synergistically
improves metabolic flux towards isobutanol
Motivated by the fact that C. thermocellum DSM1313 overexpressing CATsa F97W could produce
isobutyl acetate directly from cellulose, we further hypothesized that harnessing CATec3 Y20F
would increase the isobutyl ester production titer because CATec3 Y20F outperformed at
thermostability and catalytic efficiency towards isobutanol than CATsa F97W (Figure 4-8A). To
compare the in vivo performance, we transformed C. thermocellum M1354 with a plasmid
harboring CATec3 Y20F (HSCT0103). HSCT0103 produced 13.1 mg/L of isobutyl esters from
20 g/L cellulose fermentation (Figure 4-12A), 6.5 times high titers than the previously reported
strain (HSCT0102) overexpressing CATsa F97W that produced 2.0 mg/L of isobutyl esters58.
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Table 4-7: Endpoint fermentative metabolites of cellulose fermentation by HSCT0102 and
HSCT2105. The values represent mean ± 1 standard deviation from three biological replicates.
Strains
HSCT0102
HSCT2105

Acetate
(g/L)
1.82 ± 0.13
1.36 ± 0.03

Lactate
(g/L)
3.66 ± 0.10
1.96 ± 0.09

Formate
(g/L)
0.33 ± 0.01
0.46 ± 0.02

Ethanol
(g/L)
3.32 ± 0.15
3.12 ± 0.07

Isobutanol
(g/L)
0.11 ± 0.01
0.30 ± 0.02

Figure 4-12: Effect of the esterase deletion and CAT expression on the CBP isobutyl ester
production. (A) Isobutanol titers from cellulose fermentation by engineered C. thermocellum
strains. (C) A profile of isobutanol, and isobutyl ester production by HSCT2108.
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Surprisingly, overexpression of CATec3 Y20F also improved isobutanol titer compared
with the parental strain (M1354) and HSCT0102 (Figure 4-12B). We also observed that disruption
of two carbohydrate esterases and CATec3 Y20F overexpression (i.e., HSCT2108) synergistically
improved isobutanol production achieving titers of 1.0 g/L (Figure 4-12B). HSCT2108 produced
isobutyl esters (i.e., isobutyl acetate and isobutyl isobutyrate) up to 191.3 mg/L that was 16.6 times
higher titer compared with HSCT0103.
Motivated by the increased isobutanol by clo1313_0613 and clo1313_0693 deletions, we
further questioned whether the esterases have catalytic activity related to the isobutyl ester
production pathway. We hypothesized that the esterases may possess thioesterase activities
degrading isobutyl-CoA. To test the hypothesis, we compared esterase and thioesterase activities
of Clo1313_0613 and Clo1313_0693 (Figure 4-13). The His-tag semi-purified enzymes were
reacted with pNPA and isobutyl-CoA at the saturated concentration (Figure 4-13A). Interestingly,
Clo1313_0613 and Clo1313_0693 exhibited a relatively weak thioesterase activity towards
isobutyl-CoA, at maximum reaction rate (Vmax) of 0.29 and 0.28 (mol/min/mg), respectively. The
promiscuous thioesterase activity of Clo1313_0613 and Clo1313_0693 was 50-fold and 84-fold
lower compared to the primary esterase activity, respectively. Therefore, deletion of
Clo1313_0613 and Clo1313_0693 might reduce intracellular isobutyl-CoA degradation and
increase the isobutyl-CoA pool, leveraging the isobutanol and isobutyl ester production as
observed (Figure 4-12). Clo1313_0613 might affect the intracellular isobutyl-CoA pool more than
Clo1313_0693 because Clo1313_0693 is likely an extracellular enzyme (Figure 4-2A) and
isobutyl-CoA is an intracellular metabolite.
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Figure 4-13: Promiscuous thioesterase activity of Clo1313_0613 and Clo1313_0693. (A) SDSPAGE of His-tag purified enzymes. 0693; Clo1313_0693, 0613; Clo1313_0613, L; protein ladder.
The black arrow indicates the expected band sizes for each enzyme. (B) Maximum reaction rate
(Vmax) of Clo1313_0613 and Clo1313_0693 towards pNPA and isobutyl-CoA. The values
represent mean ± 1 stdev from three biological replicates.
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4.5.5 Deletion of lactate dehydrogenase and promoter modification
To further enhance the ester production, we next aimed to increase isobutanol flux and CATec3
Y20F expression level. First, we hypothesized that deletion of the lactate pathway would increase
not only pyruvate pool, a key precursor of the valine synthesis pathway, but also NADH
availability that can provide a driving force for isobutanol and isobutyl ester production. However,
the ldhA (clo1313_1160) deletion did not significantly improve the isobutanol and isobutyl ester
production but rather increased ethyl esters (Figure 4-14A).
We next hypothesized that higher CATec3 Y20F expression can further improve the
isobutyl ester production. Previous studies reported that plasmid-based gene expression in C.
thermocellum can cause undesired integration of plasmid into the genome by homologous
recombination215, 216. The crossover event particularly occurs at the promoter region where is
usually between 200 to 400 bp length217. We also confirmed that the plasmid-based CAT
expression under the 310 bp length of gapDH promoter triggered such plasmid integration at
genomic gapDH promoter region after 60 hours. The plasmid integration can result in loss of
plasmid in the culture population, decreasing expression level of the target protein216. Because
frequency of the homologous recombination depends on homology length218, we truncated the
gapDH promoter by eliminating 130 bp of the initial sequences to improve integrity of CATec3
Y20F expression in C. thermocellum. The truncated gapDH promoter included a putative
SigA/RpoD motif to ensure integrity of transcription initiation215. Interestingly, CATec3 Y20F
expression under the truncated promoter (HSCT3111) improved ester production by 48%
compared to the original promoter. The total ester titers reached up to 370 mg/L from 17.2 g/L
cellulose (Figure 4-14B). Especially, titers of ethyl acetate and ethyl isobutyrate were increased
by 4-fold and 2-fold, respectively. The results suggested that ethanol pathway is a major
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competitive pathway against the C4-derived ester production. The final ethanol concentration from
the HSCT3111 culture was 4.1 g/L. Although CATec3 Y20F has poor affinity to ethanol (Table
2-9), the high concentration of ethanol can compete with isobutanol for the esterification.

4.5.6 Deletion of pyruvate-formate lyase
Because C. thermocellum employs two metabolic bifurcations, pyruvate-formate lyase
(PFL) and the PFOR, at pyruvate node and the PFOR is closely related to the isobutyl-CoA and
isobutanol production206, we further tested whether deletion of PFL can activate the KOR pathway
and reduce the ethanol formation. To eliminate the PFL activity, we added 6 mM of a PFL inhibitor
sodium hypophosphite (HPP) to the culture medium173, 219. Unfortunately, HSEC3111 was not able
to grow up in the HPP containing MTC-C medium, indicating that the pfl deletion is toxic to the
cell. Lower concentration of HPP could restore the cell growth but the ester production was
decreased by 50-60% compared to the culture without HPP. One possible explanation is the PFL
deletion might reduce acetyl-CoA availability that is essential for detoxification of thiamphenicol
selection marker and acetate ester production. Also, PFL is vital for redox balance when reduced
ferredoxin is accumulated during fermentation173.
Therefore, further engineering should focus on improving pathway specificity towards
isobutanol over ethanol to reduce ethyl esters and improve isobutyl esters. Since deleting the
ethanol producing bifunctional alcohol dehydrogenase (adhE) from C. thermocellum is
detrimental to cell growth220 and often problematic221, one possible strategy is to engineer the
AdhE for higher preference towards isobutyl-CoA than acetyl-CoA.
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Figure 4-14: Effect of lactate dehydrogenase (ldhA) deletion and CAT expression under truncated
version of GapDH promoter. (A) Final titers of total esters (i.e., ethyl acetate, ethyl isobutyrate,
isobutyl acetate, and isobutyl isobutyrate). The values present mean ± 1 stdev from three biological
replicates. (B) Final titers of ethyl esters (i.e., ethyl acetate and ethyl isobutyrate). The values
present mean ± 1 stdev from three biological replicates.
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4.6 Conclusion
In this chapter, C. thermocellum as a chassis was rendered more compatible to produce esters by
disrupting endogenous esterases responsible for ester product degradation. The deletion of
carbohyrdrate esterases to improve ester production can be broadly applicable to development of
non-model microbial ester producer because the two identified carbohydrate esterases broadly
exist in both non-cellulolytic bacteria and cellulolytic bacteria. The engineered esterase-deficient
C. thermocellum was deployed to synthesize a wide range of esters at elevated temperatures with
expression of a robustness, efficiency, and compatibility of engineered ester biosynthesis module.
The comparative proteomics analysis of CAT-expressing C. thermocellum strains unveiled
that the CAT robustness with enhanced thermostability is critical for efficient ester production in
thermophiles by maintaining high level of intracellular CAT abundance. The results highlight the
significant role of enzyme thermostability on engineering heterologous pathways in a thermophilic
whole-cell biocatalyst. While the enzyme has melting temperatures higher than the maximal
growth temperatures of the host, the enzyme’s functionality in vivo can be significantly hampered
by the enzyme integrity, offering a design principle in engineering a heterologous pathway in
thermophiles (e.g., C. thermocellum) for direct conversion of cellulosic biomass to chemicals and
fuels.
In combination with gene expression and fermentation optimization, we demonstrated the
first-generation of engineered C. thermocellum capable of producing 0.34 g/L of C4-derived esters
by direct cellulose fermentation and 1 g/L of C4-derived esters with an isobutanol supplemented
cellulose fermentation.
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5. Chapter 5. Engineering community level modularity of ester
biosynthesis
In plants, ester formulation has been considered as a defensive mechanism against pathogens222,
223

, and herbiovores224, 225, or as an attractant for pollinators226, 227. Therefore, ester biosynthesis at

the community level has been largely studied from an ecological or evolutionary point of view.
However, from an engineering point of view, microbial community engineering can be an
innovative approach to efficiently synthesize a wide range of esters. For example, it is challenging
to design a strain capable of both efficiently utilizing the feedstocks and producing a target product.
The balance between resource assimilation and product formulation can be more effectively
accomplished by co-culture engineering by distributing the complicated tasks to multiple strains.
The division of labor concept for microbial community engineering can be beneficial for
specificity control and production of esters. This chapter focuses on engineering microbial
syntrophic co-culture systems to produce esters by co-utilizing mixed sugars.

5.1 Motivation
Microbes naturally exist in populations and communities where the cells communicate each other
by exchanging metabolites and molecular signals. The communication often exhibits cooperative
behaviors that improve robustness of the system against environmental fluctuation228, 229. The
cooperative behaviors also enable performing functions that are difficult or even impossible for
individual strains230, 231.
In metabolic engineering and synthetic biology, a microbial co-culture comprising of
multiple strains has gained increasing interests to overcome many technical difficulties of
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engineering monoculture, consisting of one microbial strain232. Despite of successful expansion of
bioproducts, optimizing the biosynthetic pathways remains a major challenge for industrialization
of the bioprocess14. The pathway optimization in mono-culture has pursued engineering biological
parts such as promoter strength233, ribosomal binding site (RBS)234, and gene copy number235 that
are largely relied on availability of genetic tools and parts. Moreover, engineering of complicated
biosynthetic pathways involving multiple heterologous gene expression often leads to undesirable
outputs due to multiple reasons such as metabolic imbalance236, metabolic burden237, inefficient
utilization of resources238, which are not easily predictable. In contrast, co-culture engineering can
separate multiple functions into individually optimized strains by compartmentalizing the
molecular components of each pathway. By modularizing biosynthetic pathways, the co-culture
strategy can reduce metabolic burden on individual strains and tune cellular environments optimal
for specific reactions239. Also, pathway can be optimized simply adjusting population of the strain
without reliance on availability of the genetic tools and parts. The division of labor concept has
been experimentally demonstrated in many biochemical productions requiring a long linear
heterologous pathways such as n-butanol240, oxygenated taxanes241, muconic acid242, and
resveratrol243.
Co-culture engineering can be particularly advantageous when the biosynthetic pathway
has highly interconnected precursor pathways undergoing diverging and converging steps.
Microbial ester production pathway is an important example where precursor alcohol and acylCoA pathways are diverged from pyruvate or acetyl-CoA and then converged to esters by an
alcohol acyltransferase (AAT). The alcohol and acyl-CoA pathways can be engineered for
different chain length and isomeric structures which can be condensed together into combinatorial
numbers of different ester classes. Critical to the ester biosynthesis is achieving a desirable balance
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of the alcohol and acyl-CoA pathways for optimal production. However, engineering heterologous
long chain alcohol and acyl-CoA pathways in a single strain often imposes metabolic burden
impairing protein expression and cell viability244. As a result, few studies could engineer a single
strain to efficiently produce esters derived from long chain alcohol and acyl-CoA modules50, 65.
The innate modularity of ester biosynthesis pathway suggests that microbial co-culture
engineering can be a promising approach for diverse ester production. Particularly, orthogonal
pathway engineering of alcohol and acyl-CoA in individual strains can develop a flexible and
programmable ester biosynthesis platform by modular co-culture design. For example, a co-culture
with a specialized butanol producer and a valeryl-CoA producer can be designed to produce butyl
valerate, a fatty wax ester with fragrance, flavor and fuel applications62, from fermentation. The
CATec3 Y20F is a robust AAT compatible with a wide range of alcohols and acyl-CoAs as well
as microbial hosts59 that can help the modular co-culture design for combinatorial numbers of ester
production.
In this study, we demonstrated engineering of non-linear ester biosynthesis pathway by
designing a syntrophic E. coli-E. coli co-culture. As a proof-of-concept, we first developed an E.
coli modular chassis cell for glucose independent secondary sugar utilization. Using the platform,
we constructed an E. coli strain preferring xylose over glucose by antibiotics-free genome
engineering. The engineered strain avoided glucose induced carbon catabolite repression (CCR)
allowing design of synthetic E. coli- E.coli co-cultures for ester production. An engineered E. coliE.coli co-culture compartmenting isobutanol and butyryl-CoA pathways produced 392 mg/L of
isobutyl butyrate from glucose-xylose co-fermentation, reporting the highest production titers up
to date. This work presents a modular co-culture design platform for engineering various nonlinear ester biosynthesis pathways.
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5.2 Materials and methods
5.2.1 Bacterial strains and plasmids
The E. coli strains and plasmids used in this chapter were listed in Table 5-1.

5.2.2 Media and cultivation
E. coli strains were grown in lysogeny broth (LB) medium or M9 hybrid medium80 containing
glucose or xylose as carbon sources. For the ester production by co-culture, 25 g/L glucose and 10
g/L xylose, and 5 g/L yeast extract were used as major carbon and nitrogen sources. To increase
buffer capacity, 10 g/L MOPS were added as an additional buffering reagent. Antibiotics of 100
µg/mL ampicillin and/or 100 µg/mL spectinomycin and/or 50 µg/mL kanamycin were
supplemented to media when appropriate.

5.2.3 Genetic engineering of E. coli
E. coli genome engineering was carried out using the  red mediated recombineering method 245.
The plasmid pSIM6 was used to induce homologous recombination of double strand DNA into the
genome122 and pCP20 was used to induce the FLP-mediated recombineering for subsequent gene
deletions125. For the genome substitution of XylR mutant, cells were selected through multiple
passages of culture transfers in the M9 medium containing 5 g/L glucose and 5 g/L xylose mixture
and 1 g/L yeast extract. The primers used for the genetic engineering were listed in Table 5-2.
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Table 5-1: A list of plasmids and E. coli strains used in this study.
Name
Plasmids

Descriptions

Source

pET29a

pBR322 ori, KanR, lacI, T7lac promoter

Novagen

pET::GFP

pET29a::iLOV (GFP)

This study

pET::RFP

pET29a::mCHERRY (RFP)

This study

pETite*

pBR322 ori, AmpR, lacI, T7lac promoter

Novagen

pSIM6
pCP20

pSC101 repAts, Gam, Beta, Exo under the control of a
temperature sensitive promoter
repA101ts, CmR, AmpR, FLP recombinase under the control
of a temperature senstivie protmoer.

pHM47

pET23a::ilvC, ilvD, yqhD

pHS121

pRSFDuet-1::alsS::kivD

pDL3

pETite*PT7 ::atoB, hbd, crt, ter::PT7::saat

pHS116

pRSFDuet-1::catec3 Y20F

E. coli
Top10

BL21(DE3)

122

123

124

This study

This study

Host for molecular cloning, mcrA, ∆(mrr-hsdRMS- Invitrogen
mcrBC), Phi80lacZ(del)M15, ∆lacX74, deoR, recA1,
araD139, ∆(ara-leu)7697, galU, galK, rpsL(SmR), endA1,
nupG
F– ompT gal dcm lon hsdSB(rB–mB–) λ(DE3 [lacI Novagen
lacUV5-T7p07 ind1 sam7 nin5]) [malB+]K-12(λS)

HSEC0201

BL21(DE3) ΔadhE, Δdld

Chapter 3

HSEC0415

BL21(DE3) ΔadhE, Δdld, ΔptsI, Δglk

This study

HSEC0415xyl

HSEC0315 xylR::xylR R121C, P363S

This study

HSEC0403

BL21(DE3) ΔadhE, Δdld, ΔldhA, ΔackA-pta

Chapter 3

HSEC0916

HSEC0403 harboring pHM47 and pHS121

This study

HSEC1017

HSEC0315 harboring pDL3 and pHS116

This study
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5.2.4 Analytical methods
To quantify sugars and alcohols, HPLC system (Shimadzu Inc., MD, USA) was used. 600-750 L
of samples were centrifuged at 17,000 x g for 3 minutes followed by filtering through 0.2 micron
filters. The HPLC samples were run with 5 mM H2SO4 at 0.6 mL/min on an Aminex HPX-87H
(Biorad Inc., CA, USA) column at 50℃. Refractive index detector (RID) and ultra-violet detector
(UVD) at 220 nm were used to determine metabolite concentrations.
Isobutyl acetate and isobutyl butyrate were measured by GC (HP 6890, Agilent, CA, USA)
equipped with a MS (HP 5973, Agilent, CA, USA). For the GC system, the Zebron ZB-5
(Phenomenex, CA, USA) capillary column (30 m x 0.25 mm x 0.25 m) was used to separate
analytes, and helium was used as the carrier with a flow rate of 0.5 mL/min. The oven temperature
program was set as follows: 50℃ initial temperature, 1℃/min ramp up to 58℃, 25℃/min ramp
up to 235℃, 50℃/min ramp up to 300℃, and 2-minutes bake-out at 300oC. 1 L of sampled
hexadecane layer was injected into the column in the splitless mode with an injector temperature
of 280℃. For the MS system, selected ion mode (SIM) was used to detect and quantify esters.

5.3 Modular design of E.coli-E.coli syntrophic co-culture for
isobutyl butyrate production
5.3.1 Design of E. coli chassis for glucose-independent secondary sugar utilization
Capability of utilizing renewable organic wastes or agricultural materials as feedstocks is one of
the striking benefits of bioprocessing in a mode of biochemical production. The natural materials
are comprised of mixed nutrients which often need additional process to isolate each compound.
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Table 5-2: A list of primers used in this study. The bold and underlined letters indicate restriction
and site-directed mutation sites, respectively.
Primer
name
HS847
HS848
HS849
HS850

Primer sequence (5’ to 3’)

Description

GGTTCTTTTAAAAATCAGTCACAAGTAAGGTA
GGGTTATGGTGTAGGCTGGAGCTGCTTC
TGATCTTCTCCTAAGCAGTAAATTGGGCCGCA
TCTCGTGGACATATGAATATCCTCCTTA
AAGACGAGCAGAAAGCGG

ptsI deletion forward
ptsI deletion reverse
ptsI check upstream

AGTTCCGGTATCCTTCTTG
GAAAGAATTATTTTGACTTTAGCGGAGCAGTT
GAAGAATGGTGTAGGCTGGAGCTGCTTC
GATTATCGGGGAGAGTTACCTCCCGATATAAA
AGGAAGGATCATATGAATATCCTCCTTA

ptsI check downstream

HS845

GATATTTACAGGGAGCCTGCCTTTC

glk check upstream

HS846

ACGCAGGTCGGCCTTGTG

glk check downstream

HS740

TAACCTAGGCTGCTGCCACCGCTGAGCAAT

HS739

GTGGTGATGATGGTGATGGCTGCTGCCCATGG

HS843
HS844

HS741
HS742
HS902
HS903

CCATGGGCAGCAGCCATCACCATCATCACCAC
ATGAATTATACTAAATTCGATG
ATTGCTCAGCGGTGGCAGCAGCCTAGGTTA
TTACTTCAATTTCGAATTGCAG
CTCTGAGCTCAGGAAAAGAACCATGTTTACT
AAACGTCAC
AACCAGCGGCCGCCTACAACATGACCTCGCT
ATTTACATC

HS904

CGTTAACTGTTTTGCTTTTTATGGTCTTCCG

HS905

AAGCAAAACAGTTAACGCCTTTCTCTTTTAAA
TGC

HS906

CGGTTATTCCTCGCTGCAATATTTCTACTCTG

HS907

GCAGCGAGGAATAACCGCACATTTGCGATAT
C

HS908

AGGAAAAGAACCATGTTTACTAAACGTCAC

HS909

CTACAACATGACCTCGCTATTTACATC
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glk deletion forward
glk deletion reverse

pRSFDuet-1 backbone for
pHS116 forward
pRSFDuet-1 backbone for
pHS116 reverse
CATec3 Y20F for pHS116
forward
CATec3 Y20F for pHS116
reverse
XylR cloning in a plasmid
forward
XylR cloning in a plasmid
reverse
XylR R121C mutagenesis
forward
XylR R121C mutagenesis
reverse
XylR P363S mutagenesis
forward
XylR P363S mutagenesis
reverse
XylR PCR for
recombineering forward
XylR PCR for
recombineering reverse

A possible strategy to reduce the additional separation steps is to engineer microbial catalysts
consuming the mixed nutrients better, allowing use of the mixed nutrients as feedstocks.
Lignocellulose is a representative renewable and abundant biomass comprising a mixture
of fermentable hexose (e.g., glucose) and pentose (e.g., xylose, arabinose) sugars246. However,
most microbes have hierarchical sugar preferences inhibiting efficient utilization of the mixed
sugar. E. coli, for instance, consumes glucose first over the other sugars (e.g., xylose) due to the
cAMP-CRP associated carbon catabolite repression (CCR) (Figure 5-1). When glucose is present,
intracellular cAMP level decreases and the cAMP-CRP mediated transcription of catabolite genes
is inactivated, inhibiting the secondary sugar catabolism. In contrast, when glucose is absent but
other secondary sugars are present, cAMP-CRP mediated transcription is activated, expressing the
secondary sugar catabolic systems. The non-glucose sugars are ranked in a hierarchy that the
presence of higher sugar partially inhibits the expression of the lower sugar systems 247. The
intrinsic bias results in uneven sugar utilization that accumulates or wastes the less preferred sugars
during multiple industrially relevant fermentation processes (e.g., fed-batch and continuous
fermentation)248. Therefore, efficient fermentation of mixed sugars has been a major metabolic
engineering challenge249, 250.
Co-culture engineering is a promising approach for sugar co-utilization because each strain
can be designed to orthogonally consume each sugar, avoiding competition between the strains.
To establish a model system, various E. coli co-cultures have been demonstrated through extensive
disruption of sugar assimilation machineries of each strain242, 251. However, such strategy has
caveats such as remained CCR delaying the sugar consumption242 and compromised cellular
robustness caused by the extensive genetic manipulations252, 253. We hypothesized that engineering
the CCR mechanism will be more practical to develop co-culture strain modules for various
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biochemical production. Therefore, we aimed to design a platform E. coli chassis that can select
for regulatory protein mutants relieving the CCR.
We chose HSEC0201 as a starting strain that lacks adhE and dld and also produces longer
chain alcohol and/or acyl-CoA more effectively than the wild type BL21 strain (Figure 3-5B). We
disrupted glucose assimilation pathway by deleting ptsI and glk genes, generating HSEC0415
(ΔadhE Δdld, ΔptsI, Δglk) (Table 5-1). As expected, HSEC0415 was unable to grow in a glucose
medium (Figure 5-2A). The slight growth is likely due to yeast extract in the medium because
glucose was not consumed for the 50 hours (Figure 5-2B). When grown in a xylose medium,
HSEC0415 showed 4% less growth rate (0.62 ± 0.02, 1/h) than the growth rate of HSEC0201 (0.64
± 0.07, 1/h), suggesting that the effect of ptsI and glk deletion on xylose metabolism was minimal
(Figure 5-2C, D).

5.3.2 Genomic XylR substitution by growth selection in glucose-xylose medium
The ptsI deletion disrupts the phosphotransferase system (PTS) that is involved in cAMP synthesis
(Figure 5-3A). The decreased cAMP level significantly inhibits cAMP-CRP mediated activation
of secondary sugar operons. Because the cAMP-CRP complex is an initial trigger for the catabolic
gene expression, the ptsI deletion consequences inhibition of secondary sugar consumption
delaying cell growth in a glucose-secondary sugar mixed medium. We hypothesized that mutant
regulatory proteins increasing secondary sugar assimilation capability can be selected by
HSEC0415 in a medium containing glucose and a corresponding secondary sugar. To test the
hypothesis, we PCR amplified a XylR mutant (XylR R121C, P363S) that has higher binding
affinity to operator sequences of xyl operon254. Then, we introduced the PCR fragment to
HSEC0415 via recombineering followed by two subsequent overnight culture in a glucose-xylose
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Figure 5-1: A scheme of hierarchical sugar preference dictated by carbon catabolite repression.
The A0, B0, C0 represent regulatory proteins.
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Figure 5-2: Disruption of glucose assimilation pathway. (A) Cell growth in glucose medium. (B)
Residual glucose concentration in the medium during the culture. (C) Cell growth in xylose
medium. (D) Residual xylose concentration in the medium during the culture. (A-D) The data
represent mean ± 1stdev from three biological replicates.
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mixture M9 medium without antibiotics (Figure 5-3B). Sequencing results of the XylR region
from five isolated colonies revealed that two colonies obtained the XylR substitution in the genome,
suggesting that HSEC0415 platform successfully selected for the XylR mutant. To verify the
relieved CCR, we characterized cell growth and sugar consumption of HSEC0415 and
HSEC0415xyl in a glucose-xylose M9 medium (Figure 5-3C, D). As expected, HSEC0415
preferred xylose over glucose but the xylose consumption was significantly inhibited by the
presence of glucose due to the CCR (Figure 5-3C). In contrast, HSEC0415xyl bypassed the
glucose induced CCR, consuming 5 g/L of xylose in 12 hours (Figure 5-3D). Although HSEC0415
and HSEC0415xyl did not grow in a glucose only M9 medium for 72 hours, both strains consumed
glucose after depletion of xylose, suggesting that the ptsI and glk deletions did not eradicate the
glucose assimilation ability.
Overall, a glucose-independent, xylose-preferring E. coli was successfully constructed by
the genomic XylR mutation. The results suggest that HSEC0415 chassis can serve as a selection
platform for regulatory protein mutants relieving the glucose induced CCR.

5.3.3 Compartmentation of isobutyl butyrate pathway
The independent xylose consumption of HSEC0415xyl can minimize sugar competition in
a consortium, facilitating orthogonal sugar utilization. We next hypothesized that a synthetic E.
coli-E. coli syntrophic co-culture can compartment a non-linear ester biosynthesis pathway and
improve the production. To test the strategy, we designed a co-culture for isobutyl butyrate
production from glucose and xylose (Figure 5-4A). The co-culture compartments the isobutyl
butyrate pathway into two strains that prefer different sugars.
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Figure 5-3: Selection of a genomic XylR substitution avoiding glucose induced CCR using
HSEC0415. (A) A metabolic pathway map of glucose and xylose assimilation. The red cross marks
indicate deletion of ptsI and glk. When glucose is present, xylose consumption is inhibited by the
CCR. AC, adenylate cyclase; G3P, Glyceraldehyde-3-phoshpate; PEP, phosphoenolpyruvate. (B)
A workflow of genomic XylR mutagenesis in HSEC0415. (C) A profile of HSEC0415 cell growth,
glucose, and xylose concentration in a glucose-xylose medium. (D) A profile of HSEC0415xyl
cell growth, glucose, and xylose concentration in a glucose-xylose medium. (C-D) The data
represent mean ± 1stdev from three biological replicates.
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A strain is specialized to produce isobutanol (HSEC0916), while the other strain is specialized to
produce butyryl-CoA (HSEC1017) (Figure 5-4B). Because isobutanol is a more reduced product
requiring more carbon source than butyryl-CoA, we designed the glucose consuming strain to
produce isobutanol. To synthesize isobutyl butyrate, the butyryl-CoA producing strain should
express the AAT because butyryl-CoA cannot transfer to the other strain but isobutanol can. For a
high AAT activity, a SAAT from strawberry and an engineered CATec3 Y20F were co-expressed
because they are capable of synthesizing butyrate esters59, 65, 165.

5.3.4 Isobutyl butyrate production by E. coli-E.coli co-culture co-fermenting glucose
and xylose
The co-culture can produce isobutyl acetate as a byproduct because the AATs can condense
intracellular acetyl-CoA with isobutanol. Therefore, we tested whether the product specificity can
be engineered by controlling the population. We altered inoculation ratio and measured isobutyl
butyrate and isobutyl acetate production upon the different population (Figure 5-4C). Interestingly,
the higher HSEC0916 inoculation produced the more isobutyl acetate, while isobutyl butyrate
titers were not significantly changed. This suggests that the isobutanol pathway is not likely the
bottleneck. Isobutanol was accumulated up to 0.5 g/L from the 1:1 inoculum ratio, further
supporting that butyryl-CoA or AAT activity were likely the limiting step. The highest isobutyl
butyrate titer of 133 mg/L was achieved at 1:4 inoculum ratio, 11-fold higher titer than isobutyl
butyrate production from an engineered monoculture65. The dynamic isobutyl ester profile with
different inoculum ratio demonstrates that isobutyl ester production can be engineered by
controlling the population.

145

Because the co-culture at 1:4 ratio produced ~133 mg/L of isobutyl butyrate as the main
ester product, we investigated the system to further improve isobutyl butyrate production.
Although the M9 medium additionally contained 10 g/L of MOPS, the pH rapidly decreased below
5 after 48 hours, and the production did not proceed further. Therefore, we intermittently adjusted
the pH with 5M KOH every 12 hours, maintaining the pH between 6.0 to 7.0 (Figure 5-4D, E).
The pH adjustment avoided the fermentation cessation, producing 392 mg/L of isobutyl butyrate
for 96 hours (Figure 5-4D). The co-culture maintained steady production and sugar consumption
rates over the 96 hours (Figure 5-4E), suggesting that the population was well maintained over the
fermentation. During the culture, 9.2 g/L glucose and 6.4 g/L xylose were consumed at
consumption ratio of 0.69 (g xylose/g glucose).
Overall, design of a synthetic E. coli-E.coli co-culture produced isobutyl butyrate by cofermenting glucose and xylose with robust population over 96 hours. Because the individual strains
can be further engineered to produce other esters with non-linear biosynthesis pathways, the coculture strategy can be widely applicable to various ester production.

5.4 Conclusion
In this study, we engineered a syntrophic E.coli-E.coli co-culture for isobutyl butyrate production.
The co-culture simultaneously utilized glucose and xylose and produced isobutyl butyrate up to
392 mg/L which was 32-fold higher titer than a previously reported mono-culture65.
For a robust E.coli-E.coli co-culture, we developed an E. coli chassis cell capable of
selecting regulatory protein mutants allowing orthogonal sugar utilization in a consortium. Using
the platform, we could edit XylR from the E. coli genome without an antibiotic marker.

146

Figure 5-4: Designing a synthetic E.coli-E.coli co-culture for isobutyl butyrate production. (A) A
scheme of co-culture design for isobutyl butyrate production by co-utilization of glucose and
xylose (B) Compartmentation of non-linear isobutyl butyrate biosynthesis pathway to two strains.
(C) Titers of isobutyl acetate and isobutyl butyrate at different inoculum ratio after 48 hours. The
grey dotted line represents 50% (w/w) product specificity. (D) Titers of isobutyl butyrate upon pH
adjustment. The cell inoculum ratio was at 1:4 (strain A:B) (E) A profile of consumed glucose and
xylose over the culture. (C-E) The data represent mean ± 1stdev from three biological replicates.
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The engineered strain efficiently consumed xylose in the presence of glucose, formulating a robust
population steadily co-utilizing glucose and xylose over 96 hours. Because the glucose induced
CCR is a complicated mechanism, the E. coli chassis platform will be useful to engineer sugar
preference of individual E. coli strains employable to modular microbial co-culture designs.
The co-culture could produce isobutyl butyrate as a major ester product through the
relatively simple inoculation optimization. The results demonstrate viability of the coculture
strategy for optimizing pathway balance of non-linear ester pathway. Similarly, engineering of
non-linear rosmarinic acid pathway using microbial co-culture was recently demonstrated255,
suggesting viability of the co-culture strategy for pathway balance. Because many esters have
complicated non-linear precursor pathways, the co-culture strategy will be generally applicable for
production of esters difficult in monoculture systems (Figure 5-5).
The E.coli-E.coli co-culture can exemplify multiple synthetic and/or semi-synthetic coculture designs harnessing diverse microbes specialized to produce long chain alcohols and acylCoAs. For example, some non-model Clostridia species overproduce long chain alcohols and acylCoA from various resources including sugars, organic acids, and ethanol256-259 and therefore,
hijacking their metabolism can potentially expand biological routes for ester production. Because
of limited genetic tools and parts for the non-model microbes, engineering metabolism of
individual strains for optimal pathway balance is challenging. In contrast, co-culture engineering
can simplify the pathway balance and optimization by manipulating population via inoculation
engineering and environmental control. Taken altogether, modular co-culture design can tackle
many technical challenges of ester biosynthesis.
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Figure 5-5: Modular design of microbial co-cultures for ester production.
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6. Chapter 6. Conclusion and future directions
Engineering biological modules with high modularity offers distinct advantages for scalable design,
construction, operation, and maintenance of complex biological systems. As a testbed, this
dissertation engineered modularity of ester biosynthesis across biological scale for novel
biocatalysis.
At the molecular level, an AAT with high robustness, compatibility, and efficiency was
developed by engineering promiscuity of robust CAT enzymes. The AAT module exhibited
relatively good catalytic efficiency towards a broad range of alcohols and acyl-CoAs, enabling
combinatorial ester biosynthesis. The approach can lead to a breakthrough in microbial ester
production because the conventional eukaryotic AATs lack sufficient robustness, efficiency, and
compatibility for an interchangeable catalytic module as they commonly exhibit poor enzyme
expression66, solubility67, and thermostability68 in microbial hosts. Also, high stability and
promiscuity of CATs offer a better enzyme evolvability76-78 than eukaryotic AATs, enabling it to
tolerate more functionally beneficial but destabilizing mutations76. Such characteristics provoke
many interesting scientific questions including the possibility of refining CAT’s functions for
higher specificity against small alcohols (e.g., methanol, ethanol) and/or long chain acyl-CoAs.
Due to relative short amino acid length and well identified protein structures of CATs, additional
mutagenesis via rational design and/or directed evolution can further tune CATec3 Y20F for
specific ester production.
At the cellular level, mesophilic and thermophilic whole-cell biocatalysts were developed
for ester production. In a whole-cell biocatalyst, enzyme performance does not solely rely on
catalytic efficiency because of complicated reaction environments (e.g., intracellular enzyme
abundance, precursor availability, intracellular pH, and temperature). Particularly, the precursor
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alcohol and acyl-CoA should be sufficiently supplied with amplified metabolic flux for optimal
ester production. By using metabolic engineering and synthetic biology strategies, cellular
metabolism of E. coli and C. thermocellum was successfully rewired to overproduce medium chain
esters (C6-C8) from glucose and cellulose fermentation, respectively. The whole-cell biocatalysts
further demonstrated robustness, compatibility, and efficiency of the engineered ester biosynthesis
module by efficiently producing various esters at the cellular level.
Although biological roles of the volatile esters in microbes are highly debated and elusive
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, ester biosynthesis can improve fitness of the host cells by detoxifying toxic metabolites. It has

recently been shown that for the same total carbon chain length, short-chain esters are less toxic to
microbial health than alcohols127. Especially, esters are more hydrophobic than their precursor
alcohols, enabling easy extraction during fermentation process. Moreover, ester biosynthesis can
be beneficial for cellular robustness by controlling cellular metabolism. As shown in Figure 1-2,
alcohol and acyl-CoA biosynthesis pathways exhibit modularity that can be managed by an ester
biosynthesis module having a certain substrate specificity. For example, the reversal betaoxidation cycle requires a metabolite sink to prevent uncontrolled carbon elongation iterations52.
Esterification reaction of the alcohol and acyl-CoA can serve as a metabolic controller by
generating esters as the metabolite sinks.
Such evolutionary incentives can be harnessed to develop novel ester producing strains
using modular cell (MODCELL) engineering. Modular cell harnesses the compatibility between
the production module and chassis cell for pathway optimization. Computational metabolic
pathway modeling helps design of auxotrophic chassis cell requires the production module for
healthy cell growth27. Understanding evolutionary incentive of ester biosynthesis at the cellular
level will provide many insights on implementing the modular cell engineering for ester production.
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At the microbial community level, a synthetic microbial co-culture was engineered for
isobutyl butyrate production, which involves a complicated non-linear biosynthetic pathway. For
robust co-culture designs, an E. coli chassis platform was developed by disrupting glucose
assimilation pathways. The platform can select regulatory protein mutants that avoid glucose
induced CCR and improve assimilation of secondary sugars. The platform will be helpful to
construct E. coli modules that orthogonally utilize multiple sugars in a consortium.
Although the E. coli-E.coli co-culture produced about 30-fold higher titers of isobutyl
butyrate than an engineered monoculture, it has been not well understood why and how the division
of labor can relieve metabolic burden. For instance, a quantitative definition of metabolic burden
has not been established and therefore, analyzing the performance of co-cultures is somewhat
superficial. Therefore, it is an important future direction to quantify the metabolic burden in
heterologous pathway engineering. Systems biology techniques such as transcriptomics,
proteomics, and metabolomics can offer promising ways for the quantitative analysis of metabolic
burden. Especially, identifying biomarkers responding the metabolic burden will be a critical step.
While the study focused on finding a laboratory set up to understand microbial community
system better, the results provoke many fundamental questions. One of the important questions is
evolutionary incentives of ester production by microbes in a community. Because many esters
have pleasant odors, evolution of AATs can be promoted through selection by higher organisms’
sensation. A study successfully demonstrated that volatile ester formulation by a yeast promoted
cell dispersion mediated by insect vectors260, suggesting a hypothesis that the microbial ester
production might attract animal vectors and promote the cell dispersion. Selection of ester forming
beverage fermenting yeasts is a representative example where humans’ preferences on beer and
wine can deliver a significant evolutionary driving force261. It will be an interesting engineering
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problem to develop an AAT selection platform at a laboratory scale through the interkingdom
interactions.
In conclusion, engineering modularity of ester biosynthesis facilitated scalable engineering
of biological systems. Because many biochemical synthesis pathways naturally exhibit a certain
level of modularity, engineering strategies presented in this dissertation will be useful for
developing other biochemical production platforms.
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